<?xml version="1.0" encoding="UTF-8"?>
<!-- This is a template for a FHIR resource, and needs items (marked with "${}") replacing to make a real instance -->
<!-- The resulting instance is a Bundle of Bundles, each of which is a document (having a Composition, and supporting resources) -->
<!-- 2020-02-22 -->
<!-- This is for FHIR version R5 Preview 2 (May 2020) -->
<Bundle xmlns="http://hl7.org/fhir">
	<type value="collection"/>
	<!-- Repeat at this level per document -->
	<entry>
		<fullUrl value="urn:uuid:09021211-ec9f-42bd-952e-83fdf0510b42"/>
		<!-- Top level of each document is a also FHIR Bundle, of type "document"
		 see http://hl7.org/fhir/documents.html, http://hl7.org/fhir/bundle.html
	 	 All the other resources for this document are within this. -->
		<resource>
            <Bundle>
            	<!-- When PUTing, some servers mandate an id here to match the existing id -->
            	<id value="d87493dc-6d06-495e-bee2-6e6cc3e82c18"/>
				<!-- document bundles must have an identifier (bdl-9) -->
				<identifier>
					<!-- possibly different identifier types may be needed here -->
					<system value="http://ema.europa.eu/fhir/identifier/documentid"/>
					<value value="${instance.bundle[n].Identifier}"/>
				</identifier>
				<!-- fixed code -->
				<type value="document" /> 
            	<!-- document bundles must have a date (bdl-10) -->
            	<timestamp value="2021-05-11T20:25:07Z"/>
				<!-- a repeating set of entry elements, each with a FHIR resource inside -->
				<entry>
					<!-- fullUrl is mandatory for each entry in document Bundle. It is a random uuid. http://build.fhir.org/bundle.html#bundle-unique -->
					<fullUrl value="urn:uuid:3c1dc699-3b13-47dc-8a5b-aed72858bfc3"/>
					<resource>
						<!-- the first resource must be Composition (bdl-11) -->
						<!-- This is the overall document structure. -->
						<!-- see definition http://hl7.org/fhir/composition.html, and similar for other resources -->
                        <Composition>
                        	<!-- images if requied within html text of this document -->
							
							<contained>
                                <Binary>
                                	<id value="image0"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image009.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image009.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image0"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image1"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image010.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image010.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image1"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image2"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image011.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image011.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image2"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image3"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image012.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image012.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image3"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image4"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image013.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image013.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image4"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image5"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image014.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image014.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image5"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image6"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image015.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image015.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image6"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image7"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image016.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image016.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image7"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image8"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image017.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image017.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image8"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image9"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image018.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image018.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image9"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image10"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image019.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image019.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image10"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image11"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image020.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image020.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image11"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image12"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image021.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image021.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image12"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image13"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image022.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image022.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image13"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image14"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image023.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image023.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image14"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image15"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image024.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image024.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image15"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image16"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image025.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image025.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image16"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image17"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image026.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image026.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image17"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image18"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image027.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image027.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image18"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image19"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image028.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image028.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image19"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image20"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image029.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image029.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image20"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image21"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image030.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image030.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image21"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image22"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image031.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image031.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image22"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image23"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image032.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image032.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image23"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image24"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image033.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image033.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image24"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image25"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image034.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image034.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image25"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image26"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image009.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image009.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image26"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image27"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image009.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image009.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image27"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image28"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image010.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image010.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image28"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image29"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image011.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image011.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image29"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image30"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image011.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image011.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image30"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image31"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image012.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image012.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image31"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image32"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image013.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image013.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image32"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image33"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image014.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image014.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image33"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image34"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image015.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image015.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image34"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image35"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image016.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image016.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image35"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image36"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image017.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image017.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image36"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image37"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image018.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image018.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image37"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image38"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image019.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image019.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image38"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image39"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image020.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image020.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image39"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image40"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image021.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image021.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image40"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image41"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image022.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image022.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image41"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image42"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image023.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image023.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image42"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image43"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image024.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image024.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image43"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image44"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image025.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image025.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image44"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image45"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image026.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image026.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image45"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image46"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image027.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image027.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image46"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image47"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image028.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image028.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image47"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image48"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image029.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image029.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image48"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image49"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image030.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image030.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image49"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image50"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image031.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image031.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image50"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image51"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image032.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image032.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image51"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image52"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image033.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image033.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image52"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image53"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image034.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image034.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image53"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image54"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image035.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image035.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image54"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image55"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image036.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image036.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image55"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image56"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image037.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image037.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image56"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image57"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image038.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image038.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image57"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image58"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image039.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image039.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image58"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image59"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image040.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image040.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image59"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image60"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image041.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image041.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image60"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image61"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image042.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image042.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image61"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image62"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image043.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image043.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image62"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image63"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image044.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image044.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image63"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image64"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image045.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image045.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image64"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image65"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image046.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image046.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image65"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image66"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image047.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image047.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image66"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image67"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image048.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image048.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image67"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image68"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image049.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image049.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image68"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image69"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image050.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image050.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image69"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image70"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image050.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image050.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image70"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image71"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image051.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image051.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image71"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image72"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image052.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image052.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image72"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image73"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image053.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image053.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image73"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image74"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image054.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image054.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image74"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image75"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image032.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image032.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image75"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image76"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image055.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image055.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image76"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image77"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image056.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image056.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image77"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image78"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image035.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image035.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image78"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image79"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image036.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image036.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image79"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image80"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image036.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image036.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image80"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image81"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image037.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image037.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image81"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image82"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image038.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image038.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image82"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image83"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image037.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image037.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image83"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image84"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image038.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image038.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image84"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image85"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image039.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image039.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image85"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image86"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image040.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image040.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image86"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image87"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image041.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image041.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image87"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image88"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image042.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image042.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image88"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image89"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image043.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image043.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image89"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image90"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image044.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image044.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image90"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image91"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image045.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image045.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image91"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image92"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image046.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image046.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image92"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image93"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image047.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image047.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image93"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image94"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image048.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image048.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image94"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image95"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image049.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image049.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image95"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image96"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image050.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image050.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image96"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image97"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image050.gif"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image050.gif"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image97"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image98"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image051.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image051.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image98"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image99"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image052.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image052.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image99"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image100"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image053.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image053.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image100"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image101"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image054.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image054.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image101"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image102"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image032.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image032.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image102"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image103"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image055.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image055.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image103"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image104"/>
                                	<!-- example format -->
                                	<contentType value="Abasaglar-h-2835-en_files/image056.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="Abasaglar-h-2835-en_files/image056.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image104"/>
                        		</valueReference>
               </extension>
              
              
              <contained>
                          <Binary>
                            <id value="stylesheet0"/>
                            <!-- example format -->
                            <contentType value="stylesheet/css"/>
                            <!-- data is base 64 encoded, actual bytes of the image png file -->
                            <data value="<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:BISansCond;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;}
@font-face
	{font-family:"Bahnschrift Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Bahnschrift;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight SemiConde";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold SemiConden";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Light Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiLight Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Bahnschrift SemiBold Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Candara Light";
	panose-1:2 14 5 2 3 3 3 2 2 4;}
@font-face
	{font-family:"Comic Sans MS";
	panose-1:3 15 7 2 3 3 2 2 2 4;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
	{font-family:Constantia;
	panose-1:2 3 6 2 5 3 6 3 3 3;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"Corbel Light";
	panose-1:2 11 3 3 2 2 4 2 2 4;}
@font-face
	{font-family:Ebrima;
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Franklin Gothic Medium";
	panose-1:2 11 6 3 2 1 2 2 2 4;}
@font-face
	{font-family:Gabriola;
	panose-1:4 4 6 5 5 16 2 2 13 2;}
@font-face
	{font-family:Gadugi;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;}
@font-face
	{font-family:Impact;
	panose-1:2 11 8 6 3 9 2 5 2 4;}
@font-face
	{font-family:"Ink Free";
	panose-1:3 8 4 2 0 5 0 0 0 0;}
@font-face
	{font-family:"Javanese Text";
	panose-1:2 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Leelawadee UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Leelawadee UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Lucida Console";
	panose-1:2 11 6 9 4 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;}
@font-face
	{font-family:"\@Malgun Gothic";}
@font-face
	{font-family:"Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Malgun Gothic Semilight";}
@font-face
	{font-family:"Microsoft Himalaya";
	panose-1:1 1 1 0 1 1 1 1 1 1;}
@font-face
	{font-family:"Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei";}
@font-face
	{font-family:"Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI";}
@font-face
	{font-family:"Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei Light";}
@font-face
	{font-family:"Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;}
@font-face
	{font-family:"\@Microsoft JhengHei UI Light";}
@font-face
	{font-family:"Microsoft New Tai Lue";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft PhagsPa";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Microsoft Tai Le";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei";}
@font-face
	{font-family:"Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;}
@font-face
	{font-family:"\@Microsoft YaHei UI";}
@font-face
	{font-family:"Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei Light";}
@font-face
	{font-family:"Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@Microsoft YaHei UI Light";}
@font-face
	{font-family:"Microsoft Yi Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:MingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU-ExtB";}
@font-face
	{font-family:PMingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@PMingLiU-ExtB";}
@font-face
	{font-family:MingLiU_HKSCS-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MingLiU_HKSCS-ExtB";}
@font-face
	{font-family:"Mongolian Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:"MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS UI Gothic";}
@font-face
	{font-family:"MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;}
@font-face
	{font-family:"\@MS PGothic";}
@font-face
	{font-family:"MV Boli";
	panose-1:2 0 5 0 3 2 0 9 0 0;}
@font-face
	{font-family:"Myanmar Text";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Nirmala UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Segoe Print";
	panose-1:2 0 6 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Segoe Script";
	panose-1:3 11 5 4 2 0 0 0 0 3;}
@font-face
	{font-family:"Segoe UI Black";
	panose-1:2 11 10 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Historic";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:NSimSun;
	panose-1:2 1 6 9 3 1 1 1 1 1;}
@font-face
	{font-family:"\@NSimSun";}
@font-face
	{font-family:SimSun-ExtB;
	panose-1:2 1 6 9 6 1 1 1 1 1;}
@font-face
	{font-family:"\@SimSun-ExtB";}
@font-face
	{font-family:"Sitka Small";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Text";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Subheading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Heading";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Display";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Sitka Banner";
	panose-1:2 0 5 5 0 0 0 2 0 4;}
@font-face
	{font-family:"Trebuchet MS";
	panose-1:2 11 6 3 2 2 2 2 2 4;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;}
@font-face
	{font-family:"\@Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI";}
@font-face
	{font-family:"Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semibold";}
@font-face
	{font-family:"Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Light";}
@font-face
	{font-family:"Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Light";}
@font-face
	{font-family:"Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic Medium";}
@font-face
	{font-family:"Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semilight";}
@font-face
	{font-family:"HoloLens MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;}
@font-face
	{font-family:"Agency FB";
	panose-1:2 11 5 3 2 2 2 2 2 4;}
@font-face
	{font-family:Algerian;
	panose-1:4 2 7 5 4 10 2 6 7 2;}
@font-face
	{font-family:"Book Antiqua";
	panose-1:2 4 6 2 5 3 5 3 3 4;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;}
@font-face
	{font-family:"Arial Rounded MT Bold";
	panose-1:2 15 7 4 3 5 4 3 2 4;}
@font-face
	{font-family:"Baskerville Old Face";
	panose-1:2 2 6 2 8 5 5 2 3 3;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;}
@font-face
	{font-family:"Bell MT";
	panose-1:2 2 5 3 6 3 5 2 3 3;}
@font-face
	{font-family:"Bernard MT Condensed";
	panose-1:2 5 8 6 6 9 5 2 4 4;}
@font-face
	{font-family:"Bodoni MT";
	panose-1:2 7 6 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Black";
	panose-1:2 7 10 3 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Condensed";
	panose-1:2 7 6 6 8 6 6 2 2 3;}
@font-face
	{font-family:"Bodoni MT Poster Compressed";
	panose-1:2 7 7 6 8 6 1 5 2 4;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;}
@font-face
	{font-family:"Bradley Hand ITC";
	panose-1:3 7 4 2 5 3 2 3 2 3;}
@font-face
	{font-family:"Britannic Bold";
	panose-1:2 11 9 3 6 7 3 2 2 4;}
@font-face
	{font-family:"Berlin Sans FB";
	panose-1:2 14 6 2 2 5 2 2 3 6;}
@font-face
	{font-family:"Berlin Sans FB Demi";
	panose-1:2 14 8 2 2 5 2 2 3 6;}
@font-face
	{font-family:Broadway;
	panose-1:4 4 9 5 8 11 2 2 5 2;}
@font-face
	{font-family:"Brush Script MT";
	panose-1:3 6 8 2 4 4 6 7 3 4;}
@font-face
	{font-family:"Bookshelf Symbol 7";
	panose-1:5 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Californian FB";
	panose-1:2 7 4 3 6 8 11 3 2 4;}
@font-face
	{font-family:"Calisto MT";
	panose-1:2 4 6 3 5 5 5 3 3 4;}
@font-face
	{font-family:Castellar;
	panose-1:2 10 4 2 6 4 6 1 3 1;}
@font-face
	{font-family:"Century Schoolbook";
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:Centaur;
	panose-1:2 3 5 4 5 2 5 2 3 4;}
@font-face
	{font-family:Chiller;
	panose-1:4 2 4 4 3 16 7 2 6 2;}
@font-face
	{font-family:"Colonna MT";
	panose-1:4 2 8 5 6 2 2 3 2 3;}
@font-face
	{font-family:"Cooper Black";
	panose-1:2 8 9 4 4 3 11 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Bold";
	panose-1:2 14 7 5 2 2 6 2 4 4;}
@font-face
	{font-family:"Copperplate Gothic Light";
	panose-1:2 14 5 7 2 2 6 2 4 4;}
@font-face
	{font-family:"Curlz MT";
	panose-1:4 4 4 4 5 7 2 2 2 2;}
@font-face
	{font-family:Dubai;
	panose-1:2 11 5 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Light";
	panose-1:2 11 3 3 3 4 3 3 2 4;}
@font-face
	{font-family:"Dubai Medium";
	panose-1:2 11 6 3 3 4 3 3 2 4;}
@font-face
	{font-family:Elephant;
	panose-1:2 2 9 4 9 5 5 2 3 3;}
@font-face
	{font-family:"Engravers MT";
	panose-1:2 9 7 7 8 5 5 2 3 4;}
@font-face
	{font-family:"Eras Bold ITC";
	panose-1:2 11 9 7 3 5 4 2 2 4;}
@font-face
	{font-family:"Eras Demi ITC";
	panose-1:2 11 8 5 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Light ITC";
	panose-1:2 11 4 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Eras Medium ITC";
	panose-1:2 11 6 2 3 5 4 2 8 4;}
@font-face
	{font-family:"Felix Titling";
	panose-1:4 6 5 5 6 2 2 2 10 4;}
@font-face
	{font-family:Forte;
	panose-1:3 6 9 2 4 5 2 7 2 3;}
@font-face
	{font-family:"Franklin Gothic Book";
	panose-1:2 11 5 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi";
	panose-1:2 11 7 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Demi Cond";
	panose-1:2 11 7 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Heavy";
	panose-1:2 11 9 3 2 1 2 2 2 4;}
@font-face
	{font-family:"Franklin Gothic Medium Cond";
	panose-1:2 11 6 6 3 4 2 2 2 4;}
@font-face
	{font-family:"Freestyle Script";
	panose-1:3 8 4 2 3 2 5 11 4 4;}
@font-face
	{font-family:"French Script MT";
	panose-1:3 2 4 2 4 6 7 4 6 5;}
@font-face
	{font-family:"Footlight MT Light";
	panose-1:2 4 6 2 6 3 10 2 3 4;}
@font-face
	{font-family:Garamond;
	panose-1:2 2 4 4 3 3 1 1 8 3;}
@font-face
	{font-family:Gigi;
	panose-1:4 4 5 4 6 16 7 2 13 2;}
@font-face
	{font-family:"Gill Sans MT";
	panose-1:2 11 5 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans MT Condensed";
	panose-1:2 11 5 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold Condensed";
	panose-1:2 11 10 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Gill Sans Ultra Bold";
	panose-1:2 11 10 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Gloucester MT Extra Condensed";
	panose-1:2 3 8 8 2 6 1 1 1 1;}
@font-face
	{font-family:"Gill Sans MT Ext Condensed Bold";
	panose-1:2 11 9 2 2 1 4 2 2 3;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;}
@font-face
	{font-family:"Goudy Old Style";
	panose-1:2 2 5 2 5 3 5 2 3 3;}
@font-face
	{font-family:"Goudy Stout";
	panose-1:2 2 9 4 7 3 11 2 4 1;}
@font-face
	{font-family:"Harlow Solid Italic";
	panose-1:4 3 6 4 2 15 2 2 13 2;}
@font-face
	{font-family:Harrington;
	panose-1:4 4 5 5 5 10 2 2 7 2;}
@font-face
	{font-family:Haettenschweiler;
	panose-1:2 11 7 6 4 9 2 6 2 4;}
@font-face
	{font-family:"High Tower Text";
	panose-1:2 4 5 2 5 5 6 3 3 3;}
@font-face
	{font-family:"Imprint MT Shadow";
	panose-1:4 2 6 5 6 3 3 3 2 2;}
@font-face
	{font-family:"Informal Roman";
	panose-1:3 6 4 2 3 4 6 11 2 4;}
@font-face
	{font-family:"Blackadder ITC";
	panose-1:4 2 5 5 5 16 7 2 13 2;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;}
@font-face
	{font-family:"Kristen ITC";
	panose-1:3 5 5 2 4 2 2 3 2 2;}
@font-face
	{font-family:Jokerman;
	panose-1:4 9 6 5 6 13 6 2 7 2;}
@font-face
	{font-family:"Juice ITC";
	panose-1:4 4 4 3 4 10 2 2 2 2;}
@font-face
	{font-family:"Kunstler Script";
	panose-1:3 3 4 2 2 6 7 13 13 6;}
@font-face
	{font-family:"Wide Latin";
	panose-1:2 10 10 7 5 5 5 2 4 4;}
@font-face
	{font-family:"Lucida Bright";
	panose-1:2 4 6 2 5 5 5 2 3 4;}
@font-face
	{font-family:"Lucida Calligraphy";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Fax";
	panose-1:2 6 6 2 5 5 5 2 2 4;}
@font-face
	{font-family:"Lucida Handwriting";
	panose-1:3 1 1 1 1 1 1 1 1 1;}
@font-face
	{font-family:"Lucida Sans";
	panose-1:2 11 6 2 3 5 4 2 2 4;}
@font-face
	{font-family:"Lucida Sans Typewriter";
	panose-1:2 11 5 9 3 5 4 3 2 4;}
@font-face
	{font-family:Magneto;
	panose-1:4 3 8 5 5 8 2 2 13 2;}
@font-face
	{font-family:"Maiandra GD";
	panose-1:2 14 5 2 3 3 8 2 2 4;}
@font-face
	{font-family:"Matura MT Script Capitals";
	panose-1:3 2 8 2 6 6 2 7 2 2;}
@font-face
	{font-family:Mistral;
	panose-1:3 9 7 2 3 4 7 2 4 3;}
@font-face
	{font-family:"Modern No\. 20";
	panose-1:2 7 7 4 7 5 5 2 3 3;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;}
@font-face
	{font-family:"Niagara Engraved";
	panose-1:4 2 5 2 7 7 3 3 2 2;}
@font-face
	{font-family:"Niagara Solid";
	panose-1:4 2 5 2 7 7 2 2 2 2;}
@font-face
	{font-family:"OCR A Extended";
	panose-1:2 1 5 9 2 1 2 1 3 3;}
@font-face
	{font-family:"Old English Text MT";
	panose-1:3 4 9 2 4 5 8 3 8 6;}
@font-face
	{font-family:Onyx;
	panose-1:4 5 6 2 8 7 2 2 2 3;}
@font-face
	{font-family:"MS Outlook";
	panose-1:5 1 1 0 1 0 0 0 0 0;}
@font-face
	{font-family:"Palace Script MT";
	panose-1:3 3 3 2 2 6 7 12 11 5;}
@font-face
	{font-family:Papyrus;
	panose-1:3 7 5 2 6 5 2 3 2 5;}
@font-face
	{font-family:Parchment;
	panose-1:3 4 6 2 4 7 8 4 8 4;}
@font-face
	{font-family:Perpetua;
	panose-1:2 2 5 2 6 4 1 2 3 3;}
@font-face
	{font-family:"Perpetua Titling MT";
	panose-1:2 2 5 2 6 5 5 2 8 4;}
@font-face
	{font-family:Playbill;
	panose-1:4 5 6 3 10 6 2 2 2 2;}
@font-face
	{font-family:"Poor Richard";
	panose-1:2 8 5 2 5 5 5 2 7 2;}
@font-face
	{font-family:Pristina;
	panose-1:3 6 4 2 4 4 6 8 2 4;}
@font-face
	{font-family:"Rage Italic";
	panose-1:3 7 5 2 4 5 7 7 3 4;}
@font-face
	{font-family:Ravie;
	panose-1:4 4 8 5 5 8 9 2 6 2;}
@font-face
	{font-family:"MS Reference Sans Serif";
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"MS Reference Specialty";
	panose-1:5 0 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Rockwell Condensed";
	panose-1:2 6 6 3 5 4 5 2 1 4;}
@font-face
	{font-family:Rockwell;
	panose-1:2 6 6 3 2 2 5 2 4 3;}
@font-face
	{font-family:"Rockwell Extra Bold";
	panose-1:2 6 9 3 4 5 5 2 4 3;}
@font-face
	{font-family:"Script MT Bold";
	panose-1:3 4 6 2 4 6 7 8 9 4;}
@font-face
	{font-family:"Showcard Gothic";
	panose-1:4 2 9 4 2 1 2 2 6 4;}
@font-face
	{font-family:"Snap ITC";
	panose-1:4 4 10 7 6 10 2 2 2 2;}
@font-face
	{font-family:Stencil;
	panose-1:4 4 9 5 13 8 2 2 4 4;}
@font-face
	{font-family:"Tw Cen MT";
	panose-1:2 11 6 2 2 1 4 2 6 3;}
@font-face
	{font-family:"Tw Cen MT Condensed";
	panose-1:2 11 6 6 2 1 4 2 2 3;}
@font-face
	{font-family:"Tw Cen MT Condensed Extra Bold";
	panose-1:2 11 8 3 2 2 2 2 2 4;}
@font-face
	{font-family:"Tempus Sans ITC";
	panose-1:4 2 4 4 3 13 7 2 2 2;}
@font-face
	{font-family:"Viner Hand ITC";
	panose-1:3 7 5 2 3 5 2 2 2 3;}
@font-face
	{font-family:Vivaldi;
	panose-1:3 2 6 2 5 5 6 9 8 4;}
@font-face
	{font-family:"Vladimir Script";
	panose-1:3 5 4 2 4 4 7 7 3 5;}
@font-face
	{font-family:"Wingdings 2";
	panose-1:5 2 1 2 1 5 7 7 7 7;}
@font-face
	{font-family:"Wingdings 3";
	panose-1:5 4 1 2 1 8 7 7 7 7;}
@font-face
	{font-family:AngsanaUPC;}
@font-face
	{font-family:CordiaUPC;}
@font-face
	{font-family:Abadi;}
@font-face
	{font-family:"Abadi Extra Light";}
@font-face
	{font-family:Aharoni;}
@font-face
	{font-family:Aldhabi;}
@font-face
	{font-family:Aparajita;}
@font-face
	{font-family:"Arabic Typesetting";}
@font-face
	{font-family:"Arial Nova";}
@font-face
	{font-family:"Arial Nova Cond";}
@font-face
	{font-family:"Arial Nova Cond Light";}
@font-face
	{font-family:"Arial Nova Light";}
@font-face
	{font-family:"Avenir Next LT Pro";}
@font-face
	{font-family:"Avenir Next LT Pro Light";}
@font-face
	{font-family:BatangChe;}
@font-face
	{font-family:Bembo;}
@font-face
	{font-family:Biome;}
@font-face
	{font-family:"Biome Light";}
@font-face
	{font-family:"Browallia New";}
@font-face
	{font-family:BrowalliaUPC;}
@font-face
	{font-family:Cavolini;}
@font-face
	{font-family:Dante;}
@font-face
	{font-family:DaunPenh;}
@font-face
	{font-family:David;}
@font-face
	{font-family:Daytona;}
@font-face
	{font-family:"Daytona Condensed";}
@font-face
	{font-family:"Daytona Condensed Light";}
@font-face
	{font-family:"Daytona Light";}
@font-face
	{font-family:"DengXian Light";}
@font-face
	{font-family:DilleniaUPC;}
@font-face
	{font-family:DokChampa;}
@font-face
	{font-family:DotumChe;}
@font-face
	{font-family:"Elephant Pro";}
@font-face
	{font-family:EucrosiaUPC;}
@font-face
	{font-family:Euphemia;}
@font-face
	{font-family:FangSong;}
@font-face
	{font-family:FrankRuehl;}
@font-face
	{font-family:FreesiaUPC;}
@font-face
	{font-family:"Georgia Pro";}
@font-face
	{font-family:"Georgia Pro Black";}
@font-face
	{font-family:"Georgia Pro Cond";}
@font-face
	{font-family:"Georgia Pro Cond Black";}
@font-face
	{font-family:"Georgia Pro Cond Light";}
@font-face
	{font-family:"Georgia Pro Cond Semibold";}
@font-face
	{font-family:"Georgia Pro Light";}
@font-face
	{font-family:"Georgia Pro Semibold";}
@font-face
	{font-family:"Gill Sans Nova";}
@font-face
	{font-family:"Gill Sans Nova Cond";}
@font-face
	{font-family:"Gill Sans Nova Cond Lt";}
@font-face
	{font-family:"Gill Sans Nova Cond Ultra Bold";}
@font-face
	{font-family:"Gill Sans Nova Cond XBd";}
@font-face
	{font-family:"Gill Sans Nova Light";}
@font-face
	{font-family:"Gill Sans Nova Ultra Bold";}
@font-face
	{font-family:Gisha;}
@font-face
	{font-family:Grotesque;}
@font-face
	{font-family:"Grotesque Light";}
@font-face
	{font-family:GulimChe;}
@font-face
	{font-family:Gungsuh;}
@font-face
	{font-family:GungsuhChe;}
@font-face
	{font-family:"Hadassah Friedlaender";}
@font-face
	{font-family:HGGothicE;}
@font-face
	{font-family:HGMaruGothicMPRO;}
@font-face
	{font-family:HGMinchoE;}
@font-face
	{font-family:HGPGothicE;}
@font-face
	{font-family:HGPMinchoE;}
@font-face
	{font-family:HGPSoeiKakugothicUB;}
@font-face
	{font-family:HGSGothicE;}
@font-face
	{font-family:HGSMinchoE;}
@font-face
	{font-family:HGSoeiKakugothicUB;}
@font-face
	{font-family:HGSSoeiKakugothicUB;}
@font-face
	{font-family:IrisUPC;}
@font-face
	{font-family:"Iskoola Pota";}
@font-face
	{font-family:JasmineUPC;}
@font-face
	{font-family:KaiTi;}
@font-face
	{font-family:Kalinga;}
@font-face
	{font-family:Kartika;}
@font-face
	{font-family:"Khmer UI";}
@font-face
	{font-family:Kigelia;}
@font-face
	{font-family:"Kigelia Arabic";}
@font-face
	{font-family:"Kigelia Arabic Light";}
@font-face
	{font-family:"Kigelia Light";}
@font-face
	{font-family:KodchiangUPC;}
@font-face
	{font-family:Kokila;}
@font-face
	{font-family:"Lao UI";}
@font-face
	{font-family:Leelawadee;}
@font-face
	{font-family:"Levenim MT";}
@font-face
	{font-family:LilyUPC;}
@font-face
	{font-family:"Mangal Pro";}
@font-face
	{font-family:Meiryo;}
@font-face
	{font-family:"Meiryo UI";}
@font-face
	{font-family:"Microsoft GothicNeo";}
@font-face
	{font-family:"Microsoft GothicNeo Light";}
@font-face
	{font-family:"Microsoft Uighur";}
@font-face
	{font-family:MingLiU_HKSCS;}
@font-face
	{font-family:Miriam;}
@font-face
	{font-family:"Miriam Fixed";}
@font-face
	{font-family:"Modern Love";}
@font-face
	{font-family:"Modern Love Caps";}
@font-face
	{font-family:"Modern Love Grunge";}
@font-face
	{font-family:MoolBoran;}
@font-face
	{font-family:"MS PMincho";}
@font-face
	{font-family:"MT Extra";}
@font-face
	{font-family:Narkisim;}
@font-face
	{font-family:"Neue Haas Grotesk Text Pro";}
@font-face
	{font-family:"News Gothic MT";}
@font-face
	{font-family:Nyala;}
@font-face
	{font-family:OCRB;}
@font-face
	{font-family:"Plantagenet Cherokee";}
@font-face
	{font-family:Posterama;}
@font-face
	{font-family:"Quire Sans";}
@font-face
	{font-family:"Quire Sans Light";}
@font-face
	{font-family:"Quire Sans Pro Light";}
@font-face
	{font-family:"Rockwell Light";}
@font-face
	{font-family:"Rockwell Nova";}
@font-face
	{font-family:"Rockwell Nova Cond";}
@font-face
	{font-family:"Rockwell Nova Cond Light";}
@font-face
	{font-family:"Rockwell Nova Extra Bold";}
@font-face
	{font-family:"Rockwell Nova Light";}
@font-face
	{font-family:Rod;}
@font-face
	{font-family:"Sabon Next LT";}
@font-face
	{font-family:"Sagona Book";}
@font-face
	{font-family:"Sagona ExtraLight";}
@font-face
	{font-family:"Sakkal Majalla";}
@font-face
	{font-family:"Sanskrit Text";}
@font-face
	{font-family:Selawik;}
@font-face
	{font-family:"Selawik Light";}
@font-face
	{font-family:"Selawik Semibold";}
@font-face
	{font-family:"Shonar Bangla";}
@font-face
	{font-family:"Simplified Arabic";}
@font-face
	{font-family:"Simplified Arabic Fixed";}
@font-face
	{font-family:"Sitka Banner Semibold";}
@font-face
	{font-family:"Sitka Display Semibold";}
@font-face
	{font-family:"Sitka Heading Semibold";}
@font-face
	{font-family:"Sitka Small Semibold";}
@font-face
	{font-family:"Sitka Subheading Semibold";}
@font-face
	{font-family:"Sitka Text Semibold";}
@font-face
	{font-family:"Source Sans Pro";}
@font-face
	{font-family:"Source Sans Pro Black";}
@font-face
	{font-family:"Source Sans Pro ExtraLight";}
@font-face
	{font-family:"Source Sans Pro Light";}
@font-face
	{font-family:"Source Sans Pro SemiBold";}
@font-face
	{font-family:"Speak Pro";}
@font-face
	{font-family:"Speak Pro Light";}
@font-face
	{font-family:STCaiyun;}
@font-face
	{font-family:STFangsong;}
@font-face
	{font-family:STHupo;}
@font-face
	{font-family:STKaiti;}
@font-face
	{font-family:STXihei;}
@font-face
	{font-family:STXingkai;}
@font-face
	{font-family:STXinwei;}
@font-face
	{font-family:STZhongsong;}
@font-face
	{font-family:"TH SarabunPSK";}
@font-face
	{font-family:"The Hand";}
@font-face
	{font-family:"The Hand Black";}
@font-face
	{font-family:"The Hand Extrablack";}
@font-face
	{font-family:"The Hand Light";}
@font-face
	{font-family:"The Serif Hand";}
@font-face
	{font-family:"The Serif Hand Black";}
@font-face
	{font-family:"The Serif Hand Extrablack";}
@font-face
	{font-family:"The Serif Hand Light";}
@font-face
	{font-family:"Tisa Offc Serif Pro";}
@font-face
	{font-family:"Tisa Offc Serif Pro Thin";}
@font-face
	{font-family:"Trade Gothic Next";}
@font-face
	{font-family:"Trade Gothic Next Cond";}
@font-face
	{font-family:"Trade Gothic Next Cond Hv";}
@font-face
	{font-family:"Trade Gothic Next Heavy";}
@font-face
	{font-family:"Trade Gothic Next Light";}
@font-face
	{font-family:"Traditional Arabic";}
@font-face
	{font-family:"UD Digi Kyokasho N-B";}
@font-face
	{font-family:"UD Digi Kyokasho N-R";}
@font-face
	{font-family:"UD Digi Kyokasho NK-B";}
@font-face
	{font-family:"UD Digi Kyokasho NK-R";}
@font-face
	{font-family:"UD Digi Kyokasho NP-B";}
@font-face
	{font-family:"UD Digi Kyokasho NP-R";}
@font-face
	{font-family:Univers;}
@font-face
	{font-family:"Univers Condensed";}
@font-face
	{font-family:"Univers Condensed Light";}
@font-face
	{font-family:"Univers Light";}
@font-face
	{font-family:"Urdu Typesetting";}
@font-face
	{font-family:Utsaah;}
@font-face
	{font-family:Vani;}
@font-face
	{font-family:"Verdana Pro";}
@font-face
	{font-family:"Verdana Pro Black";}
@font-face
	{font-family:"Verdana Pro Cond";}
@font-face
	{font-family:"Verdana Pro Cond Black";}
@font-face
	{font-family:"Verdana Pro Cond Light";}
@font-face
	{font-family:"Verdana Pro Cond SemiBold";}
@font-face
	{font-family:"Verdana Pro Light";}
@font-face
	{font-family:"Verdana Pro SemiBold";}
@font-face
	{font-family:Vijaya;}
@font-face
	{font-family:"Walbaum Display";}
@font-face
	{font-family:"Walbaum Display Heavy";}
@font-face
	{font-family:"Walbaum Display Light";}
@font-face
	{font-family:"Walbaum Display SemiBold";}
@font-face
	{font-family:"Walbaum Heading";}
@font-face
	{font-family:"Walbaum Text";}
@font-face
	{font-family:"Yu Mincho";}
@font-face
	{font-family:"Yu Mincho Demibold";}
@font-face
	{font-family:"Yu Mincho Light";}
@font-face
	{font-family:"TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:TimesNewRomanPSMT;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Times New Roman Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:PraxisCom-Regular;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Arial Bold";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:EUAlbertina;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"\@TimesNewRoman\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@Arial\,Italic";
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
h2
	{mso-style-link:"Heading 2 Char";
	margin:0in;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:13.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
h5
	{mso-style-link:"Heading 5 Char";
	margin:0in;
	page-break-after:avoid;
	background:#993366;
	font-size:14.0pt;
	font-family:"Arial",sans-serif;
	color:white;
	layout-grid-mode:line;
	font-weight:bold;}
h6
	{mso-style-link:"Heading 6 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-link:"Heading 7 Char";
	margin:0in;
	page-break-after:avoid;
	font-size:18.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-link:"Heading 8 Char";
	margin:0in;
	page-break-after:avoid;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-link:"Heading 9 Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Cambria",serif;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-link:"Footnote Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-name:"Comment Text\,- H19\,Annotationtext\,Char\,Comment Text Char Char\,Comment Text Char Char Char Char\,Comment Text Char Char1\,Comment Text Char Char1 Char\,Comment Text Char1 Char\,Comment Text Char1 Char Char\,Comment Text Char2 Char\,Tekst opmerking";
	mso-style-link:"Comment Text Char\,- H19 Char\,Annotationtext Char\,Char Char\,Comment Text Char Char Char\,Comment Text Char Char Char Char Char\,Comment Text Char Char1 Char1\,Comment Text Char Char1 Char Char\,Comment Text Char1 Char Char1\,Comment Text Char1 Char Char Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-link:"Header Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Arial",sans-serif;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	line-height:13.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Cambria",serif;}
span.MsoCommentReference
	{mso-style-name:"Comment Reference\,Annotationmark";}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-link:"Endnote Text Char";
	margin:0in;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;}
p.MsoToa, li.MsoToa, div.MsoToa
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-link:"Macro Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:13.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBulletCxSpFirst, li.MsoListBulletCxSpFirst, div.MsoListBulletCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBulletCxSpMiddle, li.MsoListBulletCxSpMiddle, div.MsoListBulletCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBulletCxSpLast, li.MsoListBulletCxSpLast, div.MsoListBulletCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumberCxSpFirst, li.MsoListNumberCxSpFirst, div.MsoListNumberCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumberCxSpMiddle, li.MsoListNumberCxSpMiddle, div.MsoListNumberCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumberCxSpLast, li.MsoListNumberCxSpLast, div.MsoListNumberCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2, li.MsoList2, div.MsoList2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2CxSpFirst, li.MsoList2CxSpFirst, div.MsoList2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2CxSpMiddle, li.MsoList2CxSpMiddle, div.MsoList2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList2CxSpLast, li.MsoList2CxSpLast, div.MsoList2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3, li.MsoList3, div.MsoList3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4, li.MsoList4, div.MsoList4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5, li.MsoList5, div.MsoList5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5CxSpFirst, li.MsoList5CxSpFirst, div.MsoList5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5CxSpMiddle, li.MsoList5CxSpMiddle, div.MsoList5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoList5CxSpLast, li.MsoList5CxSpLast, div.MsoList5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	text-indent:-14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2CxSpFirst, li.MsoListBullet2CxSpFirst, div.MsoListBullet2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2CxSpMiddle, li.MsoListBullet2CxSpMiddle, div.MsoListBullet2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet2CxSpLast, li.MsoListBullet2CxSpLast, div.MsoListBullet2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3CxSpFirst, li.MsoListBullet3CxSpFirst, div.MsoListBullet3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3CxSpMiddle, li.MsoListBullet3CxSpMiddle, div.MsoListBullet3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet3CxSpLast, li.MsoListBullet3CxSpLast, div.MsoListBullet3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4CxSpFirst, li.MsoListBullet4CxSpFirst, div.MsoListBullet4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4CxSpMiddle, li.MsoListBullet4CxSpMiddle, div.MsoListBullet4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet4CxSpLast, li.MsoListBullet4CxSpLast, div.MsoListBullet4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5CxSpFirst, li.MsoListBullet5CxSpFirst, div.MsoListBullet5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5CxSpMiddle, li.MsoListBullet5CxSpMiddle, div.MsoListBullet5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListBullet5CxSpLast, li.MsoListBullet5CxSpLast, div.MsoListBullet5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2CxSpFirst, li.MsoListNumber2CxSpFirst, div.MsoListNumber2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2CxSpMiddle, li.MsoListNumber2CxSpMiddle, div.MsoListNumber2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber2CxSpLast, li.MsoListNumber2CxSpLast, div.MsoListNumber2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3CxSpFirst, li.MsoListNumber3CxSpFirst, div.MsoListNumber3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3CxSpMiddle, li.MsoListNumber3CxSpMiddle, div.MsoListNumber3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber3CxSpLast, li.MsoListNumber3CxSpLast, div.MsoListNumber3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4CxSpFirst, li.MsoListNumber4CxSpFirst, div.MsoListNumber4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4CxSpMiddle, li.MsoListNumber4CxSpMiddle, div.MsoListNumber4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber4CxSpLast, li.MsoListNumber4CxSpLast, div.MsoListNumber4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5CxSpFirst, li.MsoListNumber5CxSpFirst, div.MsoListNumber5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5CxSpMiddle, li.MsoListNumber5CxSpMiddle, div.MsoListNumber5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListNumber5CxSpLast, li.MsoListNumber5CxSpLast, div.MsoListNumber5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	text-indent:-.25in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-link:"Title Char";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-link:"Closing Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-link:"Signature Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-link:"Body Text Char";
	margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:green;
	font-style:italic;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-link:"Body Text Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinueCxSpFirst, li.MsoListContinueCxSpFirst, div.MsoListContinueCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinueCxSpMiddle, li.MsoListContinueCxSpMiddle, div.MsoListContinueCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinueCxSpLast, li.MsoListContinueCxSpLast, div.MsoListContinueCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2CxSpFirst, li.MsoListContinue2CxSpFirst, div.MsoListContinue2CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2CxSpMiddle, li.MsoListContinue2CxSpMiddle, div.MsoListContinue2CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue2CxSpLast, li.MsoListContinue2CxSpLast, div.MsoListContinue2CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3CxSpFirst, li.MsoListContinue3CxSpFirst, div.MsoListContinue3CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3CxSpMiddle, li.MsoListContinue3CxSpMiddle, div.MsoListContinue3CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue3CxSpLast, li.MsoListContinue3CxSpLast, div.MsoListContinue3CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4CxSpFirst, li.MsoListContinue4CxSpFirst, div.MsoListContinue4CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4CxSpMiddle, li.MsoListContinue4CxSpMiddle, div.MsoListContinue4CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue4CxSpLast, li.MsoListContinue4CxSpLast, div.MsoListContinue4CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5CxSpFirst, li.MsoListContinue5CxSpFirst, div.MsoListContinue5CxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5CxSpMiddle, li.MsoListContinue5CxSpMiddle, div.MsoListContinue5CxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListContinue5CxSpLast, li.MsoListContinue5CxSpLast, div.MsoListContinue5CxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-indent:-56.7pt;
	line-height:13.0pt;
	background:#CCCCCC;
	border:none;
	padding:0in;
	font-size:12.0pt;
	font-family:"Cambria",serif;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-link:"Subtitle Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-link:"Salutation Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-link:"Date Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIndent
	{mso-style-link:"Body Text First Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-indent:10.5pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirstIndent2
	{mso-style-link:"Body Text First Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	text-indent:10.5pt;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-link:"Note Heading Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-link:"Body Text 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:200%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-link:"Body Text 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-link:"Body Text Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:200%;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{margin-top:0in;
	margin-right:.8in;
	margin-bottom:0in;
	margin-left:.8in;
	line-height:13.0pt;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	color:#4F81BD;
	font-style:italic;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;}
em
	{font-weight:bold;
	font-style:normal;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-link:"Document Map Char";
	margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-link:"Plain Text Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-link:"E-mail Signature Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p
	{margin-right:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
address
	{mso-style-link:"HTML Address Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-style:italic;}
pre
	{mso-style-link:"HTML Preformatted Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Courier New";}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-link:"Comment Subject Char";
	margin:0in;
	line-height:13.0pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{margin:0in;
	line-height:13.0pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-link:"Quote Char";
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-link:"Intense Quote Char";
	margin-top:10.0pt;
	margin-right:.65in;
	margin-bottom:14.0pt;
	margin-left:.65in;
	line-height:13.0pt;
	border:none;
	padding:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:#4F81BD;
	font-weight:bold;
	font-style:italic;}
p.MsoBibliography, li.MsoBibliography, div.MsoBibliography
	{margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	font-variant:small-caps;
	font-weight:bold;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-link:"Body text \(Agency\)";
	font-family:"Verdana",sans-serif;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-link:"Drafting Notes \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	font-size:11.0pt;
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-link:"Drafting Notes \(Agency\)";
	font-family:"Courier New";
	color:#339966;
	font-style:italic;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAgency
	{mso-style-name:"Table heading rows \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	font-weight:bold;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	margin:0in;
	line-height:14.0pt;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-link:"Normal \(Agency\)";
	font-family:"Verdana",sans-serif;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char\,- H19 Char\,Annotationtext Char\,Char Char\,Comment Text Char Char Char\,Comment Text Char Char Char Char Char\,Comment Text Char Char1 Char1\,Comment Text Char Char1 Char Char\,Comment Text Char1 Char Char1\,Comment Text Char1 Char Char Char";
	mso-style-link:"Comment Text\,- H19\,Annotationtext\,Char\,Comment Text Char Char\,Comment Text Char Char Char Char\,Comment Text Char Char1\,Comment Text Char Char1 Char\,Comment Text Char1 Char\,Comment Text Char1 Char Char\,Comment Text Char2 Char\,Tekst opmerking";
	font-family:"Times New Roman",serif;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-link:"Endnote Text";
	font-family:"Times New Roman",serif;}
p.PIbodytext, li.PIbodytext, div.PIbodytext
	{mso-style-name:"PI body text";
	mso-style-link:"PI body text Char";
	margin:0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.PIbodytextChar
	{mso-style-name:"PI body text Char";
	mso-style-link:"PI body text";
	font-family:"Times New Roman",serif;}
span.BodyText2Char
	{mso-style-name:"Body Text 2 Char";
	mso-style-link:"Body Text 2";
	font-family:"Times New Roman",serif;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-link:"Heading 5";
	font-family:"Arial",sans-serif;
	color:white;
	background:#993366;
	layout-grid-mode:both;
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-link:"Heading 7";
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-link:"Heading 8";
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.TableText, li.TableText, div.TableText
	{mso-style-name:"Table Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	color:black;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-link:Header;
	font-family:"Arial",sans-serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
p.TitleA, li.TitleA, div.TitleA
	{mso-style-name:"Title A";
	margin:0in;
	text-align:center;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	margin:0in;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Verdana",sans-serif;
	color:black;}
p.IFUBodyText, li.IFUBodyText, div.IFUBodyText
	{mso-style-name:"IFU Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;}
p.IFUBulletedBodyText, li.IFUBulletedBodyText, div.IFUBulletedBodyText
	{mso-style-name:"IFU Bulleted Body Text";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	text-indent:-.25in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	color:black;}
p.IFUBulletedBodyText2, li.IFUBulletedBodyText2, div.IFUBulletedBodyText2
	{mso-style-name:"IFU Bulleted Body Text 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.75in;
	text-indent:-.25in;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	color:black;}
p.TittleB, li.TittleB, div.TittleB
	{mso-style-name:"Tittle B";
	mso-style-link:"Tittle B Char";
	margin-top:0in;
	margin-right:6.0pt;
	margin-bottom:0in;
	margin-left:6.35pt;
	page-break-after:avoid;
	text-autospace:none;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.TittleBChar
	{mso-style-name:"Tittle B Char";
	mso-style-link:"Tittle B";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-link:"Body Text 3";
	font-family:"Times New Roman",serif;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-link:"Body Text";
	font-family:"Times New Roman",serif;
	color:green;
	font-style:italic;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-link:"Body Text First Indent";
	font-family:"Times New Roman",serif;
	color:green;
	font-style:normal;}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-link:"Body Text Indent";
	font-family:"Times New Roman",serif;}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-link:"Body Text First Indent 2";
	font-family:"Times New Roman",serif;}
span.BodyTextIndent2Char
	{mso-style-name:"Body Text Indent 2 Char";
	mso-style-link:"Body Text Indent 2";
	font-family:"Times New Roman",serif;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-link:"Body Text Indent 3";
	font-family:"Times New Roman",serif;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-link:Closing;
	font-family:"Times New Roman",serif;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-link:Date;
	font-family:"Times New Roman",serif;}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-link:"Document Map";
	font-family:"Tahoma",sans-serif;}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-link:"E-mail Signature";
	font-family:"Times New Roman",serif;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-link:"Footnote Text";
	font-family:"Times New Roman",serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Cambria",serif;
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Cambria",serif;
	font-weight:bold;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-link:"Heading 6";
	font-family:"Calibri",sans-serif;
	font-weight:bold;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-link:"Heading 9";
	font-family:"Cambria",serif;}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-link:"HTML Address";
	font-family:"Times New Roman",serif;
	font-style:italic;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-link:"HTML Preformatted";
	font-family:"Courier New";}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-link:"Intense Quote";
	font-family:"Times New Roman",serif;
	color:#4F81BD;
	font-weight:bold;
	font-style:italic;}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-link:"Macro Text";
	font-family:"Courier New";}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-link:"Message Header";
	font-family:"Cambria",serif;
	background:#CCCCCC;}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-link:"Note Heading";
	font-family:"Times New Roman",serif;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-link:"Plain Text";
	font-family:"Courier New";}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-link:Quote;
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-link:Salutation;
	font-family:"Times New Roman",serif;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-link:Signature;
	font-family:"Times New Roman",serif;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-link:Subtitle;
	font-family:"Cambria",serif;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-link:Title;
	font-family:"Cambria",serif;
	font-weight:bold;}
p.mdTblEntry, li.mdTblEntry, div.mdTblEntry
	{mso-style-name:"md_Tbl Entry";
	margin:0in;
	line-height:12.95pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.IFUHeading1, li.IFUHeading1, div.IFUHeading1
	{mso-style-name:"IFU Heading 1";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	color:black;
	layout-grid-mode:line;
	font-weight:bold;}
p.a, li.a, div.a
	{mso-style-name:a;
	margin:0in;
	line-height:13.0pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
span.KommentarerChar
	{mso-style-name:"Kommentarer Char";}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection3
	{page:WordSection3;}
@page WordSection4
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection4
	{page:WordSection4;}
@page WordSection5
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;}
div.WordSection5
	{page:WordSection5;}
 /* List Definitions */
 ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>"/>
                          </Binary>
                        </contained>
                        <!-- this exension is necessary per image -->
                        <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                          <valueReference>
                            <reference value="#stylesheet0"/>
                          </valueReference>
                        </extension>
              
              <status value="final"/>
							<!-- document type -->
							<type>
								<coding>
									<system value="http://spor.ema.europa.eu/v1/lists/100000155531"/>
									<code value="${document[n].documentTypeCode}"/>
									<display value="${document[n].documentTypeDisplay}"/>
								</coding>
							</type>
							<subject>
								<!-- links to the List resource in this bundle - local url format -->
								<reference value="[]"/> <!-- local url format -->
								<!--reference value="${instance.bundle[n].listUuid}"/--> <!-- uuid url format. Possible alternate format may be neeed -->
							</subject>
                        	<!-- mandatory date of the document -->
                        	<date value="2021-02-01"/>
							<author>
								<identifier>
									<system value="http://spor.ema.europa.eu/v1/locations" />
									<value value="" />
								</identifier>
							</author>
                        	<title value="${document[n].title}"/>
							<relatesTo>
								<code value="appends"/>
								<targetReference>
									<!-- reference to another Composition -->
									<reference value="${document[n].relatesTo}"/>
								</targetReference>
							</relatesTo>
							<!-- main sections of the document, to follow the QRD template -->
	               			
<section>
	
		
			<title value="B. PACKAGE LEAFLET"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><b><span lang="EN-GB">Package leaflet: Information for the user</span></b></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal; background:white"></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><b><span lang="EN-GB">ABASAGLAR 100 units/mL solution for injection</span></b><span lang="EN-GB"> <b>in a cartridge</b></span></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB">insulin glargine</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Read all of this leaflet carefully before you start using this medicine because it contains important information for you. The instructions for using the insulin pen are provided with your insulin pen. Refer to them before using your medicine.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB">-</span><span lang="EN-GB">Keep this leaflet. You may need to read it again. </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you have any further questions, ask your doctor, pharmacist or nurse.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you get any side effects, talk to your doctor, pharmacist or nurse.</span><span lang="EN-GB"> This includes any possible side effects not listed in this leaflet. See section 4.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
		
    	    
				
			    
						
		               
<section>
			<title value="What is in this leaflet"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="1.       What ABASAGLAR is and what it is used for "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="2.       What you need to know before you use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="3.       How to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="4.       Possible side effects "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="6.       Contents of the pack and other information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
	
		
		
    	    
				
			    
						
		               
<section>
			<title value="1.       What ABASAGLAR is and what it is used for"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="ABASAGLAR contains insulin glargine. This is a modified insulin, very similar to human insulin."/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is used to treat diabetes mellitus in adults, adolescents and children aged 2 years and above.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar. Insulin glargine has a long and steady blood-sugar-lowering action.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">2.       What you need to know before you use ABASAGLAR</span></b></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="Do not use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i><u><span lang="EN-GB">.</span></u></p><p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Insulin mix-ups</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check </span><span lang="EN-GB">the pack and </span><span lang="EN-GB">the insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        all other medicines to treat diabetes,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        disopyramide (used to treat certain heart conditions),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        fluoxetine (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        fibrates (used to lower high levels of blood lipids),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB"> -        sulphonamide antibiotics.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB">-        corticosteroids (such as "cortisone" used to treat inflammation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB">-        danazol (medicine acting on ovulation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        diazoxide (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        diuretics (used to treat high blood pressure or excessive fluid retention),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        isoniazid (used to treat tuberculosis),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        phenothiazine derivatives (used to treat psychiatric disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        somatropin (growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        thyroid hormones (used to treat thyroid gland disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        protease inhibitors (used to treat HIV).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        beta-blockers (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        clonidine (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        lithium salts (used to treat psychiatric disorders).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia. </span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle the cartridges</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The ABASAGLAR cartridges are to be used only in Lilly insulin pens to ensure you get the correct dose. Not all of these pens may be marketed in your country.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The pen should be used as recommended in the information provided.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The instructions for using the pen must be followed carefully for loading the cartridge, attaching the needle, and administering the insulin injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use it. Only use it if the solution is clear, colourless and water-like, and has no visible particles in it. Do not shake or mix it before use.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new cartridge if you notice that your blood sugar control is unexpectedly getting worse. This is because the insulin may have lost some of its effectiveness. If you think you may have a problem with ABASAGLAR, have it checked by your doctor or pharmacist.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Special care before injection</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before injection remove any air bubbles (see instructions for using the pen).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not re-fill and re-use empty cartridges. Do not add any other insulin to the cartridge. Do not mix ABASAGLAR with any other insulins or medicines. Do not dilute it. Mixing or diluting may change the action of ABASAGLAR.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Problems with the insulin pen?</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Refer to the instructions for using the pen.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><u><span lang="EN-GB">If the insulin pen is damaged or not working properly (due to mechanical defects) it has to be discarded, and a new insulin pen has to be used.</span></u></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you use more ABASAGLAR than you should"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR</b></span><span lang="EN-GB"> or are unsure how much you have injected</span><span lang="EN-GB">, your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you forget to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you stop using ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="Do not use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i><u><span lang="EN-GB">.</span></u></p><p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Insulin mix-ups</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check </span><span lang="EN-GB">the pack and </span><span lang="EN-GB">the insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        all other medicines to treat diabetes,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        disopyramide (used to treat certain heart conditions),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        fluoxetine (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        fibrates (used to lower high levels of blood lipids),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB"> -        sulphonamide antibiotics.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB">-        corticosteroids (such as "cortisone" used to treat inflammation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB">-        danazol (medicine acting on ovulation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        diazoxide (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        diuretics (used to treat high blood pressure or excessive fluid retention),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        isoniazid (used to treat tuberculosis),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        phenothiazine derivatives (used to treat psychiatric disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        somatropin (growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        thyroid hormones (used to treat thyroid gland disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        protease inhibitors (used to treat HIV).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        beta-blockers (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        clonidine (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        lithium salts (used to treat psychiatric disorders).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia. </span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle the cartridges</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The ABASAGLAR cartridges are to be used only in Lilly insulin pens to ensure you get the correct dose. Not all of these pens may be marketed in your country.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The pen should be used as recommended in the information provided.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The instructions for using the pen must be followed carefully for loading the cartridge, attaching the needle, and administering the insulin injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use it. Only use it if the solution is clear, colourless and water-like, and has no visible particles in it. Do not shake or mix it before use.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new cartridge if you notice that your blood sugar control is unexpectedly getting worse. This is because the insulin may have lost some of its effectiveness. If you think you may have a problem with ABASAGLAR, have it checked by your doctor or pharmacist.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Special care before injection</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before injection remove any air bubbles (see instructions for using the pen).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not re-fill and re-use empty cartridges. Do not add any other insulin to the cartridge. Do not mix ABASAGLAR with any other insulins or medicines. Do not dilute it. Mixing or diluting may change the action of ABASAGLAR.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Problems with the insulin pen?</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Refer to the instructions for using the pen.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><u><span lang="EN-GB">If the insulin pen is damaged or not working properly (due to mechanical defects) it has to be discarded, and a new insulin pen has to be used.</span></u></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you use more ABASAGLAR than you should"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR</b></span><span lang="EN-GB"> or are unsure how much you have injected</span><span lang="EN-GB">, your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you forget to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you stop using ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="4.       Possible side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">If you notice signs of your blood sugar being too low (hypoglycaemia), </span></b><span lang="EN-GB">taketheaction to increase your blood sugar levels <b>immediately</b></span><span lang="EN-GB">. Hypoglycaemia (low blood sugar) can be very serious and is very common with insulin treatment (may affect more than 1 in 10 people). Low blood sugar means that there is not enough sugar in your blood. If your blood sugar level falls too low, you may pass out (become unconscious). Serious hypoglycaemia may cause brain damage and may be life-threatening. For more information, see the box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">Severe allergic reactions </span></b><span lang="EN-GB">(rare, may affect up to 1 in 1,000 people) – the signs </span><span lang="EN-GB">may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heartbeat and sweating. Severe allergic reactions to insulins may become life-threatening. Tell a doctor straight away if you notice signs of severe allergic reaction.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:0in;line-height:normal;text-autospace:none"><b><span lang="EN-GB">Skin changes at the injection site</span></b></p><p class="MsoListParagraphCxSpLast" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:0in;line-height:normal;text-autospace:none"><span lang="EN-GB">If you inject insulin too often at the same place, the fatty tissue may shrink (lipoatrophy, may affect up to 1 in 100 people) or thicken (lipohypertrophy, may affect up to 1 in 10 people). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis, how often they occur is not known). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Common side effects </span></b><span lang="EN-GB">(may affect up to 1 in 10 people)</span></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:0in;line-height:normal;text-autospace:none"></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Skin and allergic reactions at the injection site</span></b></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;line-height:normal;text-autospace: none"></p><p class="MsoListParagraphCxSpLast" style="margin-left:0in;line-height:normal; text-autospace:none"><span lang="EN-GB">The signs may include reddening, unusually intense pain when injecting, itching, hives, swelling or inflammation. They can spread around the injection site. Most minor reactions to insulins usually disappear in a few days to a few weeks.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Rare side effects </span></b><span lang="EN-GB">(may affect up to 1 in 1,000 people)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Eye reactions</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. If you have proliferative retinopathy (an eye disease related to diabetes) severe hypoglycaemic attacks may cause temporary loss of vision.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">General disorders</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In rare cases, insulin treatment may also cause temporary build-up of water in the body, with swelling in the calves and ankles.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Very rare side-effects </span></b><span lang="EN-GB">(may affect up to1 in 10,000 people)</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In very rare cases, dysgeusia (taste disorders) and myalgia (muscular pain) can occur.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">In general, the side effects in children and adolescents of 18 years of age or less are similar to those seen in adults.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Complaints of injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) are reported relatively more frequently in children and adolescents of 18 years of age or less than in adults.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Reporting of side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background:lightgrey">the national reporting system listed in</span> </span><span lang="EN-GB"><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span style="color:windowtext;background:lightgrey">Appendix V</span></a></span><span lang="EN-GB">. By reporting side effects you can help provide more information on the safety of this medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this medicine out of the sight and reach of children.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Do not use this medicine after the expiry date which is stated on the carton and on the label of the cartridge after “EXP”. The expiry date refers to the last day of that month.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">Unopened cartridges</span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Store in a refrigerator (2°C - 8°C). Do not freeze. </span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not put ABASAGLAR next to the freezer compartment or a freezer pack. </span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep the cartridge in the outer carton in order to protect from light.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">In-use cartridges</span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Cartridges in use (in the insulin pen) or carried as a spare may be stored for a maximum of 28 days up to 30°C and away from direct heat or direct light. The cartridge in use must not be stored in a refrigerator. Do not use it after this time period.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use ABASAGLAR if you notice particles in it. Only use ABASAGLAR if the solution is clear, colourless and water like.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="6.       Contents of the pack and other information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="What ABASAGLAR contains"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The active substance is insulin glargine. Each millilitre of the solution contains 100 units of the active substance insulin glargine (equivalent to 3.64 mg).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The other ingredients are: zinc oxide, metacresol, glycerol, sodium hydroxide (see section 2 “ABASAGLAR contains sodium”), hydrochloric acid and water for injections.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal;page-break-after: avoid"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="What ABASAGLAR looks like and contents of the pack"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR 100 units/mL solution for injection in a cartridge is a clear and colourless solution.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR comes in a special cartridge to be used only in a Lilly insulin pen. Each cartridge contains 3 mL of solution for injection (equivalent to 300 units) and they are available in packs of 5 and 10 cartridges.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Not all pack sizes may be marketed.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Marketing Authorisation Holder </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Manufacturer</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly France S.A.S., rue du Colonel Lilly, F-67640 Fegersheim, France.</span></p><p class="MsoNormal"><span lang="PT" style="background:lightgrey">Eli Lilly Italia S.p.A., Via Gramsci 731-733, 50019 Sesto Fiorentino, (FI) Italy.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:-1.7pt;border-collapse:collapse" width="624"> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="FR">België/Belgique/Belgien</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="FR">Eli Lilly Benelux S.A./N.V.</span></p> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal;page-break-after:   avoid"><span lang="NL">Tél/Tel: + 32-(0)2 548 84 84</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><b><span lang="SV">Lietuva</span></b></p> <p class="MsoNormal" style="margin-right:-22.45pt;line-height:normal;   page-break-after:avoid"><span lang="SV">Eli Lilly </span><span lang="BG" style="color:black">Lietuva</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="LT">Tel. +370 (5) 2649600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal;page-break-after:   avoid"><b><span lang="EN-GB">България</span></b></p> <p class="MsoNormal" style="page-break-after:avoid;text-autospace:none"><span lang="BG">ТП "Ели   Лили   Недерланд"   Б.В. - България</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="BG">тел. +359 2 491 41 40</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">Luxembourg/Luxemburg</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Eli Lilly Benelux S.A./N.V.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="NL">Tél/Tel: + 32-(0)2 548 84 84</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="SV">Česká republika</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="CS">ELI LILLY ČR, s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="NL">Tel: + 420 234 664 111</span></p> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal;page-break-after:   avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">Magyarország</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="EN-GB">Lilly Hungária Kft.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Tel: + 36 1 328 5100</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">Danmark</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Eli Lilly Danmark A/S </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Tlf: +45 45 26 60 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="FR">Malta</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="ES">Charles de Giorgio Ltd.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="NL">Tel: + 356 25600 500</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">Deutschland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="DE">Lilly Deutschland GmbH</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="DE">Tel. + 49-(0) 6172 273 2222</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Nederland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="DA">Eli Lilly Nederland B.V. </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="NL">Tel: + 31-(0) 30 60 25 800</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="SV">Eesti</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SV">Eli Lilly Nederland B.V.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="ET">Tel</span><span lang="ET">: </span><span lang="EN-GB">+372 6 817 280</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Norge</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="NO-NYN">Eli Lilly Norge A.S. </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="NO-NYN">Tlf: + 47 22 88 18 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EL">Ελλάδα</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EL" style="layout-grid-mode:line">ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ   Α.Ε.Β.Ε. </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EL" style="layout-grid-mode:line">Τηλ: +30 210 629 4600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="SV">Österreich</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="ET">Eli Lilly Ges.m.b.H. </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="ET">Tel: + 43-(0) 1 711 780</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="ES-TRAD">España</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="ES">Lilly S.A.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="ES">Tel: + 34-91 663 50 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Polska</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SV">Eli Lilly Polska Sp. z o.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="PL">Tel: </span><span lang="EN-GB">+48 22 440 33 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">France</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="FR">Lilly France SAS</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="FR">Tél: +33-(0) 1 55 49 34 34</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="FR">Portugal</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="PT">Lilly Portugal Produtos Farmacêuticos, Lda</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="NL">Tel: + 351-21-4126600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"><span lang="DA" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Hrvatska</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="DA">Eli Lilly Hrvatska d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Tel: +385 1 2350 999</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">România</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="RO">Eli Lilly România S.R.L.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="RO">Tel: + 40 21 4023000</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">Ireland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Eli Lilly and Company (Ireland) Limited</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Tel: + 353-(0) 1 661 4377</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="RO">Slovenija</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="RO">Eli Lilly farmacevtska družba, d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="RO">Tel: +386 (0)1 580 00 10</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Ísland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="DA">Icepharma hf.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="DA">Sími + 354 540 8000</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Slovenská republika</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Eli Lilly Slovakia s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Tel: </span><span lang="SK">+ 421 220 663 111</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="ES-TRAD">Italia</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="FI">Eli Lilly Italia S.p.A.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Tel: + 39- 055 42571</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Suomi/Finland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SV">Oy Eli Lilly Finland Ab </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Puh/Tel: + 358-(0) 9 85 45 250</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">Κύπρος</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Phadisco Ltd </span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EL">Τηλ</span><span lang="EN-GB">: +357 22 715000</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Sverige</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="DE">Eli Lilly Sweden AB</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="DE">Tel: + 46-(0) 8 7378800</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="SV">Latvija</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="LV" style="color:black">Eli Lilly (Suisse) S.A   Pārstāvniecība Latvijā</span><span lang="LV">Tel: </span><b><span lang="NL">+</span></b><span lang="NL">371 67364000</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="EN-GB">United Kingdom</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Eli Lilly and Company Limited</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="EN-GB">Tel: + 44-(0) 1256 315000</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr height="0"> <td style="border:none" width="2"></td> <td style="border:none" width="310"></td> <td style="border:none" width="312"></td> </tr> </table>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="This leaflet was last revised in "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Other sources of information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Detailed information on this medicine is available on the European Medicines Agency web site: </span><span lang="EN-GB"><a href="http://www.ema.europa.eu"><span style="color:windowtext">http://www.ema.europa.eu</span></a></span><span lang="EN-GB">. </span></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><div class="WordSection2"> <div style="border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA AND HYPOGLYCAEMIA</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Always carry some sugar (at least 20 grams) with you.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Carry some information with you to show you are diabetic.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA (high blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hyperglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your insulin pen does not work properly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">-        you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Warning symptoms of hyperglycaemia</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"><span lang="EN-GB">Thirst, increased need to urinate, tiredness, dry skin, reddening of the face, loss of appetite, low blood pressure, fast heartbeat, and glucose and ketone bodies in urine. Stomach pain, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin.</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">What should you do if you experience hyperglycaemia?</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. </span></b><span lang="EN-GB">Severe hyperglycaemia or ketoacidosis must always be treated by a doctor, normally in a hospital.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPOGLYCAEMIA (low blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">If your blood sugar level falls too much you may become unconscious. Serious hypoglycaemia may cause a heart attack or brain damage and may be life-threatening. You normally should be able to recognise when your blood sugar is falling too much so that you can take the right actions.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hypoglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you inject too much insulin,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you miss meals or delay them,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you do not eat enough, or eat food containing less carbohydrate than normal (sugar and substances similar to sugar are called carbohydrates; however, artificial sweeteners are NOT carbohydrates),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you lose carbohydrates due to vomiting or diarrhoea,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you drink alcohol, particularly if you are not eating much,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are doing more exercise than usual or a different type of physical activity,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an injury or operation or other stress,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an illness or from fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have stopped taking certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> </div> <div style="border:none;border-right:solid windowtext 1.0pt;padding:0in 1.0pt 0in 0in"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> </div> <b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> </div><div style="border:none;border-right:solid windowtext 1.0pt;padding:0in 1.0pt 0in 0in"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> </div><p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p><b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><div class="WordSection3"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal; text-autospace:none"><b><span lang="EN-GB">Package leaflet: Information for the user</span></b></p> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"></p> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><b><span lang="EN-GB">ABASAGLAR 100 units/mL KwikPen solution for injection in a pre-filled pen</span></b></p> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB">insulin glargine</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Read all of this leaflet carefully including the Instructions for Use of the ABASAGLAR KwikPen pre-filled pen, before you start using this medicine because it contains important information for you.</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB">-</span><span lang="EN-GB">Keep this leaflet. You may need to read it again. </span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you have any further questions, ask your doctor, pharmacist or nurse.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you get any side effects, talk to your doctor, pharmacist or nurse.</span><span lang="EN-GB"> This includes any possible side effects not listed in this leaflet. See section 4.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">What is in this leaflet</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">1.       What ABASAGLAR is and what it is used for </span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">2.       What you need to know before you use ABASAGLAR</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">3.       How to use ABASAGLAR</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">4.       Possible side effects </span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">5.       How to store ABASAGLAR</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">6.       Contents of the pack and other information</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">1.       What ABASAGLAR is and what it is used for</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR contains insulin glargine. This is a modified insulin, very similar to human insulin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is used to treat diabetes mellitus in adults, adolescents and children aged 2 years and above.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar. Insulin glargine has a long and steady blood-sugar-lowering action.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">2.       What you need to know before you use ABASAGLAR</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Do not use ABASAGLAR</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i><u><span lang="EN-GB">.</span></u></p> <p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Insulin mix-ups</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check the </span><span lang="EN-GB">pack and </span><span lang="EN-GB">insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">all other medicines to treat diabetes,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">disopyramide (used to treat certain heart conditions),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fluoxetine (used to treat depression),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fibrates (used to lower high levels of blood lipids),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sulphonamide antibiotics.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">corticosteroids (such as "cortisone" used to treat inflammation),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">danazol (medicine acting on ovulation),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">diazoxide (used to treat high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">diuretics (used to treat high blood pressure or excessive fluid retention),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">isoniazid (used to treat tuberculosis),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">phenothiazine derivatives (used to treat psychiatric disorders),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatropin (growth hormone),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">thyroid hormones (used to treat thyroid gland disorders),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">protease inhibitors (used to treat HIV).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">beta-blockers (used to treat high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">clonidine (used to treat high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">lithium salts (used to treat psychiatric disorders).</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia </span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">3.       How to use ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Although ABASAGLAR contains the same active substance as Toujeo (insulin glargine 300 units/mL), these medicines are not interchangeable. The switch from one insulin therapy to another requires medical prescription, medical supervision and blood glucose monitoring. Please consult your doctor for further information.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Dose</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Based on your life-style and the results of your blood sugar (glucose) tests and your previous insulin usage, your doctor will:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        determine how much ABASAGLAR per day you will need and at what time,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        tell you when to check your blood sugar level, and whether you need to carry out urine tests,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        tell you when you may need to inject a higher or lower dose of ABASAGLAR.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is a long-acting insulin. Your doctor may tell you to use it in combination with a short-acting insulin or with tablets used to treat high blood sugar levels.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Many factors may influence your blood sugar level. You should know these factors so that you are able to react correctly to changes in your blood sugar level and to prevent it from becoming too high or too low. See the box at the end of this leaflet for further information.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Use in children and adolescents</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle ABASAGLAR KwikPen</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR KwikPen is a pre-filled disposable pen containing insulin glargine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Read carefully the "</span></b><b><span lang="EN-GB">ABASAGLAR KwikPen Instructions for Use" included with this package leaflet. You must use the pen as described in these Instructions for Use.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A new needle must be attached before each use. Only use needles that are compatible for use with ABASAGLAR KwikPen (see “ABASAGLAR KwikPen Instructions for Use”).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A safety test must be performed before each injection.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use the pen. Do not use ABASAGLAR KwikPen if you notice particles in it. Only use ABASAGLAR KwikPen if the solution is clear, colourless and water-like. Do not shake or mix it before use.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse. If you think you may have a problem with ABASAGLAR KwikPen, consult your doctor, pharmacist or nurse.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Empty pens must not be re-filled and must be properly discarded.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use ABASAGLAR KwikPen if it is damaged or not working properly, it has to be discarded and a new KwikPen has to be used.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">If you use more ABASAGLAR than you should</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR </b></span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">,</span><span lang="EN-GB"> your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">If you forget to use ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, </span><span lang="EN-GB">your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">If you stop using ABASAGLAR</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal"><b><span lang="EN-GB">4.       Possible side effects</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">If you notice signs of your blood sugar being too low (hypoglycaemia), </span></b><span lang="EN-GB">taketheaction to increase your blood sugar levels <b>immediately</b></span><span lang="EN-GB">. Hypoglycaemia (low blood sugar) can be very serious and is very common with insulin treatment (may affect more than 1 in 10 people). Low blood sugar means that there is not enough sugar in your blood. If your blood sugar level falls too low, you may pass out (become unconscious). Serious hypoglycaemia may cause brain damage and may be life-threatening. For more information, see the box at the end of this leaflet.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">Severe allergic reactions </span></b><span lang="EN-GB">(rare, may affect up to 1 in 1,000 people) – the signs </span><span lang="EN-GB">may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heartbeat and sweating. Severe allergic reactions to insulins may become life-threatening. Tell a doctor straight away if you notice signs of severe allergic reaction.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:0in;line-height:normal;page-break-after:avoid; text-autospace:none"><b><span lang="EN-GB">Skin changes at the injection site </span></b></p> <p class="MsoListParagraphCxSpLast" style="margin-left:0in"><span lang="EN-GB">If you inject insulin too often at the same place, the fatty tissue may shrink (lipoatrophy, may affect up to 1 in 100 people) or thicken (lipohypertrophy, may affect up to 1 in 10 people). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis, how often they occur is not known). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Common side effects </span></b><span lang="EN-GB">(may affect up to 1 in 10 people)</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoListParagraph" style="margin-top:0in;margin-right:0in;margin-bottom: 10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace: none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Skin and allergic reactions at the injection site</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The signs may include reddening, unusually intense pain when injecting, itching, hives, swelling or inflammation. They can spread around the injection site. Most minor reactions to insulins usually disappear in a few days to a few weeks.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Rare side effects </span></b><span lang="EN-GB">(may affect up to 1 in 1,000 people)</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Eye reactions</span></b></p> <p class="MsoListParagraphCxSpLast" style="margin-left:0in"><span lang="EN-GB">A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. If you have proliferative retinopathy (an eye disease related to diabetes) severe hypoglycaemic attacks may cause temporary loss of vision.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p> <p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">General disorders</span></b></p> <p class="MsoListParagraphCxSpLast" style="margin-left:0in;line-height:normal; text-autospace:none"><span lang="EN-GB">In rare cases, insulin treatment may also cause temporary build-up of water in the body, with swelling in the calves and ankles.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Very rare side-effects </span></b><span lang="EN-GB">(may affect up to1 in 10,000 people)</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In very rare cases, dysgeusia (taste disorders) and myalgia (muscular pain) can occur.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Use in children and adolescents</span></b></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">In general, the side effects in children and adolescents of 18 years of age or less are similar to those seen in adults.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Complaints of injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) are reported relatively more frequently in children and adolescents of 18 years of age or less than in adults.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Reporting of side effects</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background:lightgrey">the national reporting system listed in</span> </span><span lang="EN-GB"><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span style="color:windowtext;background:lightgrey">Appendix V</span></a></span><span lang="EN-GB">. By reporting side effects you can help provide more information on the safety of this medicine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal"><b><span lang="EN-GB">5.       How to store ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this medicine out of the sight and reach of children.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after “EXP”. The expiry date refers to the last day of that month.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">Not in-use pens</span></u></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Store in a refrigerator (2°C - 8°C). Do not freeze. </span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not put ABASAGLAR next to the freezer compartment or a freezer pack.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep the pre-filled pen in the outer carton in order to protect from light.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB"></span></u></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">In-use pens</span></u></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pre-filled pens in use or carried as a spare may be stored for a maximum of 28 days up to 30°C and away from direct heat or direct light. The pen in use must not be stored in the refrigerator. Do not use it after this time period. The pen cap must be put back on the pen after each injection in order to protect from light.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">6.       Contents of the pack and other information</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">What ABASAGLAR contains</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The active substance is insulin glargine. Each millilitre of the solution contains 100 units of the active substance insulin glargine (equivalent to 3.64 mg).</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The other ingredients are: zinc oxide, metacresol, glycerol, sodium hydroxide (see section 2 “ABASAGLAR contains sodium”), hydrochloric acid and water for injections.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">What ABASAGLAR looks like and contents of the pack</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR 100 units/mL solution for injection in a pre-filled pen, KwikPen, is a clear and colourless solution.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">ABASAGLAR is available in packs containing 5 pre‑filled pens and in multipacks comprising 2 cartons, each containing 5 pre‑filled pens.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Not all pack sizes may be marketed.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Marketing Authorisation Holder </span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Manufacturer</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly France S.A.S., rue du Colonel Lilly, F-67640 Fegersheim, France.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</span></p> <p class="MsoNormal" style="line-height:normal"></p> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:-1.7pt;border-collapse:collapse" width="624"> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">België/Belgique/Belgien</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Eli Lilly Benelux   S.A./N.V.</span></p> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><span lang="NL">Tél/Tel: + 32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="SV">Lietuva</span></b></p> <p class="MsoNormal" style="margin-right:-22.45pt;line-height:normal"><span lang="SV">Eli Lilly </span><span lang="BG" style="color:black">Lietuva</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="LT">Tel. +370 (5) 2649600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><b><span lang="EN-GB">България</span></b></p> <p class="MsoNormal" style="text-autospace:none"><span lang="BG">ТП   "Ели Лили   Недерланд"   Б.В. - България</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="BG">тел.   +359 2 491 41 40</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Luxembourg/Luxemburg</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Benelux S.A./N.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tél/Tel: +   32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> </tr> <tr style="height:56.5pt"> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Česká   republika</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="CS">ELI LILLY   ČR, s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 420 234   664 111</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Magyarország</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly Hungária Kft.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 36 1   328 5100</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Danmark</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Danmark A/S </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tlf: +45 45 26   60 00</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Malta</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Charles de   Giorgio Ltd.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 356 25600   500</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Deutschland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Lilly Deutschland   GmbH</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel. + 49-(0)   6172 273 2222</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Nederland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Nederland B.V. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 31-(0) 30   60 25 800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Eesti</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Eli Lilly   Nederland B.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel</span><span lang="ET">: </span><span lang="EN-GB">+372 6 817 280</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Norge</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Eli Lilly   Norge A.S. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Tlf: + 47 22   88 18 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EL">Ελλάδα</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ   Α.Ε.Β.Ε. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">Τηλ: +30 210 629 4600</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Österreich</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Eli Lilly   Ges.m.b.H. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel: + 43-(0) 1   711 780</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">España</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Lilly S.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Tel: + 34-91 663   50 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Polska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Eli Lilly Polska   Sp. z o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="PL">Tel: </span><span lang="EN-GB">+48 22 440 33 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">France</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Lilly France SAS</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Tél: +33-(0) 1 55   49 34 34</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Portugal</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="PT">Lilly Portugal   Produtos Farmacêuticos, Lda</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: +   351-21-4126600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Hrvatska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Hrvatska d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: +385 1   2350 999</span></p> <p class="MsoNormal" style="line-height:normal"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">România</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly România   S.R.L.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: + 40 21   4023000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"><span lang="DA" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Ireland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company (Ireland) Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 353-(0)   1 661 4377</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="RO">Slovenija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly   farmacevtska družba, d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: +386 (0)1   580 00 10</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Ísland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="DA">Icepharma hf.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Sími + 354 540   8000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Slovenská republika</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Eli Lilly Slovakia s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Tel: </span><span lang="SK">+ 421 220 663 111</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">Italia</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FI">Eli Lilly Italia   S.p.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 39- 055   42571</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Suomi/Finland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Oy Eli Lilly   Finland Ab </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Puh/Tel: +   358-(0) 9 85 45 250</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Κύπρος</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Phadisco Ltd </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL">Τηλ</span><span lang="EN-GB">: +357 22 715000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Sverige</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Eli Lilly Sweden   AB</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel: + 46-(0) 8   7378800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Latvija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV" style="color:   black">Eli Lilly (Suisse) S.A Pārstāvniecība Latvijā</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV">Tel: </span><b><span lang="NL">+</span></b><span lang="NL">371 67364000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">United   Kingdom</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 44-(0)   1256 315000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr height="0"> <td style="border:none" width="2"></td> <td style="border:none" width="310"></td> <td style="border:none" width="312"></td> </tr> </table> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">This leaflet was last </span><span lang="EN-GB">revised in </span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other sources of information</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Detailed information on this medicine is available on the European Medicines Agency web site: </span><span lang="EN-GB"><a href="http://www.ema.europa.eu"><span style="color:windowtext">http://www.ema.europa.eu</span></a></span><span lang="EN-GB">. </span></p> </div><p align="center" class="MsoNormal" style="text-align:center;line-height:normal; text-autospace:none"><b><span lang="EN-GB">Package leaflet: Information for the user</span></b></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><b><span lang="EN-GB">ABASAGLAR 100 units/mL KwikPen solution for injection in a pre-filled pen</span></b></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB">insulin glargine</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Read all of this leaflet carefully including the Instructions for Use of the ABASAGLAR KwikPen pre-filled pen, before you start using this medicine because it contains important information for you.</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB">-</span><span lang="EN-GB">Keep this leaflet. You may need to read it again. </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you have any further questions, ask your doctor, pharmacist or nurse.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you get any side effects, talk to your doctor, pharmacist or nurse.</span><span lang="EN-GB"> This includes any possible side effects not listed in this leaflet. See section 4.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
	
		
		
    	    
				
			    
						
		               
<section>
			<title value="What is in this leaflet"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <div style="border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Hypoglycaemia is also more likely to occur if</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have just begun insulin treatment or changed to another insulin preparation (when changing from your previous basal insulin to ABASAGLAR, hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your blood sugar levels are almost normal or are unstable,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you change the area of skin where you inject insulin (for example from the thigh to the upper arm),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you suffer from severe kidney or liver disease, or some other disease such as hypothyroidism.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Warning symptoms of hypoglycaemia</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your body</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that tell you that your blood sugar level is falling too much or too fast: sweating, clammy skin, anxiety, fast heart beat, high blood pressure, palpitations and irregular heartbeat. These symptoms often develop before the symptoms of a low sugar level in the brain.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your brain</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that indicate a low sugar level in the brain: headaches, intense hunger, nausea, vomiting, tiredness, sleepiness, sleep disturbances, restlessness, aggressive behaviour, lapses in concentration, impaired reactions, depression, confusion, speech disturbances (sometimes total loss of speech), visual disorders, trembling, paralysis, tingling sensations (paraesthesia), numbness and tingling sensations in the area of the mouth, dizziness, loss of self-control, inability to look after yourself, convulsions, loss of consciousness.</span></p> <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph; line-height:normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">The first symptoms which alert you to hypoglycaemia ("warning symptoms") may change, be weaker or may be missing altogether if</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are elderly, if you have had diabetes for a long time or if you suffer from a certain type of nervous disease (diabetic autonomic neuropathy),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have almost normal or, at least, greatly improved blood sugar levels,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently changed from an animal insulin to a human insulin such as ABASAGLAR,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">In such a case, you may develop severe hypoglycaemia (and even faint) before you are aware of the problem. Be familiar with your warning symptoms. If necessary, more frequent blood sugar testing can help to identify mild hypoglycaemic episodes that may otherwise be overlooked. If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">What should you do if you experience hypoglycaemia?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">1. Do not inject insulin. Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage. Caution: Artificial sweeteners and foods with artificial sweeteners (such as diet drinks) are of no help in treating hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">2. Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). Your doctor or nurse should have discussed this with you previously.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">The recovery of hypoglycaemia may be delayed because ABASAGLAR has a long action.'</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">3. If the hypoglycaemia comes back again, take another 10 to 20 g sugar.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">4. Speak to a doctor immediately if you are not able to control the hypoglycaemia or if it recurs. Tell your relatives, friends and close colleagues the following:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">If you are not able to swallow or if you are unconscious, you will require an injection of glucose or glucagon (a medicine which increases blood sugar). These injections are justified even if it is not certain that you have hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">It is advisable to test your blood sugar immediately after taking glucose to check that you really have hypoglycaemia.</span></p> </div><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="1.       What ABASAGLAR is and what it is used for "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="2.       What you need to know before you use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="3.       How to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="4.       Possible side effects "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="6.       Contents of the pack and other information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
	
		
		
    	    
				
			    
						
		               
<section>
			<title value="1.       What ABASAGLAR is and what it is used for"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="ABASAGLAR contains insulin glargine. This is a modified insulin, very similar to human insulin."/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is used to treat diabetes mellitus in adults, adolescents and children aged 2 years and above.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar. Insulin glargine has a long and steady blood-sugar-lowering action.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">2.       What you need to know before you use ABASAGLAR</span></b></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="Do not use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i><u><span lang="EN-GB">.</span></u></p><p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Insulin mix-ups</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check the </span><span lang="EN-GB">pack and </span><span lang="EN-GB">insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">all other medicines to treat diabetes,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">disopyramide (used to treat certain heart conditions),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fluoxetine (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fibrates (used to lower high levels of blood lipids),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sulphonamide antibiotics.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">corticosteroids (such as "cortisone" used to treat inflammation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">danazol (medicine acting on ovulation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">diazoxide (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">diuretics (used to treat high blood pressure or excessive fluid retention),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">isoniazid (used to treat tuberculosis),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">phenothiazine derivatives (used to treat psychiatric disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatropin (growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">thyroid hormones (used to treat thyroid gland disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">protease inhibitors (used to treat HIV).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">beta-blockers (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">clonidine (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">lithium salts (used to treat psychiatric disorders).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia </span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle ABASAGLAR KwikPen</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR KwikPen is a pre-filled disposable pen containing insulin glargine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Read carefully the "</span></b><b><span lang="EN-GB">ABASAGLAR KwikPen Instructions for Use" included with this package leaflet. You must use the pen as described in these Instructions for Use.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A new needle must be attached before each use. Only use needles that are compatible for use with ABASAGLAR KwikPen (see “ABASAGLAR KwikPen Instructions for Use”).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A safety test must be performed before each injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use the pen. Do not use ABASAGLAR KwikPen if you notice particles in it. Only use ABASAGLAR KwikPen if the solution is clear, colourless and water-like. Do not shake or mix it before use.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse. If you think you may have a problem with ABASAGLAR KwikPen, consult your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Empty pens must not be re-filled and must be properly discarded.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use ABASAGLAR KwikPen if it is damaged or not working properly, it has to be discarded and a new KwikPen has to be used.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you use more ABASAGLAR than you should"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR </b></span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">,</span><span lang="EN-GB"> your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you forget to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, </span><span lang="EN-GB">your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you stop using ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="Do not use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i><u><span lang="EN-GB">.</span></u></p><p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Insulin mix-ups</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check the </span><span lang="EN-GB">pack and </span><span lang="EN-GB">insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">all other medicines to treat diabetes,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">disopyramide (used to treat certain heart conditions),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fluoxetine (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fibrates (used to lower high levels of blood lipids),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sulphonamide antibiotics.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">corticosteroids (such as "cortisone" used to treat inflammation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">danazol (medicine acting on ovulation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">diazoxide (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;page-break-after:avoid;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Courier New"'>­</span><span lang="EN-GB">diuretics (used to treat high blood pressure or excessive fluid retention),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">isoniazid (used to treat tuberculosis),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">phenothiazine derivatives (used to treat psychiatric disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatropin (growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">thyroid hormones (used to treat thyroid gland disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">protease inhibitors (used to treat HIV).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">beta-blockers (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">clonidine (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">lithium salts (used to treat psychiatric disorders).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia </span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle ABASAGLAR KwikPen</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR KwikPen is a pre-filled disposable pen containing insulin glargine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Read carefully the "</span></b><b><span lang="EN-GB">ABASAGLAR KwikPen Instructions for Use" included with this package leaflet. You must use the pen as described in these Instructions for Use.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A new needle must be attached before each use. Only use needles that are compatible for use with ABASAGLAR KwikPen (see “ABASAGLAR KwikPen Instructions for Use”).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A safety test must be performed before each injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use the pen. Do not use ABASAGLAR KwikPen if you notice particles in it. Only use ABASAGLAR KwikPen if the solution is clear, colourless and water-like. Do not shake or mix it before use.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse. If you think you may have a problem with ABASAGLAR KwikPen, consult your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Empty pens must not be re-filled and must be properly discarded.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use ABASAGLAR KwikPen if it is damaged or not working properly, it has to be discarded and a new KwikPen has to be used.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you use more ABASAGLAR than you should"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR </b></span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">,</span><span lang="EN-GB"> your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you forget to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, </span><span lang="EN-GB">your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you stop using ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="4.       Possible side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">If you notice signs of your blood sugar being too low (hypoglycaemia), </span></b><span lang="EN-GB">taketheaction to increase your blood sugar levels <b>immediately</b></span><span lang="EN-GB">. Hypoglycaemia (low blood sugar) can be very serious and is very common with insulin treatment (may affect more than 1 in 10 people). Low blood sugar means that there is not enough sugar in your blood. If your blood sugar level falls too low, you may pass out (become unconscious). Serious hypoglycaemia may cause brain damage and may be life-threatening. For more information, see the box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">Severe allergic reactions </span></b><span lang="EN-GB">(rare, may affect up to 1 in 1,000 people) – the signs </span><span lang="EN-GB">may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heartbeat and sweating. Severe allergic reactions to insulins may become life-threatening. Tell a doctor straight away if you notice signs of severe allergic reaction.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:0in;line-height:normal;page-break-after:avoid; text-autospace:none"><b><span lang="EN-GB">Skin changes at the injection site </span></b></p><p class="MsoListParagraphCxSpLast" style="margin-left:0in"><span lang="EN-GB">If you inject insulin too often at the same place, the fatty tissue may shrink (lipoatrophy, may affect up to 1 in 100 people) or thicken (lipohypertrophy, may affect up to 1 in 10 people). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis, how often they occur is not known). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Common side effects </span></b><span lang="EN-GB">(may affect up to 1 in 10 people)</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoListParagraph" style="margin-top:0in;margin-right:0in;margin-bottom: 10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;text-autospace: none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Skin and allergic reactions at the injection site</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The signs may include reddening, unusually intense pain when injecting, itching, hives, swelling or inflammation. They can spread around the injection site. Most minor reactions to insulins usually disappear in a few days to a few weeks.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Rare side effects </span></b><span lang="EN-GB">(may affect up to 1 in 1,000 people)</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Eye reactions</span></b></p><p class="MsoListParagraphCxSpLast" style="margin-left:0in"><span lang="EN-GB">A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. If you have proliferative retinopathy (an eye disease related to diabetes) severe hypoglycaemic attacks may cause temporary loss of vision.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">General disorders</span></b></p><p class="MsoListParagraphCxSpLast" style="margin-left:0in;line-height:normal; text-autospace:none"><span lang="EN-GB">In rare cases, insulin treatment may also cause temporary build-up of water in the body, with swelling in the calves and ankles.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Very rare side-effects </span></b><span lang="EN-GB">(may affect up to1 in 10,000 people)</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In very rare cases, dysgeusia (taste disorders) and myalgia (muscular pain) can occur.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">In general, the side effects in children and adolescents of 18 years of age or less are similar to those seen in adults.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Complaints of injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) are reported relatively more frequently in children and adolescents of 18 years of age or less than in adults.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Reporting of side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background:lightgrey">the national reporting system listed in</span> </span><span lang="EN-GB"><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span style="color:windowtext;background:lightgrey">Appendix V</span></a></span><span lang="EN-GB">. By reporting side effects you can help provide more information on the safety of this medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this medicine out of the sight and reach of children.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after “EXP”. The expiry date refers to the last day of that month.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">Not in-use pens</span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Store in a refrigerator (2°C - 8°C). Do not freeze. </span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not put ABASAGLAR next to the freezer compartment or a freezer pack.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep the pre-filled pen in the outer carton in order to protect from light.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB"></span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">In-use pens</span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pre-filled pens in use or carried as a spare may be stored for a maximum of 28 days up to 30°C and away from direct heat or direct light. The pen in use must not be stored in the refrigerator. Do not use it after this time period. The pen cap must be put back on the pen after each injection in order to protect from light.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="6.       Contents of the pack and other information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="What ABASAGLAR contains"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The active substance is insulin glargine. Each millilitre of the solution contains 100 units of the active substance insulin glargine (equivalent to 3.64 mg).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The other ingredients are: zinc oxide, metacresol, glycerol, sodium hydroxide (see section 2 “ABASAGLAR contains sodium”), hydrochloric acid and water for injections.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="What ABASAGLAR looks like and contents of the pack"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR 100 units/mL solution for injection in a pre-filled pen, KwikPen, is a clear and colourless solution.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">ABASAGLAR is available in packs containing 5 pre‑filled pens and in multipacks comprising 2 cartons, each containing 5 pre‑filled pens.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Not all pack sizes may be marketed.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Marketing Authorisation Holder </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Manufacturer</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly France S.A.S., rue du Colonel Lilly, F-67640 Fegersheim, France.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:-1.7pt;border-collapse:collapse" width="624"> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">België/Belgique/Belgien</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Eli Lilly Benelux   S.A./N.V.</span></p> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><span lang="NL">Tél/Tel: + 32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="SV">Lietuva</span></b></p> <p class="MsoNormal" style="margin-right:-22.45pt;line-height:normal"><span lang="SV">Eli Lilly </span><span lang="BG" style="color:black">Lietuva</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="LT">Tel. +370 (5) 2649600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><b><span lang="EN-GB">България</span></b></p> <p class="MsoNormal" style="text-autospace:none"><span lang="BG">ТП   "Ели Лили   Недерланд"   Б.В. - България</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="BG">тел.   +359 2 491 41 40</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Luxembourg/Luxemburg</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Benelux S.A./N.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tél/Tel: +   32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> </tr> <tr style="height:56.5pt"> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Česká   republika</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="CS">ELI LILLY   ČR, s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 420 234   664 111</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Magyarország</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly Hungária Kft.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 36 1   328 5100</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Danmark</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Danmark A/S </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tlf: +45 45 26   60 00</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Malta</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Charles de   Giorgio Ltd.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 356 25600   500</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Deutschland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Lilly Deutschland   GmbH</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel. + 49-(0)   6172 273 2222</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Nederland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Nederland B.V. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 31-(0) 30   60 25 800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Eesti</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Eli Lilly   Nederland B.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel</span><span lang="ET">: </span><span lang="EN-GB">+372 6 817 280</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Norge</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Eli Lilly   Norge A.S. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Tlf: + 47 22   88 18 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EL">Ελλάδα</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ   Α.Ε.Β.Ε. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">Τηλ: +30 210 629 4600</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Österreich</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Eli Lilly   Ges.m.b.H. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel: + 43-(0) 1   711 780</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">España</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Lilly S.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Tel: + 34-91 663   50 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Polska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Eli Lilly Polska   Sp. z o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="PL">Tel: </span><span lang="EN-GB">+48 22 440 33 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">France</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Lilly France SAS</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Tél: +33-(0) 1 55   49 34 34</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Portugal</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="PT">Lilly Portugal   Produtos Farmacêuticos, Lda</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: +   351-21-4126600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Hrvatska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Hrvatska d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: +385 1   2350 999</span></p> <p class="MsoNormal" style="line-height:normal"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">România</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly România   S.R.L.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: + 40 21   4023000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"><span lang="DA" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Ireland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company (Ireland) Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 353-(0)   1 661 4377</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="RO">Slovenija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly   farmacevtska družba, d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: +386 (0)1   580 00 10</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Ísland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="DA">Icepharma hf.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Sími + 354 540   8000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Slovenská republika</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Eli Lilly Slovakia s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Tel: </span><span lang="SK">+ 421 220 663 111</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">Italia</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FI">Eli Lilly Italia   S.p.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 39- 055   42571</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Suomi/Finland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Oy Eli Lilly   Finland Ab </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Puh/Tel: +   358-(0) 9 85 45 250</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Κύπρος</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Phadisco Ltd </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL">Τηλ</span><span lang="EN-GB">: +357 22 715000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Sverige</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Eli Lilly Sweden   AB</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel: + 46-(0) 8   7378800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Latvija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV" style="color:   black">Eli Lilly (Suisse) S.A Pārstāvniecība Latvijā</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV">Tel: </span><b><span lang="NL">+</span></b><span lang="NL">371 67364000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">United   Kingdom</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 44-(0)   1256 315000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr height="0"> <td style="border:none" width="2"></td> <td style="border:none" width="310"></td> <td style="border:none" width="312"></td> </tr> </table>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="This leaflet was last revised in "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Other sources of information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Detailed information on this medicine is available on the European Medicines Agency web site: </span><span lang="EN-GB"><a href="http://www.ema.europa.eu"><span style="color:windowtext">http://www.ema.europa.eu</span></a></span><span lang="EN-GB">. </span></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><div class="WordSection4"> <div style="border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA AND HYPOGLYCAEMIA</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Always carry some sugar (at least 20 grams) with you.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Carry some information with you to show you are diabetic.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA (high blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hyperglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your insulin pen does not work properly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">- </span><span lang="EN-GB">       you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Warning symptoms of hyperglycaemia</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"><span lang="EN-GB">Thirst, increased need to urinate, tiredness, dry skin, reddening of the face, loss of appetite, low blood pressure, fast heartbeat, and glucose and ketone bodies in urine. Stomach pain, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin.</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">What should you do if you experience hyperglycaemia?</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. </span></b><span lang="EN-GB">Severe hyperglycaemia or ketoacidosis must always be treated by a doctor, normally in a hospital.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPOGLYCAEMIA (low blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">If your blood sugar level falls too much you may become unconscious. Serious hypoglycaemia may cause a heart attack or brain damage and may be life-threatening. You normally should be able to recognise when your blood sugar is falling too much so that you can take the right actions.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hypoglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you inject too much insulin,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you miss meals or delay them,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you do not eat enough, or eat food containing less carbohydrate than normal (sugar and substances similar to sugar are called carbohydrates; however, artificial sweeteners are NOT carbohydrates),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you lose carbohydrates due to vomiting or diarrhoea,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you drink alcohol, particularly if you are not eating much,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are doing more exercise than usual or a different type of physical activity,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an injury or operation or other stress,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an illness or from fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have stopped taking certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> </div> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b> <b><span style='font-size:18.0pt;font-family:"Arial",sans-serif'><br clear="all" style="page-break-before:always"/> </span></b> <p align="center" class="MsoHeading7" style="margin-top:6.0pt;text-align:center"><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Instructions for use</span></p> <p align="center" class="MsoHeading7" style="margin-top:6.0pt;text-align:center"><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>ABASAGLAR </span><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>100 units/mL KwikPen solution for injection in a pre-filled pen</span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b>i</b><b><span lang="EN-GB">nsulin glargine </span></b></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background:#A6A6A6;border-collapse:collapse"> <tr> <td style="width:384.85pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="513"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center;   line-height:normal"><b><span lang="EN-GB"><img border="0" height="76" id="Picture 3" src="#image0" width="477"/></span></b></p> </td> <td style="width:79.55pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="106"> <p class="MsoNormal" style="margin-top:6.0pt;line-height:normal"></p> </td> </tr> </table> </div> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251714560"><span style="left:0px;position: absolute;left:1px;top:-31401px;width:604px;height:1px"><img height="1" src="#image1" width="604"/></span></span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <br clear="ALL"/> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:red">PLEASE READ THESE INSTRUCTIONS BEFORE USE</span></b></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Read the instructions for use before you start taking ABASAGLAR and each time you get another ABASAGLAR KwikPen. There may be new information. This information does not take the place oftalking to your healthcare professional about your medical condition or your treatment.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">ABASAGLAR KwikPen (“Pen”) is a disposable pen containing 300 units (3 mL) of insulin glargine. You can give yourself multiple doses using one pen. The pen dials 1 unit at a time. You can give from 1 to 60 <span style="background:lightgrey">80</span> units in a single injection. <b>If your dose is more than 60 <span style="background: lightgrey">80</span> units, you will need to give yourself more than one injection. </b>The plunger only moves a little with each injection and you may not notice that it moves. The plunger will only reach the end of the cartridge when you have used all 300 units in the pen.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Do not share your pen with other people, even if the needle has been changed. Do not reuse or share needles with other people. You may give an infection to them or get an infection from them.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">This pen is not recommended for use by the blind or visually impaired without the help of someone trained to use the pen.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="margin-bottom:6.0pt;text-align:center"><b><span style='font-family:"Arial",sans-serif'>KwikPen Parts</span></b></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="86"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:84.2pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="112"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Pen Cap</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="3" nowrap="" style="width:121.5pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="162"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Cartridge Holder</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="90"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Label</span></p> </td> <td colspan="2" nowrap="" style="width:76.6pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="102"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Dose Indicator</span></p> </td> </tr> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'><img border="0" height="63" id="Picture 25" src="#image2" width="508"/></span></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"></p> </td> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Cap Clip</span></p> </td> <td colspan="3" nowrap="" style="width:82.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="111"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Rubber Seal</span></p> </td> <td nowrap="" style="width:1.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Plunger</span></p> </td> <td colspan="3" nowrap="" style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Pen Body</span></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="90"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Dose </span><span lang="EN-GB" style='font-size:9.0pt;font-family:"Arial",sans-serif'><br/> </span><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Window</span></p> </td> <td nowrap="" style="width:45.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="60"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Dose Knob</span></p> </td> </tr> <tr height="0"> <td style="border:none" width="86"></td> <td style="border:none" width="86"></td> <td style="border:none" width="27"></td> <td style="border:none" width="24"></td> <td style="border:none" width="60"></td> <td style="border:none" width="96"></td> <td style="border:none" width="6"></td> <td style="border:none" width="24"></td> <td style="border:none" width="42"></td> <td style="border:none" width="48"></td> <td style="border:none" width="42"></td> <td style="border:none" width="60"></td> </tr> </table> </div> <p class="MsoNormal" style="line-height:normal"></p> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:5.4pt;border-collapse:collapse"> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><b><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Pen Needle Parts<br/>   (Needles Not Included)</span></b></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'>Dose Knob</span></b><b><span style='font-size:10.0pt;font-family:"Arial",sans-serif'><br/>   with<br/>   green </span></b><b><span lang="EN-GB" style='font-size:10.0pt;font-family:   "Arial",sans-serif'>ring</span></b></p> </td> </tr> <tr style="height:11.2pt"> <td colspan="2" style="width:117.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="156"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td colspan="2" style="width:1.5in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="144"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Needle</span></p> </td> <td style="width:45.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="60"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="72"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="168"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> </tr> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'><img border="0" height="73" id="Picture 26" src="#image3" width="297"/></span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" width="168"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'><img border="0" height="67" id="Picture 48" src="#image4" width="71"/></span></p> </td> </tr> <tr> <td style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Outer Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Inner Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Paper Tab</span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr height="0"> <td style="border:none" width="120"></td> <td style="border:none" width="36"></td> <td style="border:none" width="84"></td> <td style="border:none" width="60"></td> <td style="border:none" width="60"></td> <td style="border:none" width="72"></td> <td style="border:none" width="168"></td> </tr> </table> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span style="layout-grid-mode:line">How to recognise your ABASAGLAR KwikPen</span></b><b><span lang="EN-GB" style='font-family:"Arial",sans-serif'>:</span></b></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Pen colour:         Light grey</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Dose Knob:         Light grey with green ring on the end</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Labels:                Light grey with green colour bars</span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <h5 style="text-align:justify;text-justify:inter-ideograph;background:transparent"><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:windowtext'>Supplies needed to give your injection:</span></h5> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">ABASAGLAR KwikPen</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">KwikPen compatible needle (BD [Becton, Dickinson and Company] pen needles recommended). </span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Swab</span></p> <p class="MsoNormal"> </p> <h5 style="background:transparent"><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Preparing </span><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:windowtext'>your Pen</span></h5> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Wash your hands with soap and water</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Check the pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> use your pen past the expiration date printed on the label or for more than 28 days after you first start using the pen.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Always use a <b>new needle</b> for each injection to help prevent infections and blocked needles.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:234.1pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 1:</span></b></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Pull the pen cap straight off.</span></p> <p class="MsoListParagraph" style="margin-left:28.35pt;line-height:normal;   text-autospace:none"><span lang="EN-GB">- Do not remove the pen label.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Wipe the rubber seal with a swab. </span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR should look clear and colourless. <b>Do not</b> use if   it is cloudy, coloured, or has particles or clumps in it.</span></p> </td> <td style="width:230.25pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="307"> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"><span style="position:relative;   z-index:251666432"><span style="position:absolute;left:50px;top:-32534px;   width:158px;height:1px"><img alt="Step1a" height="1" src="#image5" width="158"/></span></span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> </tr> <tr style="height:94.35pt"> <td style="width:234.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:94.35pt" valign="top" width="312"><br clear="ALL"/> <p class="MsoHeader" style="margin-top:6.0pt"><b><span style='font-size:11.0pt;   font-family:"Times New Roman",serif'>Step 2:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Select a new needle.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull off the paper tab from the outer needle shield.</span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> <td style="width:230.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.35pt" valign="top" width="307"> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span style="position:relative;z-index:251667456"><span style="position:absolute;   left:59px;top:-32684px;width:149px;height:1px"><img alt="Step1b" height="1" src="#image6" width="149"/></span></span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> </tr> <tr> <td style="width:234.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 3:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Push the capped needle straight onto the pen   and twist the needle on until it is tight.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:230.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="307"> <p class="MsoHeader" style="margin-top:6.0pt"><span style="position:relative;   z-index:251668480"><span style="position:absolute;left:63px;top:-32817px;   width:149px;height:1px"><img alt="Step1c" height="1" src="#image7" width="149"/></span></span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> </tr> <tr style="height:84.75pt"> <td style="width:234.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:84.75pt" valign="top" width="312"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 4:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull off the outer needle shield. <b>Do not</b>   throw it away.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull off the inner needle shield and throw it   away.</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:230.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:84.75pt" valign="top" width="307"> <p class="MsoNormal"><span style="position:relative;z-index:251662336"><span style="position:absolute;left:100px;top:-32940px;width:56px;height:1px"><img alt="Throw Away" height="1" src="#image8" width="56"/></span></span><span style="position:relative;z-index:251659264"><span style="position:absolute;left:60px;top:-32940px;width:39px;height:1px"><img alt="Keep" height="1" src="#image9" width="39"/></span></span><span style="position:relative;z-index:251658240"><span style="position:absolute;   left:46px;top:-32940px;width:162px;height:1px"><img alt="Step1d" height="1" src="#image10" width="162"/></span></span></p> </td> </tr> </table> <p class="MsoHeader" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p> <h5 style="background:transparent"><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Priming your pen</span></h5> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Prime before each injection.</span></b></p> <ul style="margin-top:0in" type="disc"> <li class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Priming your pen means removing the air from the needle and      cartridge that may collect during normal use and ensures that the pen is      working correctly</span><span lang="EN-GB">. </span></li> <li class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you <b>do not</b> prime before each injection, you may get      too much or too little insulin.</span></li> </ul> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 5:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">To prime your pen, turn the dose knob to   select 2 units.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251669504"><span style="left:0px;position:   absolute;left:76px;top:-33207px;width:141px;height:1px"><img alt="Step2a" height="1" src="#image11" width="141"/></span></span></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 6:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Hold your pen with the needle pointing up. Tap   the cartridge holder gently to collect air bubbles at the top.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <h5 align="center" style="margin-top:6.0pt;text-align:center;background:transparent"><span style="position:relative;z-index:251670528"><span style="left:0px;position:   absolute;left:73px;top:-33338px;width:144px;height:1px"><img alt="Step2b" height="1" src="#image12" width="144"/></span></span></h5> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 7:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Continue holding your pen with needle pointing   up. Push the dose knob in until it stops, and “0” is seen in the dose window.   Hold the dose knob in and count to 5 slowly.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoListParagraph" style="margin-left:28.35pt;line-height:normal;   text-autospace:none"><span lang="EN-GB">You should see insulin at the tip of   the needle.</span></p> <p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height:   normal;text-autospace:none"><span lang="EN-GB">-    If you <b>do not</b> see   insulin, repeat the priming steps, but not more than 4 times.</span></p> <p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height:   normal;text-autospace:none"><span lang="EN-GB">-    If you <b>still do not</b>   see insulin, change the needle and repeat the priming steps.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Small air bubbles are normal and will not affect your dose.</span></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251672576"><span style="left:0px;position:   absolute;left:89px;top:-33461px;width:124px;height:1px"><img height="1" src="#image13" width="124"/></span></span></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251671552"><span style="left:0px;position:   absolute;left:84px;top:-33530px;width:133px;height:1px"><img alt="Step2c_2" height="1" src="#image14" width="133"/></span></span></p> </td> </tr> </table> <p class="MsoNormal"></p> <h5 style="background:transparent"><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Selecting your dose</span></h5> <p class="IFUBulletedBodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol;color:windowtext">·</span><span lang="EN-GB" style='font-family:"Times New Roman",serif; color:windowtext'>You can give from 1 to 60<span style="background:lightgrey">80</span> units in a single injection.</span></p> <p class="IFUBulletedBodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol;color:windowtext">·</span><span lang="EN-GB" style='font-family:"Times New Roman",serif; color:windowtext'>If your dose is more than 60<span style="background:lightgrey">80</span> units, you will need to give more than one injection.</span></p> <p class="IFUBulletedBodyText2" style="margin-left:42.55pt;text-indent:-14.2pt"><span lang="EN-GB" style='font-family:"Times New Roman",serif;color:windowtext'>–   If you need help deciding how to divide up your dose, ask your healthcare professional.</span></p> <p class="IFUBodyText" style="margin-left:42.55pt;text-indent:-14.2pt"><span lang="EN-GB" style='font-family:"Times New Roman",serif'>–   You should use a new needle for each injection and repeat the priming step.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p> <table align="left" border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:  6.75pt"> <tr> <td style="width:229.8pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="306"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 8:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Turn the dose knob to select the number of   units you need to inject. The dose indicator should line up with your dose.</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The pen dials 1 unit at a time.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The dose knob clicks as you turn it.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">DO NOT dial your dose by counting the clicks because you may dial   the wrong dose.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The dose can be corrected by turning the dose knob in either   direction until the correct dose lines up with the dose indicator.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The <b>even</b> numbers are printed on the dial.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The <b>odd </b>numbers, after the number 1, are shown as full   lines.</span></p> <p class="MsoListParagraphCxSpLast" style="line-height:normal;text-autospace:   none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><b><span lang="EN-GB">Always check the number in the Dose Window   to make sure you have dialled the correct dose</span></b><span lang="EN-GB">.</span></p> <p class="MsoNormal"> </p> </td> <td style="width:234.55pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="313"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251673600"><span style="position:absolute;left:69px;top:-33884px;   width:141px;height:1px"><img alt="Step3a" height="1" src="#image15" width="141"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:53.7pt;margin-bottom:.0001pt"><span lang="EN-GB"><img border="0" height="128" id="Group 37" src="#image16" width="132"/></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">(Example: 12 units   shown in the dose window)</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:53.7pt;margin-bottom:.0001pt"><span lang="EN-GB"><img border="0" height="129" id="Group 48" src="#image17" width="144"/></span></p> <p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">(Example: 25 units   shown in the dose window)</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> </table> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">The pen will not let you dial more than the number of units left in the pen.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">If you need to inject more than the number of units left in the pen, you may either:</span></p> <p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-    inject the amount left in your pen and then use a new pen to give the rest of your dose, <b>or</b></span></p> <p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-    get a new pen and inject the full dose.</span></p> <p class="MsoListParagraph" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">It is normal to see a small amount of insulin left in the pen that you cannot inject.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p> <p class="MsoHeading8"><span style='font-family:"Times New Roman",serif'>Giving your injection</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Inject your insulin as your healthcare professional has shown you.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Change (rotate) your injection site for each injection.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> try to change your dose while injecting.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="width:466.1pt;border-collapse:collapse;border:none" width="621"> <tr> <td style="width:239.3pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="319"> <h2 style="margin-top:6.0pt"><span style="font-size:11.0pt">Step 9:</span></h2> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Choose your injection site.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">ABASAGLAR is injected under the skin   (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Prepare your skin as recommended by your   healthcare professional.</span></p> <p class="MsoNormal"> </p> </td> <td style="width:3.15in;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="302"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251661312"><span style="left:0px;position:   absolute;left:85px;top:-34636px;width:117px;height:1px"><img height="1" src="#image18" width="117"/></span></span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> </td> </tr> <tr style="height:75.55pt"> <td style="width:239.3pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:75.55pt" valign="top" width="319"><br clear="ALL"/> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 10: </span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Insert the needle into your skin.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Push the dose knob all the way in</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:67.4pt;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol">·</span><span style="position:relative;z-index:251664384"><span style="left:0px;position:absolute;left:244px;top:-34867px;width:38px;   height:1px"><img alt="5sec" height="1" src="#image19" width="38"/></span></span><span style="position:relative;z-index:-1895809024"><span style="left:0px;   position:absolute;left:231px;top:-34867px;width:66px;height:1px"><img alt="clock" height="1" src="#image20" width="66"/></span></span><span lang="EN-GB">Continue to hold the dose knob in and <b>slowly count</b> to 5   before removing the needle.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> try to inject your insulin by   turning the dose knob. You will <b>NOT</b> receive your insulin by turning   the dose knob.</span></p> </td> <td style="width:3.15in;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:75.55pt" valign="top" width="302"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251679744"><span style="left:0px;position:   absolute;left:40px;top:-34823px;width:205px;height:1px"><img height="1" src="#image21" width="205"/></span></span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> </td> </tr> <tr style="height:112.95pt"> <td style="width:239.3pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:112.95pt" valign="top" width="319"><br clear="ALL"/> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 11:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull the needle out of your skin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- A drop of insulin at the needle tip is normal. It   will not affect your dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Check the number in the dose window</span></p> <p class="MsoNormal" style="margin-left:10.35pt;line-height:normal;text-autospace:   none"></p> <p class="MsoNormal" style="margin-left:28.35pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you see “0” in the dose window, you have received   the full amount you dialled.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you do not see “0” in the dose window, <b>do not</b>   redial. Insert the needle into your skin and finish your injection.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you <b>still</b> do not think you received the   full amount you dialled for your injection, <b>do not start over or repeat   that injection</b>. Monitor your blood glucose as instructed by your healthcare   professional.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you normally need to give 2 injections for your   full dose, be sure to give your second injection.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">The plunger only moves a little with each injection   and you may not notice that it moves.</span></p> <p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">If you see blood   after you take the needle out of your skin, press the injection site lightly   with a piece of gauze or swab. <b>Do not</b> rub the area.</span></p> </td> <td style="width:3.15in;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:112.95pt" valign="top" width="302"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251675648"><span style="left:0px;position:   absolute;left:56px;top:-35052px;width:174px;height:1px"><img alt="Step4c" height="1" src="#image22" width="174"/></span></span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> </td> </tr> </table> <p class="MsoNormal"></p> <b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b> <p class="MsoHeading8"><span style='font-family:"Times New Roman",serif'>After your injection</span></p> <p class="MsoNormal"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 12:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Carefully replace the outer needle shield.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251676672"><span style="position:absolute;left:75px;top:-35622px;   width:148px;height:1px"><img alt="Step5a" height="1" src="#image23" width="148"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 13:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Unscrew the capped needle and dispose of it as   directed by your healthcare professional.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Do not store the pen with the needle attached   to prevent leaking, blocking the needle, and air from entering the pen.</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251677696"><span style="position:absolute;left:79px;top:-35763px;   width:144px;height:1px"><img alt="Step5b" height="1" src="#image24" width="144"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> <tr> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 14:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Replace the pen cap by lining up the cap clip   with the dose indicator and pushing straight on.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251678720"><span style="position:absolute;left:36px;top:-35923px;   width:193px;height:1px"><img alt="Step5c" height="1" src="#image25" width="193"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> </table> <p class="MsoNormal"></p> <p class="TableText" style="margin-top:0in;text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Disposing of pens and needles</span></b></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Put used needles in a closable, puncture-resistant sharps container. </span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Do not recycle the filled sharps container.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Ask your healthcare professional about options to dispose of the pens and sharps container properly.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">The directions regarding needle handling are not intended to replace local, healthcare professional or institutional policies.</span></p> <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"></p> <p class="TableText" style="margin-top:0in;text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Storing your pen</span></b></p> <p class="TableText" style="text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Unused pens</span></b></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Store unused pens in the refrigerator at 2 ° C to 8 ° C.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> freeze ABASAGLAR. <b>Do not</b> use if it has been frozen.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Unused pens may be used until the expiration date printed on the label, if the pen has been kept in the refrigerator.</span></p> <p class="TableText" style="text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>In-use pen</span></b></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Store the pen you are currently using at room temperature [below 30 ° C] and away from heat and light.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Throw away the pen you are using after 28 days, even if it still has insulin left in it. </span></p> <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"></p> <p class="TableText" style="margin-top:0in;text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>General information about the safe and effective use of your pen</span></b></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><b><span lang="EN-GB">Keep your pen and needles out of the sight and reach of children. </span></b></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> use your pen if any part looks broken or damaged.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Always carry an extra pen in case yours is lost or damaged.</span></p> <p class="TableText" style="text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Troubleshooting</span></b></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">If you cannot remove the pen cap, gently twist the cap back and forth, and then pull the cap straight off.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">If the dose knob it is hard to push:</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:56.7pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB">- Pushing the dose knob more slowly will make it easier to inject.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:56.7pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB">- Your needle may be blocked. Put on a new needle and prime the pen.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:56.7pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB">- You may have dust, food, or liquid inside the pen. Throw the pen away and get a new pen.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any questions or problems with your ABASAGLAR KwikPen, contact your healthcare professional for assistance.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;text-align:justify;text-justify: inter-ideograph;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;text-align:justify;text-justify: inter-ideograph;line-height:normal"><b><span lang="EN-GB">This leaflet was last </span><span lang="EN-GB">revised in </span></b></p> <span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; color:black'><br clear="all" style="page-break-before:always"/> </span> <p align="center" class="MsoNormal" style="margin-top:14.0pt;margin-right:6.0pt; margin-bottom:11.0pt;margin-left:6.35pt;text-align:center;page-break-after: avoid;text-autospace:none"></p> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal; text-autospace:none"><b><span lang="EN-GB">Package leaflet: Information for the user</span></b></p> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"></p> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><b><span lang="EN-GB">ABASAGLAR 100 units/mL Tempo Pen solution for injection in a pre-filled pen</span></b></p> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB">insulin glargine</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Read all of this leaflet carefully including the Instructions for Use of the ABASAGLAR Tempo pre-filled pen, before you start using this medicine because it contains important information for you.</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB">-</span><span lang="EN-GB">Keep this leaflet. You may need to read it again. </span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you have any further questions, ask your doctor, pharmacist or nurse.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</span></p> <p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you get any side effects, talk to your doctor, pharmacist or nurse.</span><span lang="EN-GB"> This includes any possible side effects not listed in this leaflet. See section 4.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">What is in this leaflet</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">1.       What ABASAGLAR is and what it is used for </span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">2.       What you need to know before you use ABASAGLAR</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">3.       How to use ABASAGLAR</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">4.       Possible side effects </span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">5.       How to store ABASAGLAR</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">6.       Contents of the pack and other information</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">1.       What ABASAGLAR is and what it is used for</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR contains insulin glargine. This is a modified insulin, very similar to human insulin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is used to treat diabetes mellitus in adults, adolescents and children aged 2 years and above.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar. Insulin glargine has a long and steady blood-sugar-lowering action.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">2.       What you need to know before you use ABASAGLAR</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Do not use ABASAGLAR</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i></p> <p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><a name="_Hlk38985814"><i><span lang="EN-GB">Insulin mix-ups</span></i></a></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check the pack and the insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"><i><span lang="EN-GB">Tempo Pen</span></i></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">The Tempo Pen contains a magnet. If you have a medical device fitted, such as a heart pacemaker, this may not work correctly if the Tempo Pen is held too close. </span><span lang="EN-GB">T</span><span lang="EN-GB">he magnetic field extends to approximately 1.5 cm</span><span lang="EN-GB">.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">all other medicines to treat diabetes,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">disopyramide (used to treat certain heart conditions),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fluoxetine (used to treat depression),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fibrates (used to lower high levels of blood lipids),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sulphonamide antibiotics.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">corticosteroids (such as "cortisone" used to treat inflammation),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">danazol (medicine acting on ovulation),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">diazoxide (used to treat high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">diuretics (used to treat high blood pressure or excessive fluid retention),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">isoniazid (used to treat tuberculosis),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">phenothiazine derivatives (used to treat psychiatric disorders),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatropin (growth hormone),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">thyroid hormones (used to treat thyroid gland disorders),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">protease inhibitors (used to treat HIV).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">beta-blockers (used to treat high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">clonidine (used to treat high blood pressure),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">lithium salts (used to treat psychiatric disorders).</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia </span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">3.       How to use ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Although ABASAGLAR contains the same active substance as Toujeo (insulin glargine 300 units/mL), these medicines are not interchangeable. The switch from one insulin therapy to another requires medical prescription, medical supervision and blood glucose monitoring. Please consult your doctor for further information.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Dose</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Based on your life-style and the results of your blood sugar (glucose) tests and your previous insulin usage, your doctor will:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        determine how much ABASAGLAR per day you will need and at what time,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        tell you when to check your blood sugar level, and whether you need to carry out urine tests,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        tell you when you may need to inject a higher or lower dose of ABASAGLAR.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is a long-acting insulin. Your doctor may tell you to use it in combination with a short-acting insulin or with tablets used to treat high blood sugar levels.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Many factors may influence your blood sugar level. You should know these factors so that you are able to react correctly to changes in your blood sugar level and to prevent it from becoming too high or too low. See the box at the end of this leaflet for further information.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Use in children and adolescents</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle ABASAGLAR Tempo Pen</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR Tempo Pen is a pre-filled disposable pen containing insulin glargine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Read carefully the "</span></b><b><span lang="EN-GB">ABASAGLAR Tempo Pen Instructions for Use" included with this package leaflet. You must use the pen as described in these Instructions for Use.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A new needle must be attached before each use. Only use needles that are compatible for use with ABASAGLAR Tempo Pen (see “ABASAGLAR Tempo Pen Instructions for Use”).</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A safety test must be performed before each injection.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use the pen. Do not use ABASAGLAR Tempo Pen if you notice particles in it. Only use ABASAGLAR Tempo Pen if the solution is clear, colourless and water-like. Do not shake or mix it before use.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse. If you think you may have a problem with ABASAGLAR Tempo Pen, consult your doctor, pharmacist or nurse.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Empty pens must not be re-filled and must be properly discarded.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use ABASAGLAR Tempo Pen if it is damaged or not working properly, it has to be discarded and a new Tempo Pen has to be used.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoCommentText"><a name="_Hlk56610361"><span lang="EN-GB" style="font-size:11.0pt">The Tempo Pen is designed to work with the Tempo Smart Button.</span></a><span lang="EN-GB" style="font-size:11.0pt"> The optional additional feature Tempo Smart Button is a product available for the Tempo Pen, which may be used for transmitting dose information to a mobile application. The Tempo Pen can be used with or without the Tempo Smart Button attached. See instructions provided with the Tempo Smart Button and the mobile application for further information. </span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">If you use more ABASAGLAR than you should</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR </b></span><span lang="EN-GB">or are unsure how much you have injected</span><b><span lang="EN-GB">,</span></b><span lang="EN-GB">, your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">If you forget to use ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">If you stop using ABASAGLAR</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal"><b><span lang="EN-GB">4.       Possible side effects</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">If you notice signs of your blood sugar being too low (hypoglycaemia), </span></b><span lang="EN-GB">taketheaction to increase your blood sugar levels <b>immediately</b></span><span lang="EN-GB">. Hypoglycaemia (low blood sugar) can be very serious and is very common with insulin treatment (may affect more than 1 in 10 people). Low blood sugar means that there is not enough sugar in your blood. If your blood sugar level falls too low, you may pass out (become unconscious). Serious hypoglycaemia may cause brain damage and may be life-threatening. For more information, see the box at the end of this leaflet.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">Severe allergic reactions </span></b><span lang="EN-GB">(rare, may affect up to 1 in 1,000 people) – the signs </span><span lang="EN-GB">may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heartbeat and sweating. Severe allergic reactions to insulins may become life-threatening. Tell a doctor straight away if you notice signs of severe allergic reaction.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Skin changes at the injection site</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">If you inject insulin too often at the same place, the fatty tissue may shrink (lipoatrophy, may affect up to 1 in 100 people) or thicken (lipohypertrophy, may affect up to 1 in 10 people). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis, how often they occur is not known). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Common side effects </span></b><span lang="EN-GB">(may affect up to 1 in 10 people)</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoListParagraph" style="margin-top:0in;margin-right:0in;margin-bottom: 10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-after: avoid;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Skin and allergic reactions at the injection site</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The signs may include reddening, unusually intense pain when injecting, itching, hives, swelling or inflammation. They can spread around the injection site. Most minor reactions to insulins usually disappear in a few days to a few weeks.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Rare side effects </span></b><span lang="EN-GB">(may affect up to 1 in 1,000 people)</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Eye reactions</span></b></p> <p class="MsoListParagraphCxSpLast" style="margin-left:0in"><span lang="EN-GB">A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. If you have proliferative retinopathy (an eye disease related to diabetes) severe hypoglycaemic attacks may cause temporary loss of vision.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p> <p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">General disorders</span></b></p> <p class="MsoListParagraphCxSpLast" style="margin-left:0in;line-height:normal; text-autospace:none"><span lang="EN-GB">In rare cases, insulin treatment may also cause temporary build-up of water in the body, with swelling in the calves and ankles.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Very rare side-effects </span></b><span lang="EN-GB">(may affect up to1 in 10,000 people)</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In very rare cases, dysgeusia (taste disorders) and myalgia (muscular pain) can occur.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Use in children and adolescents</span></b></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">In general, the side effects in children and adolescents of 18 years of age or less are similar to those seen in adults.</span></p> <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Complaints of injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) are reported relatively more frequently in children and adolescents of 18 years of age or less than in adults.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Reporting of side effects</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background:lightgrey">the national reporting system listed in</span> </span><span lang="EN-GB"><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span style="color:windowtext;background:lightgrey">Appendix V</span></a></span><span lang="EN-GB">. By reporting side effects you can help provide more information on the safety of this medicine.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:0in;margin-right:-.1pt;margin-bottom:0in; margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height: normal"><b><span lang="EN-GB">5.       How to store ABASAGLAR</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this medicine out of the sight and reach of children.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after “EXP”. The expiry date refers to the last day of that month.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">Not in-use pens</span></u></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Store in a refrigerator (2 °C – 8 °C). Do not freeze. </span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not put ABASAGLAR next to the freezer compartment or a freezer pack.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep the pre-filled pen in the outer carton in order to protect from light.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB"></span></u></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">In-use pens</span></u></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pre-filled pens in use or carried as a spare may be stored for a maximum of 28 days up to 30 °C and away from direct heat or direct light. The pen in use must not be stored in the refrigerator. Do not use it after this time period. The pen cap must be put back on the pen after each injection in order to protect from light.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">6.       Contents of the pack and other information</span></b></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">What ABASAGLAR contains</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The active substance is insulin glargine. Each millilitre of the solution contains 100 units of the active substance insulin glargine (equivalent to 3.64 mg).</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The other ingredients are: zinc oxide, metacresol, glycerol, sodium hydroxide (see section 2 “ABASAGLAR contains sodium”), hydrochloric acid and water for injections.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The Tempo Pen contains a magnet <a name="_Hlk45788345">(see section 2, "Warnings and precautions").</a></span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">What ABASAGLAR looks like and contents of the pack</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR <a name="_Hlk44089800">100 units/m</a>L solution for injection in a pre-filled pen, Tempo Pen, is a clear and colourless solution. </span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">ABASAGLAR is available in packs containing 5 pre‑filled pens and in multipacks comprising 2 cartons, each containing 5 pre‑filled pens.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Not all pack sizes may be marketed.</span></p> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Marketing Authorisation Holder </span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Manufacturer</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly France S.A.S., rue du Colonel Lilly, F-67640 Fegersheim, France.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</span></p> <p class="MsoNormal" style="line-height:normal"></p> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:-1.7pt;border-collapse:collapse" width="624"> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">België/Belgique/Belgien</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Eli Lilly Benelux   S.A./N.V.</span></p> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><span lang="NL">Tél/Tel: + 32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="SV">Lietuva</span></b></p> <p class="MsoNormal" style="margin-right:-22.45pt;line-height:normal"><span lang="SV">Eli Lilly </span><span lang="BG" style="color:black">Lietuva</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="LT">Tel. +370 (5) 2649600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><b><span lang="EN-GB">България</span></b></p> <p class="MsoNormal" style="text-autospace:none"><span lang="BG">ТП   "Ели Лили   Недерланд"   Б.В. - България</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="BG">тел.   +359 2 491 41 40</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Luxembourg/Luxemburg</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Benelux S.A./N.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tél/Tel: +   32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> </tr> <tr style="height:56.5pt"> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Česká   republika</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="CS">ELI LILLY   ČR, s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 420 234   664 111</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Magyarország</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly Hungária Kft.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 36 1   328 5100</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Danmark</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Danmark A/S </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tlf: +45 45 26   60 00</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Malta</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Charles de   Giorgio Ltd.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 356 25600   500</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Deutschland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Lilly Deutschland   GmbH</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel. + 49-(0)   6172 273 2222</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Nederland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Nederland B.V. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 31-(0) 30   60 25 800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Eesti</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="SV" style="color:black">Eli Lilly Nederland   B.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel</span><span lang="ET">: </span><span lang="EN-GB">+372 6 817 280</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Norge</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Eli Lilly   Norge A.S. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Tlf: + 47 22   88 18 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EL">Ελλάδα</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ   Α.Ε.Β.Ε. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">Τηλ: +30 210 629 4600</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Österreich</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Eli Lilly   Ges.m.b.H. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel: + 43-(0) 1   711 780</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">España</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Lilly S.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Tel: + 34-91 663   50 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Polska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Eli Lilly Polska   Sp. z o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="PL">Tel: </span><span lang="EN-GB">+48 22 440 33 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">France</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Lilly France SAS</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Tél: +33-(0) 1 55   49 34 34</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Portugal</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="PT">Lilly Portugal   Produtos Farmacêuticos, Lda</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: +   351-21-4126600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Hrvatska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Hrvatska d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: +385 1   2350 999</span></p> <p class="MsoNormal" style="line-height:normal"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">România</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly România   S.R.L.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: + 40 21   4023000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"><span lang="DA" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Ireland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company (Ireland) Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 353-(0)   1 661 4377</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="RO">Slovenija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly   farmacevtska družba, d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: +386 (0)1   580 00 10</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Ísland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="DA">Icepharma hf.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Sími + 354 540   8000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Slovenská republika</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Eli Lilly Slovakia s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Tel: </span><span lang="SK">+ 421 220 663 111</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">Italia</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FI">Eli Lilly Italia   S.p.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 39- 055   42571</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Suomi/Finland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Oy Eli Lilly   Finland Ab </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Puh/Tel: +   358-(0) 9 85 45 250</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Κύπρος</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Phadisco Ltd </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL">Τηλ</span><span lang="EN-GB">: +357 22 715000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Sverige</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Eli Lilly Sweden   AB</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel: + 46-(0) 8   7378800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Latvija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV" style="color:   black">Eli Lilly (Suisse) S.A Pārstāvniecība Latvijā</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV">Tel: </span><b><span lang="NL">+</span></b><span lang="NL">371 67364000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">United   Kingdom</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 44-(0)   1256 315000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr height="0"> <td style="border:none" width="2"></td> <td style="border:none" width="310"></td> <td style="border:none" width="312"></td> </tr> </table> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">This leaflet was last </span><span lang="EN-GB">revised in </span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other sources of information</span></b></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p> <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Detailed information on this medicine is available on the European Medicines Agency web site: </span><span lang="EN-GB"><a href="http://www.ema.europa.eu/"><span style="color:windowtext">http://www.ema.europa.eu</span></a></span><span lang="EN-GB">. </span></p> </div><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><b><span style='font-size:18.0pt;font-family:"Arial",sans-serif'><br clear="all" style="page-break-before:always"/> </span></b><span style='font-size:18.0pt;font-family:"Arial",sans-serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p align="center" class="MsoHeading7" style="margin-top:6.0pt;text-align:center"><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>Instructions for use</span></p><p align="center" class="MsoHeading7" style="margin-top:6.0pt;text-align:center"><span style='font-size:11.0pt;font-family:"Times New Roman",serif'>ABASAGLAR </span><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'>100 units/mL KwikPen solution for injection in a pre-filled pen</span></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b>i</b><b><span lang="EN-GB">nsulin glargine </span></b></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background:#A6A6A6;border-collapse:collapse"> <tr> <td style="width:384.85pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="513"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center;   line-height:normal"><b><span lang="EN-GB"><img border="0" height="76" id="Picture 3" src="#image26" width="477"/></span></b></p> </td> <td style="width:79.55pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="106"> <p class="MsoNormal" style="margin-top:6.0pt;line-height:normal"></p> </td> </tr> </table> </div><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="background:#A6A6A6;border-collapse:collapse"> <tr> <td style="width:384.85pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="513"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center;   line-height:normal"><b><span lang="EN-GB"><img border="0" height="76" id="Picture 3" src="#image27" width="477"/></span></b></p> </td> <td style="width:79.55pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="106"> <p class="MsoNormal" style="margin-top:6.0pt;line-height:normal"></p> </td> </tr> </table><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251714560"><span style="left:0px;position: absolute;left:1px;top:-31401px;width:604px;height:1px"><img height="1" src="#image28" width="604"/></span></span></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><br clear="ALL"/><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:red">PLEASE READ THESE INSTRUCTIONS BEFORE USE</span></b></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Read the instructions for use before you start taking ABASAGLAR and each time you get another ABASAGLAR KwikPen. There may be new information. This information does not take the place oftalking to your healthcare professional about your medical condition or your treatment.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">ABASAGLAR KwikPen (“Pen”) is a disposable pen containing 300 units (3 mL) of insulin glargine. You can give yourself multiple doses using one pen. The pen dials 1 unit at a time. You can give from 1 to 60 <span style="background:lightgrey">80</span> units in a single injection. <b>If your dose is more than 60 <span style="background: lightgrey">80</span> units, you will need to give yourself more than one injection. </b>The plunger only moves a little with each injection and you may not notice that it moves. The plunger will only reach the end of the cartridge when you have used all 300 units in the pen.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Do not share your pen with other people, even if the needle has been changed. Do not reuse or share needles with other people. You may give an infection to them or get an infection from them.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">This pen is not recommended for use by the blind or visually impaired without the help of someone trained to use the pen.</span></p><p class="MsoNormal" style="line-height:normal"></p><div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="margin-bottom:6.0pt;text-align:center"><b><span style='font-family:"Arial",sans-serif'>KwikPen Parts</span></b></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="86"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:84.2pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="112"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Pen Cap</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="3" nowrap="" style="width:121.5pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="162"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Cartridge Holder</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="90"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Label</span></p> </td> <td colspan="2" nowrap="" style="width:76.6pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="102"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Dose Indicator</span></p> </td> </tr> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'><img border="0" height="63" id="Picture 25" src="#image29" width="508"/></span></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"></p> </td> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Cap Clip</span></p> </td> <td colspan="3" nowrap="" style="width:82.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="111"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Rubber Seal</span></p> </td> <td nowrap="" style="width:1.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Plunger</span></p> </td> <td colspan="3" nowrap="" style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Pen Body</span></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="90"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Dose </span><span lang="EN-GB" style='font-size:9.0pt;font-family:"Arial",sans-serif'><br/> </span><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Window</span></p> </td> <td nowrap="" style="width:45.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="60"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Dose Knob</span></p> </td> </tr> <tr height="0"> <td style="border:none" width="86"></td> <td style="border:none" width="86"></td> <td style="border:none" width="27"></td> <td style="border:none" width="24"></td> <td style="border:none" width="60"></td> <td style="border:none" width="96"></td> <td style="border:none" width="6"></td> <td style="border:none" width="24"></td> <td style="border:none" width="42"></td> <td style="border:none" width="48"></td> <td style="border:none" width="42"></td> <td style="border:none" width="60"></td> </tr> </table> </div><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="margin-bottom:6.0pt;text-align:center"><b><span style='font-family:"Arial",sans-serif'>KwikPen Parts</span></b></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="86"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:84.2pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="112"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Pen Cap</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="3" nowrap="" style="width:121.5pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="162"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Cartridge Holder</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="90"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Label</span></p> </td> <td colspan="2" nowrap="" style="width:76.6pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="102"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Dose Indicator</span></p> </td> </tr> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'><img border="0" height="63" id="Picture 25" src="#image30" width="508"/></span></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"></p> </td> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Cap Clip</span></p> </td> <td colspan="3" nowrap="" style="width:82.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="111"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Rubber Seal</span></p> </td> <td nowrap="" style="width:1.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Plunger</span></p> </td> <td colspan="3" nowrap="" style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Pen Body</span></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="90"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Dose </span><span lang="EN-GB" style='font-size:9.0pt;font-family:"Arial",sans-serif'><br/> </span><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Window</span></p> </td> <td nowrap="" style="width:45.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="60"> <p class="MsoNormal" style="margin-top:2.0pt"><span style='font-size:9.0pt;   font-family:"Arial",sans-serif'>Dose Knob</span></p> </td> </tr> <tr height="0"> <td style="border:none" width="86"></td> <td style="border:none" width="86"></td> <td style="border:none" width="27"></td> <td style="border:none" width="24"></td> <td style="border:none" width="60"></td> <td style="border:none" width="96"></td> <td style="border:none" width="6"></td> <td style="border:none" width="24"></td> <td style="border:none" width="42"></td> <td style="border:none" width="48"></td> <td style="border:none" width="42"></td> <td style="border:none" width="60"></td> </tr> </table><p class="MsoNormal" style="line-height:normal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:5.4pt;border-collapse:collapse"> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><b><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Pen Needle Parts<br/>   (Needles Not Included)</span></b></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'>Dose Knob</span></b><b><span style='font-size:10.0pt;font-family:"Arial",sans-serif'><br/>   with<br/>   green </span></b><b><span lang="EN-GB" style='font-size:10.0pt;font-family:   "Arial",sans-serif'>ring</span></b></p> </td> </tr> <tr style="height:11.2pt"> <td colspan="2" style="width:117.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="156"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td colspan="2" style="width:1.5in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="144"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Needle</span></p> </td> <td style="width:45.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="60"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="72"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="168"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> </tr> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'><img border="0" height="73" id="Picture 26" src="#image31" width="297"/></span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" width="168"> <p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB" style='font-size:10.0pt;font-family:"Arial",sans-serif'><img border="0" height="67" id="Picture 48" src="#image32" width="71"/></span></p> </td> </tr> <tr> <td style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Outer Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Inner Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span style='font-size:10.0pt;font-family:"Arial",sans-serif'>Paper Tab</span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr height="0"> <td style="border:none" width="120"></td> <td style="border:none" width="36"></td> <td style="border:none" width="84"></td> <td style="border:none" width="60"></td> <td style="border:none" width="60"></td> <td style="border:none" width="72"></td> <td style="border:none" width="168"></td> </tr> </table><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal"></p><p class="MsoNormal"><b><span style="layout-grid-mode:line">How to recognise your ABASAGLAR KwikPen</span></b><b><span lang="EN-GB" style='font-family:"Arial",sans-serif'>:</span></b></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Pen colour:         Light grey</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Dose Knob:         Light grey with green ring on the end</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Labels:                Light grey with green colour bars</span></p><p class="MsoHeader" style="margin-top:6.0pt"></p><h5 style="text-align:justify;text-justify:inter-ideograph;background:transparent"><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:windowtext'>Supplies needed to give your injection:</span></h5><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:windowtext'>Supplies needed to give your injection:</span><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">ABASAGLAR KwikPen</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">KwikPen compatible needle (BD [Becton, Dickinson and Company] pen needles recommended). </span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Swab</span></p><p class="MsoNormal"> </p><h5 style="background:transparent"><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Preparing </span><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:windowtext'>your Pen</span></h5><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Preparing </span><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:windowtext'>your Pen</span><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Wash your hands with soap and water</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Check the pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> use your pen past the expiration date printed on the label or for more than 28 days after you first start using the pen.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Always use a <b>new needle</b> for each injection to help prevent infections and blocked needles.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:234.1pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 1:</span></b></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Pull the pen cap straight off.</span></p> <p class="MsoListParagraph" style="margin-left:28.35pt;line-height:normal;   text-autospace:none"><span lang="EN-GB">- Do not remove the pen label.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Wipe the rubber seal with a swab. </span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR should look clear and colourless. <b>Do not</b> use if   it is cloudy, coloured, or has particles or clumps in it.</span></p> </td> <td style="width:230.25pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="307"> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"><span style="position:relative;   z-index:251666432"><span style="position:absolute;left:50px;top:-32534px;   width:158px;height:1px"><img alt="Step1a" height="1" src="#image33" width="158"/></span></span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> </tr> <tr style="height:94.35pt"> <td style="width:234.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:94.35pt" valign="top" width="312"><br clear="ALL"/> <p class="MsoHeader" style="margin-top:6.0pt"><b><span style='font-size:11.0pt;   font-family:"Times New Roman",serif'>Step 2:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Select a new needle.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull off the paper tab from the outer needle shield.</span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> <td style="width:230.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.35pt" valign="top" width="307"> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span style="position:relative;z-index:251667456"><span style="position:absolute;   left:59px;top:-32684px;width:149px;height:1px"><img alt="Step1b" height="1" src="#image34" width="149"/></span></span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> </tr> <tr> <td style="width:234.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 3:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Push the capped needle straight onto the pen   and twist the needle on until it is tight.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:230.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="307"> <p class="MsoHeader" style="margin-top:6.0pt"><span style="position:relative;   z-index:251668480"><span style="position:absolute;left:63px;top:-32817px;   width:149px;height:1px"><img alt="Step1c" height="1" src="#image35" width="149"/></span></span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> </td> </tr> <tr style="height:84.75pt"> <td style="width:234.1pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:84.75pt" valign="top" width="312"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 4:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull off the outer needle shield. <b>Do not</b>   throw it away.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull off the inner needle shield and throw it   away.</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:230.25pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:84.75pt" valign="top" width="307"> <p class="MsoNormal"><span style="position:relative;z-index:251662336"><span style="position:absolute;left:100px;top:-32940px;width:56px;height:1px"><img alt="Throw Away" height="1" src="#image36" width="56"/></span></span><span style="position:relative;z-index:251659264"><span style="position:absolute;left:60px;top:-32940px;width:39px;height:1px"><img alt="Keep" height="1" src="#image37" width="39"/></span></span><span style="position:relative;z-index:251658240"><span style="position:absolute;   left:46px;top:-32940px;width:162px;height:1px"><img alt="Step1d" height="1" src="#image38" width="162"/></span></span></p> </td> </tr> </table><p class="MsoHeader" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p><h5 style="background:transparent"><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Priming your pen</span></h5><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Priming your pen</span><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Prime before each injection.</span></b></p><ul style="margin-top:0in" type="disc"> <li class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Priming your pen means removing the air from the needle and      cartridge that may collect during normal use and ensures that the pen is      working correctly</span><span lang="EN-GB">. </span></li> <li class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you <b>do not</b> prime before each injection, you may get      too much or too little insulin.</span></li> </ul><li class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Priming your pen means removing the air from the needle and      cartridge that may collect during normal use and ensures that the pen is      working correctly</span><span lang="EN-GB">. </span></li><span lang="EN-GB">Priming your pen means removing the air from the needle and      cartridge that may collect during normal use and ensures that the pen is      working correctly</span><span lang="EN-GB">. </span><li class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you <b>do not</b> prime before each injection, you may get      too much or too little insulin.</span></li><span lang="EN-GB">If you <b>do not</b> prime before each injection, you may get      too much or too little insulin.</span><b>do not</b><p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 5:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">To prime your pen, turn the dose knob to   select 2 units.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251669504"><span style="left:0px;position:   absolute;left:76px;top:-33207px;width:141px;height:1px"><img alt="Step2a" height="1" src="#image39" width="141"/></span></span></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 6:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Hold your pen with the needle pointing up. Tap   the cartridge holder gently to collect air bubbles at the top.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <h5 align="center" style="margin-top:6.0pt;text-align:center;background:transparent"><span style="position:relative;z-index:251670528"><span style="left:0px;position:   absolute;left:73px;top:-33338px;width:144px;height:1px"><img alt="Step2b" height="1" src="#image40" width="144"/></span></span></h5> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 7:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Continue holding your pen with needle pointing   up. Push the dose knob in until it stops, and “0” is seen in the dose window.   Hold the dose knob in and count to 5 slowly.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoListParagraph" style="margin-left:28.35pt;line-height:normal;   text-autospace:none"><span lang="EN-GB">You should see insulin at the tip of   the needle.</span></p> <p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height:   normal;text-autospace:none"><span lang="EN-GB">-    If you <b>do not</b> see   insulin, repeat the priming steps, but not more than 4 times.</span></p> <p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height:   normal;text-autospace:none"><span lang="EN-GB">-    If you <b>still do not</b>   see insulin, change the needle and repeat the priming steps.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Small air bubbles are normal and will not affect your dose.</span></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251672576"><span style="left:0px;position:   absolute;left:89px;top:-33461px;width:124px;height:1px"><img height="1" src="#image41" width="124"/></span></span></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251671552"><span style="left:0px;position:   absolute;left:84px;top:-33530px;width:133px;height:1px"><img alt="Step2c_2" height="1" src="#image42" width="133"/></span></span></p> </td> </tr> </table><p class="MsoNormal"></p><h5 style="background:transparent"><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Selecting your dose</span></h5><span style='font-size:11.0pt;font-family: "Times New Roman",serif;color:windowtext'>Selecting your dose</span><p class="IFUBulletedBodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol;color:windowtext">·</span><span lang="EN-GB" style='font-family:"Times New Roman",serif; color:windowtext'>You can give from 1 to 60<span style="background:lightgrey">80</span> units in a single injection.</span></p><p class="IFUBulletedBodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol;color:windowtext">·</span><span lang="EN-GB" style='font-family:"Times New Roman",serif; color:windowtext'>If your dose is more than 60<span style="background:lightgrey">80</span> units, you will need to give more than one injection.</span></p><p class="IFUBulletedBodyText2" style="margin-left:42.55pt;text-indent:-14.2pt"><span lang="EN-GB" style='font-family:"Times New Roman",serif;color:windowtext'>–   If you need help deciding how to divide up your dose, ask your healthcare professional.</span></p><p class="IFUBodyText" style="margin-left:42.55pt;text-indent:-14.2pt"><span lang="EN-GB" style='font-family:"Times New Roman",serif'>–   You should use a new needle for each injection and repeat the priming step.</span></p><p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p><table align="left" border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:  6.75pt"> <tr> <td style="width:229.8pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="306"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 8:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Turn the dose knob to select the number of   units you need to inject. The dose indicator should line up with your dose.</span></p> <p class="MsoListParagraphCxSpFirst" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The pen dials 1 unit at a time.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The dose knob clicks as you turn it.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">DO NOT dial your dose by counting the clicks because you may dial   the wrong dose.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The dose can be corrected by turning the dose knob in either   direction until the correct dose lines up with the dose indicator.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The <b>even</b> numbers are printed on the dial.</span></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:0in;line-height:normal;   text-autospace:none"></p> <p class="MsoListParagraphCxSpMiddle" style="margin-left:42.55pt;text-indent:   -14.2pt;line-height:normal;text-autospace:none"><span lang="EN-GB">-</span><span lang="EN-GB">The <b>odd </b>numbers, after the number 1, are shown as full   lines.</span></p> <p class="MsoListParagraphCxSpLast" style="line-height:normal;text-autospace:   none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><b><span lang="EN-GB">Always check the number in the Dose Window   to make sure you have dialled the correct dose</span></b><span lang="EN-GB">.</span></p> <p class="MsoNormal"> </p> </td> <td style="width:234.55pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="313"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251673600"><span style="position:absolute;left:69px;top:-33884px;   width:141px;height:1px"><img alt="Step3a" height="1" src="#image43" width="141"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:53.7pt;margin-bottom:.0001pt"><span lang="EN-GB"><img border="0" height="128" id="Group 37" src="#image44" width="132"/></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">(Example: 12 units   shown in the dose window)</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:53.7pt;margin-bottom:.0001pt"><span lang="EN-GB"><img border="0" height="129" id="Group 48" src="#image45" width="144"/></span></p> <p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">(Example: 25 units   shown in the dose window)</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> </table><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">The pen will not let you dial more than the number of units left in the pen.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">If you need to inject more than the number of units left in the pen, you may either:</span></p><p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-    inject the amount left in your pen and then use a new pen to give the rest of your dose, <b>or</b></span></p><p class="MsoNormal" style="margin-left:42.55pt;text-indent:-14.2pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-    get a new pen and inject the full dose.</span></p><p class="MsoListParagraph" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">It is normal to see a small amount of insulin left in the pen that you cannot inject.</span></p><p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p><p class="MsoHeading8"><span style='font-family:"Times New Roman",serif'>Giving your injection</span></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Inject your insulin as your healthcare professional has shown you.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Change (rotate) your injection site for each injection.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> try to change your dose while injecting.</span></p><p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:0in; margin-left:.25in;margin-bottom:.0001pt"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="width:466.1pt;border-collapse:collapse;border:none" width="621"> <tr> <td style="width:239.3pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="319"> <h2 style="margin-top:6.0pt"><span style="font-size:11.0pt">Step 9:</span></h2> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Choose your injection site.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">ABASAGLAR is injected under the skin   (subcutaneously) of your stomach area, buttocks, upper legs or upper arms.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Prepare your skin as recommended by your   healthcare professional.</span></p> <p class="MsoNormal"> </p> </td> <td style="width:3.15in;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="302"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251661312"><span style="left:0px;position:   absolute;left:85px;top:-34636px;width:117px;height:1px"><img height="1" src="#image46" width="117"/></span></span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> </td> </tr> <tr style="height:75.55pt"> <td style="width:239.3pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:75.55pt" valign="top" width="319"><br clear="ALL"/> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 10: </span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Insert the needle into your skin.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Push the dose knob all the way in</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:67.4pt;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-family:Symbol">·</span><span style="position:relative;z-index:251664384"><span style="left:0px;position:absolute;left:244px;top:-34867px;width:38px;   height:1px"><img alt="5sec" height="1" src="#image47" width="38"/></span></span><span style="position:relative;z-index:-1895809024"><span style="left:0px;   position:absolute;left:231px;top:-34867px;width:66px;height:1px"><img alt="clock" height="1" src="#image48" width="66"/></span></span><span lang="EN-GB">Continue to hold the dose knob in and <b>slowly count</b> to 5   before removing the needle.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> try to inject your insulin by   turning the dose knob. You will <b>NOT</b> receive your insulin by turning   the dose knob.</span></p> </td> <td style="width:3.15in;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:75.55pt" valign="top" width="302"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251679744"><span style="left:0px;position:   absolute;left:40px;top:-34823px;width:205px;height:1px"><img height="1" src="#image49" width="205"/></span></span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> </td> </tr> <tr style="height:112.95pt"> <td style="width:239.3pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt;height:112.95pt" valign="top" width="319"><br clear="ALL"/> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 11:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Pull the needle out of your skin.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- A drop of insulin at the needle tip is normal. It   will not affect your dose.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Check the number in the dose window</span></p> <p class="MsoNormal" style="margin-left:10.35pt;line-height:normal;text-autospace:   none"></p> <p class="MsoNormal" style="margin-left:28.35pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you see “0” in the dose window, you have received   the full amount you dialled.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you do not see “0” in the dose window, <b>do not</b>   redial. Insert the needle into your skin and finish your injection.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you <b>still</b> do not think you received the   full amount you dialled for your injection, <b>do not start over or repeat   that injection</b>. Monitor your blood glucose as instructed by your healthcare   professional.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;margin-right:0in;margin-bottom:   0in;margin-left:28.35pt;margin-bottom:.0001pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">- If you normally need to give 2 injections for your   full dose, be sure to give your second injection.</span></p> <p class="MsoNormal" style="margin-top:6.0pt;line-height:normal;text-autospace:   none"><span lang="EN-GB">The plunger only moves a little with each injection   and you may not notice that it moves.</span></p> <p class="MsoNormal" style="margin-top:6.0pt"><span lang="EN-GB">If you see blood   after you take the needle out of your skin, press the injection site lightly   with a piece of gauze or swab. <b>Do not</b> rub the area.</span></p> </td> <td style="width:3.15in;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:112.95pt" valign="top" width="302"> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251675648"><span style="left:0px;position:   absolute;left:56px;top:-35052px;width:174px;height:1px"><img alt="Step4c" height="1" src="#image50" width="174"/></span></span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> </td> </tr> </table><p class="MsoNormal"></p><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b><span style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p class="MsoHeading8"><span style='font-family:"Times New Roman",serif'>After your injection</span></p><p class="MsoNormal"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 12:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Carefully replace the outer needle shield.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251676672"><span style="position:absolute;left:75px;top:-35622px;   width:148px;height:1px"><img alt="Step5a" height="1" src="#image51" width="148"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> <tr style="page-break-inside:avoid"> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 13:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Unscrew the capped needle and dispose of it as   directed by your healthcare professional.</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Do not store the pen with the needle attached   to prevent leaking, blocking the needle, and air from entering the pen.</span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251677696"><span style="position:absolute;left:79px;top:-35763px;   width:144px;height:1px"><img alt="Step5b" height="1" src="#image52" width="144"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> <tr> <td style="width:243.7pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><b><span lang="EN-GB">Step 14:</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;   line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:   Symbol">·</span><span lang="EN-GB">Replace the pen cap by lining up the cap clip   with the dose indicator and pushing straight on.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> <td style="width:243.75pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="325"> <p class="MsoNormal" style="margin-top:6.0pt"><span style="position:relative;   z-index:251678720"><span style="position:absolute;left:36px;top:-35923px;   width:193px;height:1px"><img alt="Step5c" height="1" src="#image53" width="193"/></span></span></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> <p class="MsoNormal" style="margin-top:6.0pt"></p> </td> </tr> </table><p class="MsoNormal"></p><p class="TableText" style="margin-top:0in;text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Disposing of pens and needles</span></b></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Put used needles in a closable, puncture-resistant sharps container. </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Do not recycle the filled sharps container.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">Ask your healthcare professional about options to dispose of the pens and sharps container properly.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">The directions regarding needle handling are not intended to replace local, healthcare professional or institutional policies.</span></p><p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"></p><p class="TableText" style="margin-top:0in;text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Storing your pen</span></b></p><p class="TableText" style="text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Unused pens</span></b></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Store unused pens in the refrigerator at 2 ° C to 8 ° C.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> freeze ABASAGLAR. <b>Do not</b> use if it has been frozen.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Unused pens may be used until the expiration date printed on the label, if the pen has been kept in the refrigerator.</span></p><p class="TableText" style="text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>In-use pen</span></b></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Store the pen you are currently using at room temperature [below 30 ° C] and away from heat and light.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Throw away the pen you are using after 28 days, even if it still has insulin left in it. </span></p><p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph"></p><p class="TableText" style="margin-top:0in;text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>General information about the safe and effective use of your pen</span></b></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><b><span lang="EN-GB">Keep your pen and needles out of the sight and reach of children. </span></b></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Do not</span></b><span lang="EN-GB"> use your pen if any part looks broken or damaged.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">Always carry an extra pen in case yours is lost or damaged.</span></p><p class="TableText" style="text-align:justify;text-justify:inter-ideograph; page-break-after:auto"><b><span style='font-size:11.0pt;font-family:"Times New Roman",serif; color:windowtext'>Troubleshooting</span></b></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family: Symbol">·</span><span lang="EN-GB">If you cannot remove the pen cap, gently twist the cap back and forth, and then pull the cap straight off.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:28.35pt;text-indent: -28.35pt;line-height:normal;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><span lang="EN-GB">If the dose knob it is hard to push:</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:56.7pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB">- Pushing the dose knob more slowly will make it easier to inject.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left:56.7pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB">- Your needle may be blocked. Put on a new needle and prime the pen.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:56.7pt;text-indent:-28.35pt; line-height:normal;text-autospace:none"><span lang="EN-GB">- You may have dust, food, or liquid inside the pen. Throw the pen away and get a new pen.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any questions or problems with your ABASAGLAR KwikPen, contact your healthcare professional for assistance.</span></p><p class="MsoNormal" style="margin-right:-.1pt;text-align:justify;text-justify: inter-ideograph;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;text-align:justify;text-justify: inter-ideograph;line-height:normal"><b><span lang="EN-GB">This leaflet was last </span><span lang="EN-GB">revised in </span></b></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; color:black'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p align="center" class="MsoNormal" style="margin-top:14.0pt;margin-right:6.0pt; margin-bottom:11.0pt;margin-left:6.35pt;text-align:center;page-break-after: avoid;text-autospace:none"></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal; text-autospace:none"><b><span lang="EN-GB">Package leaflet: Information for the user</span></b></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><b><span lang="EN-GB">ABASAGLAR 100 units/mL Tempo Pen solution for injection in a pre-filled pen</span></b></p><p align="center" class="MsoNormal" style="text-align:center;line-height:normal"><span lang="EN-GB">insulin glargine</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Read all of this leaflet carefully including the Instructions for Use of the ABASAGLAR Tempo pre-filled pen, before you start using this medicine because it contains important information for you.</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoListParagraphCxSpFirst" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB">-</span><span lang="EN-GB">Keep this leaflet. You may need to read it again. </span></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you have any further questions, ask your doctor, pharmacist or nurse.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-top:0in;margin-right:-.1pt; margin-bottom:0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left:28.35pt;text-indent:-28.35pt; line-height:normal"><span lang="EN-GB">-</span><span lang="EN-GB">If you get any side effects, talk to your doctor, pharmacist or nurse.</span><span lang="EN-GB"> This includes any possible side effects not listed in this leaflet. See section 4.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
	
		
		
    	    
				
			    
						
		               
<section>
			<title value="What is in this leaflet"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <div style="border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Hypoglycaemia is also more likely to occur if</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have just begun insulin treatment or changed to another insulin preparation (when changing from your previous basal insulin to ABASAGLAR, hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your blood sugar levels are almost normal or are unstable,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you change the area of skin where you inject insulin (for example from the thigh to the upper arm),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you suffer from severe kidney or liver disease, or some other disease such as hypothyroidism.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Warning symptoms of hypoglycaemia</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your body</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that tell you that your blood sugar level is falling too much or too fast: sweating, clammy skin, anxiety, fast heart beat, high blood pressure, palpitations and irregular heartbeat. These symptoms often develop before the symptoms of a low sugar level in the brain.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your brain</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that indicate a low sugar level in the brain: headaches, intense hunger, nausea, vomiting, tiredness, sleepiness, sleep disturbances, restlessness, aggressive behaviour, lapses in concentration, impaired reactions, depression, confusion, speech disturbances (sometimes total loss of speech), visual disorders, trembling, paralysis, tingling sensations (paraesthesia), numbness and tingling sensations in the area of the mouth, dizziness, loss of self-control, inability to look after yourself, convulsions, loss of consciousness.</span></p> <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph; line-height:normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">The first symptoms which alert you to hypoglycaemia ("warning symptoms") may change, be weaker or may be missing altogether if</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are elderly, if you have had diabetes for a long time or if you suffer from a certain type of nervous disease (diabetic autonomic neuropathy),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have almost normal or, at least, greatly improved blood sugar levels,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently changed from an animal insulin to a human insulin such as ABASAGLAR,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">In such a case, you may develop severe hypoglycaemia (and even faint) before you are aware of the problem. Be familiar with your warning symptoms. If necessary, more frequent blood sugar testing can help to identify mild hypoglycaemic episodes that may otherwise be overlooked. If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">What should you do if you experience hypoglycaemia?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">1. Do not inject insulin. Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage. Caution: Artificial sweeteners and foods with artificial sweeteners (such as diet drinks) are of no help in treating hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">2. Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). Your doctor or nurse should have discussed this with you previously.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">The recovery of hypoglycaemia may be delayed because ABASAGLAR has a long action.'</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">3. If the hypoglycaemia comes back again, take another 10 to 20 g sugar.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">4. Speak to a doctor immediately if you are not able to control the hypoglycaemia or if it recurs. Tell your relatives, friends and close colleagues the following:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">If you are not able to swallow or if you are unconscious, you will require an injection of glucose or glucagon (a medicine which increases blood sugar). These injections are justified even if it is not certain that you have hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">It is advisable to test your blood sugar immediately after taking glucose to check that you really have hypoglycaemia.</span></p> </div><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="1.       What ABASAGLAR is and what it is used for "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="2.       What you need to know before you use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="3.       How to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="4.       Possible side effects "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="6.       Contents of the pack and other information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
	
		
		
    	    
				
			    
						
		               
<section>
			<title value="1.       What ABASAGLAR is and what it is used for"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="ABASAGLAR contains insulin glargine. This is a modified insulin, very similar to human insulin."/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is used to treat diabetes mellitus in adults, adolescents and children aged 2 years and above.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Diabetes mellitus is a disease where your body does not produce enough insulin to control the level of blood sugar. Insulin glargine has a long and steady blood-sugar-lowering action.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">2.       What you need to know before you use ABASAGLAR</span></b></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="Do not use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i></p><p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><a name="_Hlk38985814"><i><span lang="EN-GB">Insulin mix-ups</span></i></a></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check the pack and the insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><i><span lang="EN-GB">Tempo Pen</span></i></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">The Tempo Pen contains a magnet. If you have a medical device fitted, such as a heart pacemaker, this may not work correctly if the Tempo Pen is held too close. </span><span lang="EN-GB">T</span><span lang="EN-GB">he magnetic field extends to approximately 1.5 cm</span><span lang="EN-GB">.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">all other medicines to treat diabetes,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">disopyramide (used to treat certain heart conditions),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fluoxetine (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fibrates (used to lower high levels of blood lipids),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sulphonamide antibiotics.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">corticosteroids (such as "cortisone" used to treat inflammation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">danazol (medicine acting on ovulation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">diazoxide (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">diuretics (used to treat high blood pressure or excessive fluid retention),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">isoniazid (used to treat tuberculosis),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">phenothiazine derivatives (used to treat psychiatric disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatropin (growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">thyroid hormones (used to treat thyroid gland disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">protease inhibitors (used to treat HIV).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">beta-blockers (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">clonidine (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">lithium salts (used to treat psychiatric disorders).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia </span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle ABASAGLAR Tempo Pen</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR Tempo Pen is a pre-filled disposable pen containing insulin glargine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Read carefully the "</span></b><b><span lang="EN-GB">ABASAGLAR Tempo Pen Instructions for Use" included with this package leaflet. You must use the pen as described in these Instructions for Use.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A new needle must be attached before each use. Only use needles that are compatible for use with ABASAGLAR Tempo Pen (see “ABASAGLAR Tempo Pen Instructions for Use”).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A safety test must be performed before each injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use the pen. Do not use ABASAGLAR Tempo Pen if you notice particles in it. Only use ABASAGLAR Tempo Pen if the solution is clear, colourless and water-like. Do not shake or mix it before use.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse. If you think you may have a problem with ABASAGLAR Tempo Pen, consult your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Empty pens must not be re-filled and must be properly discarded.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use ABASAGLAR Tempo Pen if it is damaged or not working properly, it has to be discarded and a new Tempo Pen has to be used.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoCommentText"><a name="_Hlk56610361"><span lang="EN-GB" style="font-size:11.0pt">The Tempo Pen is designed to work with the Tempo Smart Button.</span></a><span lang="EN-GB" style="font-size:11.0pt"> The optional additional feature Tempo Smart Button is a product available for the Tempo Pen, which may be used for transmitting dose information to a mobile application. The Tempo Pen can be used with or without the Tempo Smart Button attached. See instructions provided with the Tempo Smart Button and the mobile application for further information. </span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you use more ABASAGLAR than you should"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR </b></span><span lang="EN-GB">or are unsure how much you have injected</span><b><span lang="EN-GB">,</span></b><span lang="EN-GB">, your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you forget to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you stop using ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="Do not use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are allergic to insulin glargine or any of the other ingredients of this medicine (listed in section 6).</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Warnings and precautions </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Talk to your doctor, pharmacist or nurse before using ABASAGLAR.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If your blood sugar is too low (hypoglycaemia), follow the guidance for hypoglycaemia (see box at the end of this leaflet).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal"><i><span lang="EN-GB">Skin changes at the injection site</span></i></p><p class="MsoNormal"><span lang="EN-GB">The injection site should be rotated to prevent skin changes such as lumps under the skin. The insulin may not work well if you inject into a lumpy area (See How to use Abasaglar). Contact your doctor if you are currently injecting into a lumpy area before you start injecting into a different area. Your doctor may tell you to check your blood sugar more closely, and to adjust your insulin or your other antidiabetic medications dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Travel</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Before travelling consult your doctor. You may need to talk about:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the availability of your insulin in the country you are visiting,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        supplies of insulin etc.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        correct storage of your insulin while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        timing of meals and insulin administration while travelling,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        the possible effects of changing to different time zones,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        possible new health risks in the countries to be visited,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        what you should do in emergency situations when you feel unwell or become ill.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Illnesses and injuries</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In the following situations, the management of your diabetes may require a lot of care (for example, adjustment to insulin dose, blood and urine tests):</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are ill or have a major injury then your blood sugar level may increase (hyperglycaemia).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you are not eating enough your blood sugar level may become too low (hypoglycaemia).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In most cases you will need a doctor. <b>Make sure that you contact a doctor early.</b></span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have type 1 diabetes (insulin dependent diabetes mellitus), do not stop your insulin and continue to get enough carbohydrates. Always tell people who are caring for you or treating you that you require insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Insulin treatment can cause the body to produce antibodies to insulin (substances that act against insulin). However, only very rarely, this will require a change to your insulin dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. Inform your doctor as soon as possible if you experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><a name="_Hlk38985814"><i><span lang="EN-GB">Insulin mix-ups</span></i></a></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">You must always check the pack and the insulin label before each injection to avoid mix-ups between ABASAGLAR and other insulins.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"><i><span lang="EN-GB">Tempo Pen</span></i></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">The Tempo Pen contains a magnet. If you have a medical device fitted, such as a heart pacemaker, this may not work correctly if the Tempo Pen is held too close. </span><span lang="EN-GB">T</span><span lang="EN-GB">he magnetic field extends to approximately 1.5 cm</span><span lang="EN-GB">.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Children</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">There is no experience with the use of ABASAGLAR in children below the age of 2 years.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Other medicines and ABASAGLAR</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Some medicines cause changes in the blood sugar level (decrease, increase or both depending on the situation). In each case, it may be necessary to adjust your insulin dose to avoid blood sugar levels that are either too low or too high. Be careful when you start or stop taking another medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Before taking a medicine ask your doctor if it can affect your blood sugar level and what action, if any, you need to take.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to fall (hypoglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">all other medicines to treat diabetes,</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">disopyramide (used to treat certain heart conditions),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fluoxetine (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">fibrates (used to lower high levels of blood lipids),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">monoamine oxidase (MAO) inhibitors (used to treat depression),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">pentoxifylline, propoxyphene, salicylates (such as aspirin, used to relieve pain and lower fever), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sulphonamide antibiotics.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Medicines that may cause your blood sugar level to rise (hyperglycaemia) include:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">corticosteroids (such as "cortisone" used to treat inflammation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">danazol (medicine acting on ovulation),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">diazoxide (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">diuretics (used to treat high blood pressure or excessive fluid retention),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">glucagon (pancreas hormone used to treat severe hypoglycaemia),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">isoniazid (used to treat tuberculosis),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">oestrogens and progestogens (such as in the contraceptive pill used for birth control), </span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">phenothiazine derivatives (used to treat psychiatric disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">somatropin (growth hormone),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline used to treat asthma),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">thyroid hormones (used to treat thyroid gland disorders),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">atypical antipsychotic medicines (such as clozapine, olanzapine),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">protease inhibitors (used to treat HIV).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><i><span lang="EN-GB">Your blood sugar level may either rise or fall if you take:</span></i></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">beta-blockers (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">clonidine (used to treat high blood pressure),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB" style='font-size:10.0pt; font-family:"Courier New"'>­</span><span lang="EN-GB">lithium salts (used to treat psychiatric disorders).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pentamidine (used to treat some infections caused by parasites) may cause hypoglycaemia which may sometimes be followed by hyperglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Beta-blockers like other sympatholytic medicines (such as clonidine, guanethidine, and reserpine) may weaken or suppress entirely the first warning symptoms which help you to recognise a hypoglycaemia </span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">If you are not sure whether you are taking one of those medicines ask your doctor or pharmacist.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">ABASAGLAR with alcohol</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your blood sugar levels may either rise or fall if you drink alcohol.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Pregnancy and breast-feeding</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Ask your doctor or pharmacist for advice before taking any medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Inform your doctor if you are planning to become pregnant, or if you are already pregnant. Your insulin dose may need to be changed during pregnancy and after giving birth. Particularly careful control of your diabetes, and prevention of hypoglycaemia, is important for the health of your baby.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are breast-feeding consult your doctor as you may require adjustments in your insulin doses and your diet.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Driving and using machines</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your ability to concentrate or react may be reduced if:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hypoglycaemia (low blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have hyperglycaemia (high blood sugar levels),</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        you have problems with your sight.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this possible problem in mind in all situations where you might put yourself and others at risk (such as driving a car or using machines). You should contact your doctor for advice on driving if:</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        you have frequent episodes of hypoglycaemia,</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        the first warning symptoms which help you to recognise hypoglycaemia are reduced or absent.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">ABASAGLAR contains sodium</span></b></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">This medicine contains less than 1 mmol (23 mg) sodium per dose, which means it is essentially ‘sodium-free’.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR can be used in adolescents and children aged 2 years and above. Use this medicine exactly as your doctor has told you.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Frequency of administration</span></b></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">You need one injection of ABASAGLAR every day, at the same time of the day.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Method of administration</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR is injected under the skin. Do NOT inject ABASAGLAR in a vein, since this will change its action and may cause hypoglycaemia.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Your doctor will show you in which area of the skin you should inject ABASAGLAR. With each injection, change the puncture site within the particular area of skin that you are using.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">How to handle ABASAGLAR Tempo Pen</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR Tempo Pen is a pre-filled disposable pen containing insulin glargine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Read carefully the "</span></b><b><span lang="EN-GB">ABASAGLAR Tempo Pen Instructions for Use" included with this package leaflet. You must use the pen as described in these Instructions for Use.</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A new needle must be attached before each use. Only use needles that are compatible for use with ABASAGLAR Tempo Pen (see “ABASAGLAR Tempo Pen Instructions for Use”).</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">A safety test must be performed before each injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Look at the cartridge before you use the pen. Do not use ABASAGLAR Tempo Pen if you notice particles in it. Only use ABASAGLAR Tempo Pen if the solution is clear, colourless and water-like. Do not shake or mix it before use.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">To prevent the possible transmission of disease, each pen must be used by one patient only.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse. If you think you may have a problem with ABASAGLAR Tempo Pen, consult your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Empty pens must not be re-filled and must be properly discarded.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use ABASAGLAR Tempo Pen if it is damaged or not working properly, it has to be discarded and a new Tempo Pen has to be used.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoCommentText"><a name="_Hlk56610361"><span lang="EN-GB" style="font-size:11.0pt">The Tempo Pen is designed to work with the Tempo Smart Button.</span></a><span lang="EN-GB" style="font-size:11.0pt"> The optional additional feature Tempo Smart Button is a product available for the Tempo Pen, which may be used for transmitting dose information to a mobile application. The Tempo Pen can be used with or without the Tempo Smart Button attached. See instructions provided with the Tempo Smart Button and the mobile application for further information. </span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you use more ABASAGLAR than you should"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you <b>have injected too much ABASAGLAR </b></span><span lang="EN-GB">or are unsure how much you have injected</span><b><span lang="EN-GB">,</span></b><span lang="EN-GB">, your blood sugar level may become too low (hypoglycaemia). Check your blood sugar frequently. In general, to prevent hypoglycaemia you must eat more food and monitor your blood sugar. For information on the treatment of hypoglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you forget to use ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        If you have missed a dose of ABASAGLAR or if you have not injected enough insulin </span><span lang="EN-GB">or are unsure how much you have injected</span><span lang="EN-GB">, your blood sugar level may become too high (hyperglycaemia). Check your blood sugar frequently. For information on the treatment of hyperglycaemia, see box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">-        Do not take a double dose to make up for a forgotten dose.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:.55pt;line-height:normal;page-break-after: avoid"><b><span lang="EN-GB">After injecting</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you are unsure how much you have injected then check your blood sugar levels before deciding if you need another injection.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="If you stop using ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">This could lead to severe hyperglycaemia (very high blood sugar) and ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar). Do not stop ABASAGLAR without speaking to a doctor, who will tell you what needs to be done.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="4.       Possible side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">If you notice signs of your blood sugar being too low (hypoglycaemia), </span></b><span lang="EN-GB">taketheaction to increase your blood sugar levels <b>immediately</b></span><span lang="EN-GB">. Hypoglycaemia (low blood sugar) can be very serious and is very common with insulin treatment (may affect more than 1 in 10 people). Low blood sugar means that there is not enough sugar in your blood. If your blood sugar level falls too low, you may pass out (become unconscious). Serious hypoglycaemia may cause brain damage and may be life-threatening. For more information, see the box at the end of this leaflet.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><b><span lang="EN-GB">Severe allergic reactions </span></b><span lang="EN-GB">(rare, may affect up to 1 in 1,000 people) – the signs </span><span lang="EN-GB">may include large-scale skin reactions (rash and itching all over the body), severe swelling of skin or mucous membranes (angiooedema), shortness of breath, a fall in blood pressure with rapid heartbeat and sweating. Severe allergic reactions to insulins may become life-threatening. Tell a doctor straight away if you notice signs of severe allergic reaction.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Skin changes at the injection site</span></b></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><span lang="EN-GB">If you inject insulin too often at the same place, the fatty tissue may shrink (lipoatrophy, may affect up to 1 in 100 people) or thicken (lipohypertrophy, may affect up to 1 in 10 people). Lumps under the skin may also be caused by build-up of a protein called amyloid (cutaneous amyloidosis, how often they occur is not known). The insulin may not work very well if you inject into a lumpy area. Change the injection site with each injection to help prevent these skin changes.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;page-break-after:avoid;text-autospace: none"><b><span lang="EN-GB">Common side effects </span></b><span lang="EN-GB">(may affect up to 1 in 10 people)</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoListParagraph" style="margin-top:0in;margin-right:0in;margin-bottom: 10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal;page-break-after: avoid;text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Skin and allergic reactions at the injection site</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">The signs may include reddening, unusually intense pain when injecting, itching, hives, swelling or inflammation. They can spread around the injection site. Most minor reactions to insulins usually disappear in a few days to a few weeks.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Rare side effects </span></b><span lang="EN-GB">(may affect up to 1 in 1,000 people)</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">Eye reactions</span></b></p><p class="MsoListParagraphCxSpLast" style="margin-left:0in"><span lang="EN-GB">A marked change (improvement or worsening) in your blood sugar control can disturb your vision temporarily. If you have proliferative retinopathy (an eye disease related to diabetes) severe hypoglycaemic attacks may cause temporary loss of vision.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p><p class="MsoListParagraphCxSpFirst" style="margin-top:0in;margin-right:0in; margin-bottom:10.0pt;margin-left:28.35pt;text-indent:-28.35pt;line-height:normal; text-autospace:none"><span lang="EN-GB" style="font-family:Symbol">·</span><b><span lang="EN-GB">General disorders</span></b></p><p class="MsoListParagraphCxSpLast" style="margin-left:0in;line-height:normal; text-autospace:none"><span lang="EN-GB">In rare cases, insulin treatment may also cause temporary build-up of water in the body, with swelling in the calves and ankles.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="EN-GB">Very rare side-effects </span></b><span lang="EN-GB">(may affect up to1 in 10,000 people)</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">In very rare cases, dysgeusia (taste disorders) and myalgia (muscular pain) can occur.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Use in children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"><span lang="EN-GB">In general, the side effects in children and adolescents of 18 years of age or less are similar to those seen in adults.</span></p><p class="MsoNormal" style="margin-right:-1.45pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Complaints of injection site reactions (injection site pain, injection site reaction) and skin reactions (rash, urticaria) are reported relatively more frequently in children and adolescents of 18 years of age or less than in adults.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Reporting of side effects"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background:lightgrey">the national reporting system listed in</span> </span><span lang="EN-GB"><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><span style="color:windowtext;background:lightgrey">Appendix V</span></a></span><span lang="EN-GB">. By reporting side effects you can help provide more information on the safety of this medicine.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store ABASAGLAR"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep this medicine out of the sight and reach of children.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not use this medicine after the expiry date which is stated on the carton and on the label of the pen after “EXP”. The expiry date refers to the last day of that month.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">Not in-use pens</span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Store in a refrigerator (2 °C – 8 °C). Do not freeze. </span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not put ABASAGLAR next to the freezer compartment or a freezer pack.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Keep the pre-filled pen in the outer carton in order to protect from light.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB"></span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><u><span lang="EN-GB">In-use pens</span></u></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Pre-filled pens in use or carried as a spare may be stored for a maximum of 28 days up to 30 °C and away from direct heat or direct light. The pen in use must not be stored in the refrigerator. Do not use it after this time period. The pen cap must be put back on the pen after each injection in order to protect from light.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="6.       Contents of the pack and other information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="What ABASAGLAR contains"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The active substance is insulin glargine. Each millilitre of the solution contains 100 units of the active substance insulin glargine (equivalent to 3.64 mg).</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The other ingredients are: zinc oxide, metacresol, glycerol, sodium hydroxide (see section 2 “ABASAGLAR contains sodium”), hydrochloric acid and water for injections.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"><span lang="EN-GB">-        The Tempo Pen contains a magnet <a name="_Hlk45788345">(see section 2, "Warnings and precautions").</a></span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="What ABASAGLAR looks like and contents of the pack"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">ABASAGLAR <a name="_Hlk44089800">100 units/m</a>L solution for injection in a pre-filled pen, Tempo Pen, is a clear and colourless solution. </span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">ABASAGLAR is available in packs containing 5 pre‑filled pens and in multipacks comprising 2 cartons, each containing 5 pre‑filled pens.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Not all pack sizes may be marketed.</span></p><p class="MsoNormal" style="line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Marketing Authorisation Holder </span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands.</span></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><b><span lang="EN-GB">Manufacturer</span></b></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly France S.A.S., rue du Colonel Lilly, F-67640 Fegersheim, France.</span></p><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="line-height:normal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:-1.7pt;border-collapse:collapse" width="624"> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">België/Belgique/Belgien</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Eli Lilly Benelux   S.A./N.V.</span></p> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><span lang="NL">Tél/Tel: + 32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><b><span lang="SV">Lietuva</span></b></p> <p class="MsoNormal" style="margin-right:-22.45pt;line-height:normal"><span lang="SV">Eli Lilly </span><span lang="BG" style="color:black">Lietuva</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="LT">Tel. +370 (5) 2649600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="margin-right:1.7pt;line-height:normal"><b><span lang="EN-GB">България</span></b></p> <p class="MsoNormal" style="text-autospace:none"><span lang="BG">ТП   "Ели Лили   Недерланд"   Б.В. - България</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="BG">тел.   +359 2 491 41 40</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Luxembourg/Luxemburg</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Benelux S.A./N.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tél/Tel: +   32-(0)2 548 84 84</span></p> <p class="PIbodytext"></p> </td> </tr> <tr style="height:56.5pt"> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Česká   republika</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="CS">ELI LILLY   ČR, s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 420 234   664 111</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt;   height:56.5pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Magyarország</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none"><span lang="EN-GB">Lilly Hungária Kft.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 36 1   328 5100</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Danmark</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly   Danmark A/S </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tlf: +45 45 26   60 00</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Malta</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Charles de   Giorgio Ltd.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 356 25600   500</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Deutschland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Lilly Deutschland   GmbH</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel. + 49-(0)   6172 273 2222</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Nederland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Nederland B.V. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: + 31-(0) 30   60 25 800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Eesti</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="SV" style="color:black">Eli Lilly Nederland   B.V.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel</span><span lang="ET">: </span><span lang="EN-GB">+372 6 817 280</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Norge</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Eli Lilly   Norge A.S. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NO-NYN">Tlf: + 47 22   88 18 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> <td style="width:232.2pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="310"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EL">Ελλάδα</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">ΦΑΡΜΑΣΕΡΒ-ΛΙΛΛΥ   Α.Ε.Β.Ε. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL" style="layout-grid-mode:   line">Τηλ: +30 210 629 4600</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Österreich</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Eli Lilly   Ges.m.b.H. </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ET">Tel: + 43-(0) 1   711 780</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">España</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Lilly S.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="ES">Tel: + 34-91 663   50 00</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Polska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Eli Lilly Polska   Sp. z o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="PL">Tel: </span><span lang="EN-GB">+48 22 440 33 00</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">France</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Lilly France SAS</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="FR">Tél: +33-(0) 1 55   49 34 34</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="FR">Portugal</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="PT">Lilly Portugal   Produtos Farmacêuticos, Lda</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="NL">Tel: +   351-21-4126600</span></p> <p class="PIbodytext" style="page-break-after:avoid"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Hrvatska</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Eli Lilly   Hrvatska d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: +385 1   2350 999</span></p> <p class="MsoNormal" style="line-height:normal"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">România</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly România   S.R.L.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: + 40 21   4023000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"><span lang="DA" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Ireland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company (Ireland) Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 353-(0)   1 661 4377</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="RO">Slovenija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Eli Lilly   farmacevtska družba, d.o.o.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="RO">Tel: +386 (0)1   580 00 10</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Ísland</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid;   text-autospace:none"><span lang="DA">Icepharma hf.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DA">Sími + 354 540   8000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><b><span lang="DA">Slovenská republika</span></b></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Eli Lilly Slovakia s.r.o.</span></p> <p class="MsoNormal" style="line-height:normal;page-break-after:avoid"><span lang="SK">Tel: </span><span lang="SK">+ 421 220 663 111</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="ES-TRAD">Italia</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="FI">Eli Lilly Italia   S.p.A.</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 39- 055   42571</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Suomi/Finland</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="SV">Oy Eli Lilly   Finland Ab </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Puh/Tel: +   358-(0) 9 85 45 250</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">Κύπρος</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Phadisco Ltd </span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EL">Τηλ</span><span lang="EN-GB">: +357 22 715000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="DA">Sverige</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Eli Lilly Sweden   AB</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="DE">Tel: + 46-(0) 8   7378800</span></p> <p class="PIbodytext"></p> </td> </tr> <tr> <td colspan="2" style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="SV">Latvija</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV" style="color:   black">Eli Lilly (Suisse) S.A Pārstāvniecība Latvijā</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="LV">Tel: </span><b><span lang="NL">+</span></b><span lang="NL">371 67364000</span></p> <p class="PIbodytext"></p> </td> <td style="width:233.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="312"> <p class="MsoNormal" style="line-height:normal"><b><span lang="EN-GB">United   Kingdom</span></b></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Eli Lilly and   Company Limited</span></p> <p class="MsoNormal" style="line-height:normal"><span lang="EN-GB">Tel: + 44-(0)   1256 315000</span></p> <p class="PIbodytext"></p> </td> </tr> <tr height="0"> <td style="border:none" width="2"></td> <td style="border:none" width="310"></td> <td style="border:none" width="312"></td> </tr> </table>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="This leaflet was last revised in "/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Other sources of information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"></p><p class="MsoNormal" style="margin-right:-.1pt;line-height:normal"><span lang="EN-GB">Detailed information on this medicine is available on the European Medicines Agency web site: </span><span lang="EN-GB"><a href="http://www.ema.europa.eu/"><span style="color:windowtext">http://www.ema.europa.eu</span></a></span><span lang="EN-GB">. </span></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><div class="WordSection5"> <div style="border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA AND HYPOGLYCAEMIA</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Always carry some sugar (at least 20 grams) with you.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Carry some information with you to show you are diabetic.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA (high blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hyperglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your insulin pen does not work properly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">- </span><span lang="EN-GB">       you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Warning symptoms of hyperglycaemia</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"><span lang="EN-GB">Thirst, increased need to urinate, tiredness, dry skin, reddening of the face, loss of appetite, low blood pressure, fast heartbeat, and glucose and ketone bodies in urine. Stomach pain, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin.</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">What should you do if you experience hyperglycaemia?</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. </span></b><span lang="EN-GB">Severe hyperglycaemia or ketoacidosis must always be treated by a doctor, normally in a hospital.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPOGLYCAEMIA (low blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">If your blood sugar level falls too much you may become unconscious. Serious hypoglycaemia may cause a heart attack or brain damage and may be life-threatening. You normally should be able to recognise when your blood sugar is falling too much so that you can take the right actions.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hypoglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you inject too much insulin,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you miss meals or delay them,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you do not eat enough, or eat food containing less carbohydrate than normal (sugar and substances similar to sugar are called carbohydrates; however, artificial sweeteners are NOT carbohydrates),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you lose carbohydrates due to vomiting or diarrhoea,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you drink alcohol, particularly if you are not eating much,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are doing more exercise than usual or a different type of physical activity,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an injury or operation or other stress,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an illness or from fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have stopped taking certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> </div> <p class="MsoNormal" style="line-height:normal;text-autospace:none"></p> <b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b> <div style="border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Hypoglycaemia is also more likely to occur if</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have just begun insulin treatment or changed to another insulin preparation (when changing from your previous basal insulin to ABASAGLAR, hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your blood sugar levels are almost normal or are unstable,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you change the area of skin where you inject insulin (for example from the thigh to the upper arm),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you suffer from severe kidney or liver disease, or some other disease such as hypothyroidism.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Warning symptoms of hypoglycaemia</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your body</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that tell you that your blood sugar level is falling too much or too fast: sweating, clammy skin, anxiety, fast heart beat, high blood pressure, palpitations and irregular heartbeat. These symptoms often develop before the symptoms of a low sugar level in the brain.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your brain</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that indicate a low sugar level in the brain: headaches, intense hunger, nausea, vomiting, tiredness, sleepiness, sleep disturbances, restlessness, aggressive behaviour, lapses in concentration, impaired reactions, depression, confusion, speech disturbances (sometimes total loss of speech), visual disorders, trembling, paralysis, tingling sensations (paraesthesia), numbness and tingling sensations in the area of the mouth, dizziness, loss of self-control, inability to look after yourself, convulsions, loss of consciousness.</span></p> <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph; line-height:normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">The first symptoms which alert you to hypoglycaemia ("warning symptoms") may change, be weaker or may be missing altogether if</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are elderly, if you have had diabetes for a long time or if you suffer from a certain type of nervous disease (diabetic autonomic neuropathy),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have almost normal or, at least, greatly improved blood sugar levels,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently changed from an animal insulin to a human insulin such as ABASAGLAR,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">In such a case, you may develop severe hypoglycaemia (and even faint) before you are aware of the problem. Be familiar with your warning symptoms. If necessary, more frequent blood sugar testing can help to identify mild hypoglycaemic episodes that may otherwise be overlooked. If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">What should you do if you experience hypoglycaemia?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">1. Do not inject insulin. Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage. Caution: Artificial sweeteners and foods with artificial sweeteners (such as diet drinks) are of no help in treating hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">2. Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). Your doctor or nurse should have discussed this with you previously.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">The recovery of hypoglycaemia may be delayed because ABASAGLAR has a long action.'</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">3. If the hypoglycaemia comes back again, take another 10 to 20 g sugar.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">4. Speak to a doctor immediately if you are not able to control the hypoglycaemia or if it recurs. Tell your relatives, friends and close colleagues the following:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><a name="_Hlk57019084"><span lang="EN-GB">If you are not able to swallow or if you are unconscious, you will require an injection of glucose or glucagon (a medicine which increases blood sugar). These injections are justified even if it is not certain that you have hypoglycaemia.</span></a></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">It is advisable to test your blood sugar immediately after taking glucose to check that you really have hypoglycaemia.</span></p> </div> <b><span style='font-size:18.0pt;font-family:"Arial",sans-serif'><br clear="all" style="page-break-before:always"/> </span></b> <p align="center" class="MsoHeading7" style="margin-top:6.0pt;text-align:center"><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>Instructions for use</span></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:black">ABASAGLAR 100units/mL Tempo Pen solution for injection in a pre-filled pen</span></b></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:black">insulin glargine </span></b></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251717632"><span style="left:0px;position: absolute;left:47px;top:-46258px;width:509px;height:1px"><img alt="Chart  Description automatically generated" height="1" src="#image54" width="509"/></span></span></p> <br clear="ALL"/> <p align="center" class="MsoNormal" style="margin-top:6.0pt;margin-right:0in; margin-bottom:6.0pt;margin-left:0in;text-align:center;page-break-after:avoid"><b><span lang="EN-GB" style="color:red">PLEASE READ THESE INSTRUCTIONS BEFORE USE</span></b></p> <p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>Read the instructions for use before you start using ABASAGLAR and each time you get another ABASAGLAR Tempo Pen. There may be new information. This information does not take the place of talking to your healthcare professional about your medical condition or your treatment.</span></p> <p class="IFUBodyText" style="margin-top:0in"></p> <p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>ABASAGLAR Tempo Pen (“Pen”) is a disposable prefilled pen containing 300 units (3 mL) of insulin glargine. You can give yourself multiple doses using one pen. The pen dials 1 unit at a time. You can give from 1 to 80 units in a single injection. <b>If your dose is more than 80 units, you will need to give yourself more than one injection.</b> The plunger only moves a little with each injection, and you may not notice that it moves. The plunger will only reach the end of the cartridge when you have used all 300 units in the </span><span style='font-family:"Times New Roman",serif'>pen.</span></p> <p class="IFUBodyText" style="margin-top:0in"></p> <p class="mdTblEntry" style="line-height:normal"><span lang="EN-GB" style="font-size:11.0pt">The Tempo Pen is designed to work with the Tempo Smart Button. The Tempo Smart Button is an optional product that can be attached to the Tempo Pen dose knob and aids in transmitting Abasaglar dose information from the Tempo Pen to a compatible mobile application. The Tempo Pen injects insulin with or without the Tempo Smart Button attached. Your Smart Button must be attached to a Tempo Pen to record or transfer dose data. Push the Smart Button straight down on the dose knob until you hear a snap or feel the Smart Button snap into place. To transmit data to the mobile application, follow the instructions provided with the Tempo Smart Button and the instructions with the mobile application</span><span style="font-size:11.0pt">.</span></p> <p class="mdTblEntry" style="text-align:justify;text-justify:inter-ideograph; line-height:normal"></p> <p class="IFUBodyText" style="margin-top:0in"><b><span style='font-family:"Times New Roman",serif'>Do not share your pen with other people, even if the needle has been changed. Do not reuse or share needles with other people. You may give an infection to them or get an infection from them.</span></b></p> <p class="IFUBodyText" style="margin-top:0in"></p> <p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>This pen is not recommended for use by the blind or visually impaired without the help of someone trained to use the pen.</span></p> <span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; color:black'><br clear="all" style="page-break-before:always"/> </span> <p class="MsoNormal" style="line-height:normal"></p> <p class="MsoHeader" style="margin-top:6.0pt;page-break-after:avoid"></p> <div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="margin-bottom:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:black">Tempo Pen Parts</span></b></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="86"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:84.2pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="112"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Pen Cap</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="3" nowrap="" style="width:121.5pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="162"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Cartridge Holder</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="90"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span lang="EN-GB" style="color:black">Label</span></p> </td> <td colspan="2" nowrap="" style="width:76.6pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="102"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span lang="EN-GB" style="color:black">Dose Indicator</span></p> </td> </tr> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="margin-left:15.9pt;text-align:center"><span lang="EN-GB"><img alt="A close up of a antenna  Description automatically generated" border="0" height="77" id="Picture 197" src="#image55" width="498"/></span></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"></p> </td> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Cap Clip</span></p> </td> <td colspan="3" nowrap="" style="width:82.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="111"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Rubber Seal</span></p> </td> <td nowrap="" style="width:1.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Plunger</span></p> </td> <td colspan="3" nowrap="" style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Pen Body</span></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="90"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Dose <br/>   Window</span></p> </td> <td nowrap="" style="width:45.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="60"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Dose Knob</span></p> </td> </tr> <tr height="0"> <td style="border:none" width="86"></td> <td style="border:none" width="86"></td> <td style="border:none" width="27"></td> <td style="border:none" width="24"></td> <td style="border:none" width="60"></td> <td style="border:none" width="96"></td> <td style="border:none" width="6"></td> <td style="border:none" width="24"></td> <td style="border:none" width="42"></td> <td style="border:none" width="48"></td> <td style="border:none" width="42"></td> <td style="border:none" width="60"></td> </tr> </table> </div> <p class="MsoNormal"></p> <div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style="color:black">Pen Needle Parts<br/>   (Needles Not Included)</span></b></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB">Dose Knob</span></b></p> </td> </tr> <tr style="height:11.2pt"> <td colspan="2" style="width:117.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="156"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td colspan="2" style="width:1.5in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="144"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Needle</span></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> <td style="width:45.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="60"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="72"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="168"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> </tr> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251697152"><span style="left:0px;position:   absolute;left:24px;top:-47077px;width:297px;height:1px"><img height="1" src="#image56" width="297"/></span></span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251698176"><span style="left:0px;position:   absolute;left:42px;top:-47077px;width:68px;height:1px"><img height="1" src="#image57" width="68"/></span></span></p> </td> </tr> <tr> <td style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Outer Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Inner Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Paper Tab</span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr height="0"> <td style="border:none" width="120"></td> <td style="border:none" width="36"></td> <td style="border:none" width="84"></td> <td style="border:none" width="60"></td> <td style="border:none" width="60"></td> <td style="border:none" width="72"></td> <td style="border:none" width="168"></td> </tr> </table> </div> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>How to recognise your ABASAGLAR Tempo pen:</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Pen colour: Light grey</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Dose Knob: Light grey</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Labels: Light grey with green colour bars</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Supplies needed to give your injection:</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Tempo Pen containing your insulin</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Tempo Pen compatible needle (BD [Becton, Dickinson and Company] pen needles recommended)</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Swab</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>Needles and swab are not included.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Preparing your pen</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Wash your hands with soap and water.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Check the pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> use your pen past the expiration date printed on the pen label or for more than 28 days after you first start using the pen.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Always use a <b>new needle</b> for each injection to help prevent infections and blocked needles.</span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 1:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull the pen cap straight   off.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    <b>Do not</b> remove the pen   label.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Wipe the rubber seal with a   swab.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif;color:black'>ABASAGLAR should</span><span style='font-family:"Times New Roman",serif'> look clear and colourless. <b>Do   not</b> use if it is cloudy, coloured, or has particles or clumps in it.</span></p> </td> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251699200"><span style="left:0px;position:absolute;left:57px;top:-47491px;width:155px;   height:1px"><img height="1" src="#image58" width="155"/></span></span></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 2:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Select a new needle.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull off the paper tab from   the outer needle shield.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251700224"><span style="left:0px;position:absolute;left:70px;top:-47655px;width:156px;   height:1px"><img alt="Step1b" height="1" src="#image59" width="156"/></span></span></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 3:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Push the capped needle   straight onto the pen and twist the needle on until it is tight.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251701248"><span style="left:0px;position:absolute;left:70px;top:-47783px;width:156px;   height:1px"><img alt="Step1c" height="1" src="#image60" width="156"/></span></span></p> </td> </tr> <tr style="height:94.9pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.9pt" valign="top" width="367"> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 4:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull off the outer needle   shield. <b>Do not</b> throw it away.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull off the inner needle   shield and throw it away.</span></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.9pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251702272"><span style="left:0px;position:absolute;left:42px;top:-47929px;width:212px;   height:1px"><img alt="Step1d" height="1" src="#image61" width="212"/></span></span></p> </td> </tr> </table> <p class="IFUHeading1" style="margin-top:0in"></p> <p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>Priming your pen</span></p> <p class="IFUHeading1" style="margin-top:0in"></p> <p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>Prime before each injection.</span></p> <p class="IFUHeading1" style="margin-top:0in"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Priming your pen means removing the air from the needle and cartridge that may collect during normal use and ensures that the pen is working correctly.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     If you <b>do not</b> prime before each injection, you may get too much or too little insulin.</span></p> <p class="MsoHeader" style="margin-top:6.0pt;page-break-after:avoid"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 5:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     To prime your pen, turn the   dose knob to select 2 units.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.75pt 2.9pt 5.75pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251703296"><span style="left:0px;position:absolute;left:74px;top:-48224px;width:150px;   height:1px"><img height="1" src="#image62" width="150"/></span></span></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 6:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Hold your pen with the   needle pointing up. Tap the cartridge holder gently to collect air bubbles at   the top.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251704320"><span style="left:0px;position:absolute;left:72px;top:-48348px;width:152px;   height:1px"><img alt="Step2b" height="1" src="#image63" width="152"/></span></span></p> </td> </tr> <tr style="height:89.45pt"> <td rowspan="2" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:89.45pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 7:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Continue holding your pen   with needle pointing up. Push the dose knob in until it stops, and “0” is   seen in the dose window. Hold the dose knob in and count to 5 slowly.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>You should see insulin at the tip   of the needle.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you <b>do not</b> see   insulin, repeat the priming steps, but not more than 4 times.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you <b>still do not</b>   see insulin, change the needle and repeat the priming steps.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif'>Small air bubbles are normal and will not affect   your dose.</span></p> </td> <td style="width:275.4pt;border:none;padding:1.45pt 5.75pt 2.9pt 5.75pt;   height:89.45pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251695104"><span style="left:0px;position:absolute;left:76px;top:-48463px;width:148px;   height:1px"><img height="1" src="#image64" width="148"/></span></span></p> </td> </tr> <tr style="height:89.4pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:89.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251694080"><span style="left:0px;position:absolute;left:85px;top:-48586px;width:111px;   height:1px"><img height="1" src="#image65" width="111"/></span></span></p> </td> </tr> </table> <p class="IFUBulletedBodyText" style="margin-left:.25in"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Selecting your dose</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     You can give from 1 to 80 units in a single injection.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     If your dose is more than 80 units, you will need to give more than one injection.</span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    </span><span style='font-family: "Times New Roman",serif'>If you need help deciding how to divide up your dose, ask your healthcare professional.</span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    You should use a new needle for each injection and repeat the priming step.</span></p> <span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span> <p class="MsoNormal"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="height:120.4pt"> <td rowspan="3" style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:120.4pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   8:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Turn the dose knob to   select the number of units you need to inject. The dose indicator should line   up with your dose.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   pen dials 1 unit at a time.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   dose knob clicks as you turn it.</span></p> <p class="IFUBulletedBodyText"><span style='font-family:"Times New Roman",serif'>–    </span><b><span style='font-family:"Times New Roman",serif'>DO NOT</span></b><span style='font-family:   "Times New Roman",serif'>dial your dose by counting the clicks because you   may dial the wrong dose.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   dose can be corrected by turning the dose knob in either direction until the   correct dose lines up with the dose indicator.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   <b>even</b> numbers are printed on the dial.</span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   <b>odd</b> numbers, after the number 1, are shown as full lines.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     <b>Always check the number   in the dose window to make sure you have dialled the correct dose.</b></span></p> </td> <td style="width:275.4pt;border:none;border-top:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:120.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251706368"><span style="left:0px;position:absolute;left:81px;top:-48889px;width:134px;   height:1px"><img height="1" src="#image66" width="134"/></span></span><span style="position:relative;z-index:251705344"><span style="left:0px;position:   absolute;left:72px;top:-48889px;width:154px;height:1px"><img height="1" src="#image67" width="154"/></span></span></p> </td> </tr> <tr style="height:120.45pt"> <td style="width:275.4pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:120.45pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251707392"><span style="left:0px;position:absolute;left:86px;top:-49050px;width:133px;   height:1px"><img height="1" src="#image68" width="133"/></span></span><span style="position:relative;z-index:251688960"><span style="left:0px;position:   absolute;left:152px;top:-49050px;width:193px;height:1px"><img alt="(Example: 12 units shown in the dose window) " height="1" src="#image69" width="193"/></span></span></p> </td> </tr> <tr style="height:120.45pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:120.45pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251691008"><span style="left:0px;position:absolute;left:147px;top:-49211px;width:193px;   height:1px"><img alt="(Example: 25 units shown in the dose window) " height="1" src="#image70" width="193"/></span></span></p> </td> </tr> </table> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     The pen will not let you dial more than the number of units left in the pen.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     If you need to inject more than the number of units left in the pen, you may either:</span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    inject the amount left in your pen and then use a new pen to give the rest of your dose, <b>or</b></span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    get a new pen and inject the full dose.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     It is normal to see a small amount of insulin left in the pen that you cannot inject.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Giving your injection</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Inject your insulin as your healthcare professional has shown you.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Change (rotate) your injection site for each injection.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> try to change your dose while injecting.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"></p> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td colspan="2" style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 9:</span></b></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif'>Choose your injection site.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     ABASAGLAR is injected under   the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper   arms.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Prepare your skin as   recommended by your healthcare professional.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251708416"><span style="left:0px;position:absolute;left:56px;top:-49610px;width:150px;   height:1px"><img height="1" src="#image71" width="150"/></span></span></p> </td> </tr> <tr> <td colspan="2" style="width:275.4pt;border:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 10:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style="position:relative;z-index:251709440"><span style="left:0px;position:   absolute;left:379px;top:-49817px;width:151px;height:1px"><img height="1" src="#image72" width="151"/></span></span><span style='font-family:"Times New Roman",serif'>•     Insert the needle into your   skin.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Push the dose knob all the   way in.</span></p> </td> <td rowspan="3" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"></p> </td> </tr> <tr> <td style="width:203.4pt;border:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="271"> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Continue to hold the dose   knob in and <b>slowly count</b> to 5 before removing the needle.</span></p> </td> <td style="width:1.0in;border:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p class="MsoHeader" style="margin-top:6.0pt;page-break-after:avoid"><span style="position:relative;z-index:251710464"><span style="position:absolute;   left:5px;top:-49945px;width:55px;height:1px"><img height="1" src="#image73" width="55"/></span></span></p> </td> </tr> <tr> <td colspan="2" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Do not</span></b><span style='font-family:"Times New Roman",serif'> try to inject your insulin by   turning the dose knob. You will <b>NOT</b> receive your insulin by turning   the dose knob.</span></p> </td> </tr> <tr> <td colspan="2" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 11:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull the needle out of your   skin.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    A drop of insulin at the   needle tip is normal. It will not affect your dose.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Check the number in the   dose window</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you see “0” in the dose   window, you have received the full amount you dialled.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you do not see “0” in the   dose window, <b>do not</b> redial. Insert the needle into your skin and   finish your injection.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you<b> still do not</b>   think you received the full amount you dialled for your injection<b>, do not   start over or repeat that injection. </b>Monitor your blood glucose as   instructed by your healthcare professional.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you normally need to give   2 injections for your full dose, be sure to give your second injection.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif'>The plunger only moves a little with each injection,   and you may not notice that it moves.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif;color:black'>If you see blood after you take the   needle out of your skin, press the injection site lightly with a piece of   gauze or swab. <b>Do not</b> rub the area.</span></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251711488"><span style="left:0px;position:absolute;left:80px;top:-50069px;width:135px;   height:1px"><img height="1" src="#image74" width="135"/></span></span></p> </td> </tr> <tr height="0"> <td style="border:none" width="265"></td> <td style="border:none" width="92"></td> <td style="border:none" width="351"></td> </tr> </table> <p class="MsoNormal"><b><span lang="EN-GB">After your injection</span></b></p> <p class="MsoNormal"><span style="position:relative;z-index:251716608"><span style="position:absolute;left:433px;top:-50572px;width:148px;height:1px"><img alt="Step5a" height="1" src="#image75" width="148"/></span></span></p> <br clear="ALL"/> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="height:94.55pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.55pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   12:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Carefully replace the outer   needle shield.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.75pt 2.15pt 5.75pt;height:94.55pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   13:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Unscrew the capped needle   and dispose of it as described below (see <b>Disposing of pens and needles</b>   section).</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> store the pen   with the needle attached to prevent leaking, blocking the needle, and air   from entering the pen.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251712512"><span style="left:0px;position:absolute;left:82px;top:-50719px;width:154px;   height:1px"><img alt="Step5b" height="1" src="#image76" width="154"/></span></span></p> </td> </tr> <tr style="height:78.7pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:78.7pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   14:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Replace the pen cap by   lining up the cap clip with the dose indicator and pushing straight on.</span></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:78.7pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251713536"><span style="left:0px;position:absolute;left:37px;top:-50892px;width:232px;   height:1px"><img height="1" src="#image77" width="232"/></span></span></p> </td> </tr> </table> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><b><span style='font-family:"Times New Roman",serif'>Disposing of pens and needles</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Put used needles in a closable, puncture-resistant sharps container.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> recycle the filled sharps container.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Ask your healthcare professional about options to dispose of the pens and sharps container properly.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     The directions regarding needle handling are not intended to replace local, healthcare professional or institutional policies.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><b><span style='font-family:"Times New Roman",serif'>Storing your pen</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p> <p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>Unused pens</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Store unused pens in the refrigerator at (2 °C to 8 °C).</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> freeze ABASAGLAR. <b>Do not</b> use if it has been frozen.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Unused pens may be used until the expiration date printed on the label, if the pen has been kept in the refrigerator.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p> <p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>In-use pen</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Store the pen you are currently using at room temperature [below (30 °C)] and away from dust, food and liquids, heat and light.</span></p> <p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"><span lang="EN-GB">•     Throw away the pen you are using after 28 days, even if it still has insulin left in it.</span></p> <p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"></p> <p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"><b><span lang="EN-GB">General information about the safe and effective use of your pen</span></b></p> <p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Keep your pen and needles out of the sight and reach of children.</b></span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> use your pen if any part looks broken or damaged.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Always carry an extra pen in case yours is lost or damaged.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><b><span style='font-family:"Times New Roman",serif'>Troubleshooting</span></b></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     If you cannot remove the pen cap, gently twist the cap back and forth, and then pull the cap straight off.</span></p> <p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     If the dose knob is hard to push:</span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in"><span style='font-family: "Times New Roman",serif'>–    Pushing the dose knob more slowly will make it easier to inject.</span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in"><span style='font-family: "Times New Roman",serif'>–    Your needle may be blocked. Put on a new needle and prime the pen.</span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in"><span style='font-family: "Times New Roman",serif'>–    You may have dust, food, or liquid inside the pen. Throw the pen away and get a new pen. You may need to get a prescription from your healthcare professional.</span></p> <p class="IFUBulletedBodyText2" style="margin-top:0in"></p> <p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>If you have any questions or problems with your ABASAGLAR Tempo Pen, contact your healthcare professional for help.</span></p> <p class="IFUBodyText" style="margin-top:0in"></p> <p class="MsoNormal" style="margin-right:-.1pt;text-align:justify;text-justify: inter-ideograph;line-height:normal"><b><span lang="EN-GB">This leaflet was last </span><span lang="EN-GB">revised in </span></b></p> <p class="MsoNormal" style="margin-top:0in;margin-right:6.0pt;margin-bottom:0in; margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none"></p> </div><div style="border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA AND HYPOGLYCAEMIA</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Always carry some sugar (at least 20 grams) with you.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Carry some information with you to show you are diabetic.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPERGLYCAEMIA (high blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">If your blood sugar is too high (hyperglycaemia), you may not have injected enough insulin.</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hyperglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your insulin pen does not work properly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">- </span><span lang="EN-GB">       you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;border:none; padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Warning symptoms of hyperglycaemia</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"><span lang="EN-GB">Thirst, increased need to urinate, tiredness, dry skin, reddening of the face, loss of appetite, low blood pressure, fast heartbeat, and glucose and ketone bodies in urine. Stomach pain, fast and deep breathing, sleepiness or even loss of consciousness may be signs of a serious condition (ketoacidosis) resulting from lack of insulin.</span></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">What should you do if you experience hyperglycaemia?</span></b></p> <p class="MsoNormal" style="border:none;padding:0in"></p> <p class="MsoNormal" style="border:none;padding:0in"><b><span lang="EN-GB">Test your blood sugar level and your urine for ketones as soon as any of the above symptoms occur. </span></b><span lang="EN-GB">Severe hyperglycaemia or ketoacidosis must always be treated by a doctor, normally in a hospital.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">HYPOGLYCAEMIA (low blood sugar levels)</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">If your blood sugar level falls too much you may become unconscious. Serious hypoglycaemia may cause a heart attack or brain damage and may be life-threatening. You normally should be able to recognise when your blood sugar is falling too much so that you can take the right actions.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Why does hypoglycaemia occur?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples include:</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you inject too much insulin,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you miss meals or delay them,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you do not eat enough, or eat food containing less carbohydrate than normal (sugar and substances similar to sugar are called carbohydrates; however, artificial sweeteners are NOT carbohydrates),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you lose carbohydrates due to vomiting or diarrhoea,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you drink alcohol, particularly if you are not eating much,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are doing more exercise than usual or a different type of physical activity,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an injury or operation or other stress,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are recovering from an illness or from fever,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have stopped taking certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> </div><p class="MsoNormal" style="line-height:normal;text-autospace:none"></p><b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span></b><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><div style="border:solid windowtext 1.0pt;padding:1.0pt 1.0pt 1.0pt 1.0pt"> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Hypoglycaemia is also more likely to occur if</span></b></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have just begun insulin treatment or changed to another insulin preparation (when changing from your previous basal insulin to ABASAGLAR, hypoglycaemia, if it occurs, may be more likely to occur in the morning than at night),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        your blood sugar levels are almost normal or are unstable,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you change the area of skin where you inject insulin (for example from the thigh to the upper arm),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you suffer from severe kidney or liver disease, or some other disease such as hypothyroidism.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">Warning symptoms of hypoglycaemia</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your body</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that tell you that your blood sugar level is falling too much or too fast: sweating, clammy skin, anxiety, fast heart beat, high blood pressure, palpitations and irregular heartbeat. These symptoms often develop before the symptoms of a low sugar level in the brain.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><i><span lang="EN-GB">- In your brain</span></i></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">Examples of symptoms that indicate a low sugar level in the brain: headaches, intense hunger, nausea, vomiting, tiredness, sleepiness, sleep disturbances, restlessness, aggressive behaviour, lapses in concentration, impaired reactions, depression, confusion, speech disturbances (sometimes total loss of speech), visual disorders, trembling, paralysis, tingling sensations (paraesthesia), numbness and tingling sensations in the area of the mouth, dizziness, loss of self-control, inability to look after yourself, convulsions, loss of consciousness.</span></p> <p class="MsoNormal" style="text-align:justify;text-justify:inter-ideograph; line-height:normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">The first symptoms which alert you to hypoglycaemia ("warning symptoms") may change, be weaker or may be missing altogether if</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are elderly, if you have had diabetes for a long time or if you suffer from a certain type of nervous disease (diabetic autonomic neuropathy),</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have almost normal or, at least, greatly improved blood sugar levels,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you have recently changed from an animal insulin to a human insulin such as ABASAGLAR,</span></p> <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;line-height: normal;text-autospace:none;border:none;padding:0in"><span lang="EN-GB">-        you are taking or have taken certain other medicines (see section 2, "Other medicines and ABASAGLAR").</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">In such a case, you may develop severe hypoglycaemia (and even faint) before you are aware of the problem. Be familiar with your warning symptoms. If necessary, more frequent blood sugar testing can help to identify mild hypoglycaemic episodes that may otherwise be overlooked. If you are not confident about recognising your warning symptoms, avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><b><span lang="EN-GB">What should you do if you experience hypoglycaemia?</span></b></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">1. Do not inject insulin. Immediately take about 10 to 20 g sugar, such as glucose, sugar cubes or a sugar-sweetened beverage. Caution: Artificial sweeteners and foods with artificial sweeteners (such as diet drinks) are of no help in treating hypoglycaemia.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">2. Then eat something that has a long-acting effect in raising your blood sugar (such as bread or pasta). Your doctor or nurse should have discussed this with you previously.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">The recovery of hypoglycaemia may be delayed because ABASAGLAR has a long action.'</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">3. If the hypoglycaemia comes back again, take another 10 to 20 g sugar.</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">4. Speak to a doctor immediately if you are not able to control the hypoglycaemia or if it recurs. Tell your relatives, friends and close colleagues the following:</span></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><a name="_Hlk57019084"><span lang="EN-GB">If you are not able to swallow or if you are unconscious, you will require an injection of glucose or glucagon (a medicine which increases blood sugar). These injections are justified even if it is not certain that you have hypoglycaemia.</span></a></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"></p> <p class="MsoNormal" style="line-height:normal;text-autospace:none;border:none; padding:0in"><span lang="EN-GB">It is advisable to test your blood sugar immediately after taking glucose to check that you really have hypoglycaemia.</span></p> </div><b><span style='font-size:18.0pt;font-family:"Arial",sans-serif'><br clear="all" style="page-break-before:always"/> </span></b><span style='font-size:18.0pt;font-family:"Arial",sans-serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p align="center" class="MsoHeading7" style="margin-top:6.0pt;text-align:center"><span style='font-size:11.0pt;font-family:"Times New Roman",serif;color:black'>Instructions for use</span></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:black">ABASAGLAR 100units/mL Tempo Pen solution for injection in a pre-filled pen</span></b></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:black">insulin glargine </span></b></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"></p><p align="center" class="MsoNormal" style="margin-top:6.0pt;text-align:center"><span style="position:relative;z-index:251717632"><span style="left:0px;position: absolute;left:47px;top:-46258px;width:509px;height:1px"><img alt="Chart  Description automatically generated" height="1" src="#image78" width="509"/></span></span></p><br clear="ALL"/><p align="center" class="MsoNormal" style="margin-top:6.0pt;margin-right:0in; margin-bottom:6.0pt;margin-left:0in;text-align:center;page-break-after:avoid"><b><span lang="EN-GB" style="color:red">PLEASE READ THESE INSTRUCTIONS BEFORE USE</span></b></p><p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>Read the instructions for use before you start using ABASAGLAR and each time you get another ABASAGLAR Tempo Pen. There may be new information. This information does not take the place of talking to your healthcare professional about your medical condition or your treatment.</span></p><p class="IFUBodyText" style="margin-top:0in"></p><p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>ABASAGLAR Tempo Pen (“Pen”) is a disposable prefilled pen containing 300 units (3 mL) of insulin glargine. You can give yourself multiple doses using one pen. The pen dials 1 unit at a time. You can give from 1 to 80 units in a single injection. <b>If your dose is more than 80 units, you will need to give yourself more than one injection.</b> The plunger only moves a little with each injection, and you may not notice that it moves. The plunger will only reach the end of the cartridge when you have used all 300 units in the </span><span style='font-family:"Times New Roman",serif'>pen.</span></p><p class="IFUBodyText" style="margin-top:0in"></p><p class="mdTblEntry" style="line-height:normal"><span lang="EN-GB" style="font-size:11.0pt">The Tempo Pen is designed to work with the Tempo Smart Button. The Tempo Smart Button is an optional product that can be attached to the Tempo Pen dose knob and aids in transmitting Abasaglar dose information from the Tempo Pen to a compatible mobile application. The Tempo Pen injects insulin with or without the Tempo Smart Button attached. Your Smart Button must be attached to a Tempo Pen to record or transfer dose data. Push the Smart Button straight down on the dose knob until you hear a snap or feel the Smart Button snap into place. To transmit data to the mobile application, follow the instructions provided with the Tempo Smart Button and the instructions with the mobile application</span><span style="font-size:11.0pt">.</span></p><p class="mdTblEntry" style="text-align:justify;text-justify:inter-ideograph; line-height:normal"></p><p class="IFUBodyText" style="margin-top:0in"><b><span style='font-family:"Times New Roman",serif'>Do not share your pen with other people, even if the needle has been changed. Do not reuse or share needles with other people. You may give an infection to them or get an infection from them.</span></b></p><p class="IFUBodyText" style="margin-top:0in"></p><p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>This pen is not recommended for use by the blind or visually impaired without the help of someone trained to use the pen.</span></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; color:black'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p class="MsoNormal" style="line-height:normal"></p><p class="MsoHeader" style="margin-top:6.0pt;page-break-after:avoid"></p><div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="margin-bottom:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:black">Tempo Pen Parts</span></b></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="86"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:84.2pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="112"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Pen Cap</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="3" nowrap="" style="width:121.5pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="162"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Cartridge Holder</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="90"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span lang="EN-GB" style="color:black">Label</span></p> </td> <td colspan="2" nowrap="" style="width:76.6pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="102"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span lang="EN-GB" style="color:black">Dose Indicator</span></p> </td> </tr> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="margin-left:15.9pt;text-align:center"><span lang="EN-GB"><img alt="A close up of a antenna  Description automatically generated" border="0" height="77" id="Picture 197" src="#image79" width="498"/></span></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"></p> </td> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Cap Clip</span></p> </td> <td colspan="3" nowrap="" style="width:82.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="111"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Rubber Seal</span></p> </td> <td nowrap="" style="width:1.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Plunger</span></p> </td> <td colspan="3" nowrap="" style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Pen Body</span></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="90"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Dose <br/>   Window</span></p> </td> <td nowrap="" style="width:45.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="60"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Dose Knob</span></p> </td> </tr> <tr height="0"> <td style="border:none" width="86"></td> <td style="border:none" width="86"></td> <td style="border:none" width="27"></td> <td style="border:none" width="24"></td> <td style="border:none" width="60"></td> <td style="border:none" width="96"></td> <td style="border:none" width="6"></td> <td style="border:none" width="24"></td> <td style="border:none" width="42"></td> <td style="border:none" width="48"></td> <td style="border:none" width="42"></td> <td style="border:none" width="60"></td> </tr> </table> </div><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="margin-bottom:6.0pt;text-align:center"><b><span lang="EN-GB" style="color:black">Tempo Pen Parts</span></b></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="86"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:84.2pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="112"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Pen Cap</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="3" nowrap="" style="width:121.5pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="162"> <p align="center" class="MsoNormal" style="margin-bottom:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Cartridge Holder</span></p> </td> <td nowrap="" style="width:.25in;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="24"> <p class="MsoNormal" style="margin-bottom:2.0pt"></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="bottom" width="90"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span lang="EN-GB" style="color:black">Label</span></p> </td> <td colspan="2" nowrap="" style="width:76.6pt;padding:   0in 5.4pt 0in 5.4pt" valign="bottom" width="102"> <p class="MsoNormal" style="margin-bottom:2.0pt"><span lang="EN-GB" style="color:black">Dose Indicator</span></p> </td> </tr> <tr> <td colspan="12" nowrap="" style="width:450.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="600"> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="text-align:center"></p> <p align="center" class="MsoNormal" style="margin-left:15.9pt;text-align:center"><span lang="EN-GB"><img alt="A close up of a antenna  Description automatically generated" border="0" height="77" id="Picture 197" src="#image80" width="498"/></span></p> </td> </tr> <tr> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"></p> </td> <td nowrap="" style="width:64.3pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="86"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Cap Clip</span></p> </td> <td colspan="3" nowrap="" style="width:82.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="111"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Rubber Seal</span></p> </td> <td nowrap="" style="width:1.0in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Plunger</span></p> </td> <td colspan="3" nowrap="" style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Pen Body</span></p> </td> <td colspan="2" nowrap="" style="width:67.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="90"> <p align="center" class="MsoNormal" style="margin-top:2.0pt;text-align:center"><span lang="EN-GB" style="color:black">Dose <br/>   Window</span></p> </td> <td nowrap="" style="width:45.1pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="60"> <p class="MsoNormal" style="margin-top:2.0pt"><span lang="EN-GB" style="color:black">Dose Knob</span></p> </td> </tr> <tr height="0"> <td style="border:none" width="86"></td> <td style="border:none" width="86"></td> <td style="border:none" width="27"></td> <td style="border:none" width="24"></td> <td style="border:none" width="60"></td> <td style="border:none" width="96"></td> <td style="border:none" width="6"></td> <td style="border:none" width="24"></td> <td style="border:none" width="42"></td> <td style="border:none" width="48"></td> <td style="border:none" width="42"></td> <td style="border:none" width="60"></td> </tr> </table><p class="MsoNormal"></p><div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style="color:black">Pen Needle Parts<br/>   (Needles Not Included)</span></b></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB">Dose Knob</span></b></p> </td> </tr> <tr style="height:11.2pt"> <td colspan="2" style="width:117.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="156"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td colspan="2" style="width:1.5in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="144"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Needle</span></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> <td style="width:45.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="60"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="72"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="168"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> </tr> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251697152"><span style="left:0px;position:   absolute;left:24px;top:-47077px;width:297px;height:1px"><img height="1" src="#image81" width="297"/></span></span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251698176"><span style="left:0px;position:   absolute;left:42px;top:-47077px;width:68px;height:1px"><img height="1" src="#image82" width="68"/></span></span></p> </td> </tr> <tr> <td style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Outer Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Inner Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Paper Tab</span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr height="0"> <td style="border:none" width="120"></td> <td style="border:none" width="36"></td> <td style="border:none" width="84"></td> <td style="border:none" width="60"></td> <td style="border:none" width="60"></td> <td style="border:none" width="72"></td> <td style="border:none" width="168"></td> </tr> </table> </div><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style="color:black">Pen Needle Parts<br/>   (Needles Not Included)</span></b></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB">Dose Knob</span></b></p> </td> </tr> <tr style="height:11.2pt"> <td colspan="2" style="width:117.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="156"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td colspan="2" style="width:1.5in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="144"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Needle</span></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> <td style="width:45.0pt;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="60"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="72"> <p class="MsoNormal" style="margin-bottom:1.0pt"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt;   height:11.2pt" valign="bottom" width="168"> <p align="center" class="MsoNormal" style="margin-bottom:1.0pt;text-align:center"></p> </td> </tr> <tr> <td colspan="5" style="width:3.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="360"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251697152"><span style="left:0px;position:   absolute;left:24px;top:-47077px;width:297px;height:1px"><img height="1" src="#image83" width="297"/></span></span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" width="168"> <p align="center" class="MsoNormal" style="text-align:center"><span style="position:relative;z-index:251698176"><span style="left:0px;position:   absolute;left:42px;top:-47077px;width:68px;height:1px"><img height="1" src="#image84" width="68"/></span></span></p> </td> </tr> <tr> <td style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Outer Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Inner Needle<br/>   Shield</span></p> </td> <td colspan="2" style="width:1.25in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="margin-top:1.0pt;text-align:center"><span lang="EN-GB" style="color:black">Paper Tab</span></p> </td> <td style="width:.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="72"> <p class="MsoNormal"></p> </td> <td style="width:1.75in;padding:0in 5.4pt 0in 5.4pt" valign="top" width="168"> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> </tr> <tr height="0"> <td style="border:none" width="120"></td> <td style="border:none" width="36"></td> <td style="border:none" width="84"></td> <td style="border:none" width="60"></td> <td style="border:none" width="60"></td> <td style="border:none" width="72"></td> <td style="border:none" width="168"></td> </tr> </table><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>How to recognise your ABASAGLAR Tempo pen:</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Pen colour: Light grey</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Dose Knob: Light grey</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Labels: Light grey with green colour bars</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Supplies needed to give your injection:</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Tempo Pen containing your insulin</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Tempo Pen compatible needle (BD [Becton, Dickinson and Company] pen needles recommended)</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Swab</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>Needles and swab are not included.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Preparing your pen</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Wash your hands with soap and water.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Check the pen to make sure you are taking the right type of insulin. This is especially important if you use more than 1 type of insulin.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> use your pen past the expiration date printed on the pen label or for more than 28 days after you first start using the pen.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Always use a <b>new needle</b> for each injection to help prevent infections and blocked needles.</span></p><p class="MsoHeader" style="margin-top:6.0pt"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 1:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull the pen cap straight   off.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    <b>Do not</b> remove the pen   label.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Wipe the rubber seal with a   swab.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif;color:black'>ABASAGLAR should</span><span style='font-family:"Times New Roman",serif'> look clear and colourless. <b>Do   not</b> use if it is cloudy, coloured, or has particles or clumps in it.</span></p> </td> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251699200"><span style="left:0px;position:absolute;left:57px;top:-47491px;width:155px;   height:1px"><img height="1" src="#image85" width="155"/></span></span></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 2:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Select a new needle.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull off the paper tab from   the outer needle shield.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251700224"><span style="left:0px;position:absolute;left:70px;top:-47655px;width:156px;   height:1px"><img alt="Step1b" height="1" src="#image86" width="156"/></span></span></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 3:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Push the capped needle   straight onto the pen and twist the needle on until it is tight.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251701248"><span style="left:0px;position:absolute;left:70px;top:-47783px;width:156px;   height:1px"><img alt="Step1c" height="1" src="#image87" width="156"/></span></span></p> </td> </tr> <tr style="height:94.9pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.9pt" valign="top" width="367"> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 4:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull off the outer needle   shield. <b>Do not</b> throw it away.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull off the inner needle   shield and throw it away.</span></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.9pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251702272"><span style="left:0px;position:absolute;left:42px;top:-47929px;width:212px;   height:1px"><img alt="Step1d" height="1" src="#image88" width="212"/></span></span></p> </td> </tr> </table><p class="IFUHeading1" style="margin-top:0in"></p><p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>Priming your pen</span></p><p class="IFUHeading1" style="margin-top:0in"></p><p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>Prime before each injection.</span></p><p class="IFUHeading1" style="margin-top:0in"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Priming your pen means removing the air from the needle and cartridge that may collect during normal use and ensures that the pen is working correctly.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     If you <b>do not</b> prime before each injection, you may get too much or too little insulin.</span></p><p class="MsoHeader" style="margin-top:6.0pt;page-break-after:avoid"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 5:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     To prime your pen, turn the   dose knob to select 2 units.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.75pt 2.9pt 5.75pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251703296"><span style="left:0px;position:absolute;left:74px;top:-48224px;width:150px;   height:1px"><img height="1" src="#image89" width="150"/></span></span></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 6:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Hold your pen with the   needle pointing up. Tap the cartridge holder gently to collect air bubbles at   the top.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251704320"><span style="left:0px;position:absolute;left:72px;top:-48348px;width:152px;   height:1px"><img alt="Step2b" height="1" src="#image90" width="152"/></span></span></p> </td> </tr> <tr style="height:89.45pt"> <td rowspan="2" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:89.45pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 7:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Continue holding your pen   with needle pointing up. Push the dose knob in until it stops, and “0” is   seen in the dose window. Hold the dose knob in and count to 5 slowly.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>You should see insulin at the tip   of the needle.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you <b>do not</b> see   insulin, repeat the priming steps, but not more than 4 times.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you <b>still do not</b>   see insulin, change the needle and repeat the priming steps.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif'>Small air bubbles are normal and will not affect   your dose.</span></p> </td> <td style="width:275.4pt;border:none;padding:1.45pt 5.75pt 2.9pt 5.75pt;   height:89.45pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251695104"><span style="left:0px;position:absolute;left:76px;top:-48463px;width:148px;   height:1px"><img height="1" src="#image91" width="148"/></span></span></p> </td> </tr> <tr style="height:89.4pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:89.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251694080"><span style="left:0px;position:absolute;left:85px;top:-48586px;width:111px;   height:1px"><img height="1" src="#image92" width="111"/></span></span></p> </td> </tr> </table><p class="IFUBulletedBodyText" style="margin-left:.25in"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Selecting your dose</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     You can give from 1 to 80 units in a single injection.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     If your dose is more than 80 units, you will need to give more than one injection.</span></p><p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    </span><span style='font-family: "Times New Roman",serif'>If you need help deciding how to divide up your dose, ask your healthcare professional.</span></p><p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    You should use a new needle for each injection and repeat the priming step.</span></p><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif'><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p class="MsoNormal"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="height:120.4pt"> <td rowspan="3" style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt;height:120.4pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   8:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Turn the dose knob to   select the number of units you need to inject. The dose indicator should line   up with your dose.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   pen dials 1 unit at a time.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   dose knob clicks as you turn it.</span></p> <p class="IFUBulletedBodyText"><span style='font-family:"Times New Roman",serif'>–    </span><b><span style='font-family:"Times New Roman",serif'>DO NOT</span></b><span style='font-family:   "Times New Roman",serif'>dial your dose by counting the clicks because you   may dial the wrong dose.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   dose can be corrected by turning the dose knob in either direction until the   correct dose lines up with the dose indicator.</span></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   <b>even</b> numbers are printed on the dial.</span></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="MsoHeader" style="margin-top:6.0pt"></p> <p class="IFUBulletedBodyText2"><span style='font-family:"Times New Roman",serif'>–    The   <b>odd</b> numbers, after the number 1, are shown as full lines.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     <b>Always check the number   in the dose window to make sure you have dialled the correct dose.</b></span></p> </td> <td style="width:275.4pt;border:none;border-top:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:120.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251706368"><span style="left:0px;position:absolute;left:81px;top:-48889px;width:134px;   height:1px"><img height="1" src="#image93" width="134"/></span></span><span style="position:relative;z-index:251705344"><span style="left:0px;position:   absolute;left:72px;top:-48889px;width:154px;height:1px"><img height="1" src="#image94" width="154"/></span></span></p> </td> </tr> <tr style="height:120.45pt"> <td style="width:275.4pt;border:none;padding:0in 5.4pt 0in 5.4pt;   height:120.45pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251707392"><span style="left:0px;position:absolute;left:86px;top:-49050px;width:133px;   height:1px"><img height="1" src="#image95" width="133"/></span></span><span style="position:relative;z-index:251688960"><span style="left:0px;position:   absolute;left:152px;top:-49050px;width:193px;height:1px"><img alt="(Example: 12 units shown in the dose window) " height="1" src="#image96" width="193"/></span></span></p> </td> </tr> <tr style="height:120.45pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:120.45pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251691008"><span style="left:0px;position:absolute;left:147px;top:-49211px;width:193px;   height:1px"><img alt="(Example: 25 units shown in the dose window) " height="1" src="#image97" width="193"/></span></span></p> </td> </tr> </table><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     The pen will not let you dial more than the number of units left in the pen.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     If you need to inject more than the number of units left in the pen, you may either:</span></p><p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    inject the amount left in your pen and then use a new pen to give the rest of your dose, <b>or</b></span></p><p class="IFUBulletedBodyText2" style="margin-top:0in;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>–    get a new pen and inject the full dose.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     It is normal to see a small amount of insulin left in the pen that you cannot inject.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><b><span style='font-family:"Times New Roman",serif'>Giving your injection</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Inject your insulin as your healthcare professional has shown you.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     Change (rotate) your injection site for each injection.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-17.85pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> try to change your dose while injecting.</span></p><p class="IFUBulletedBodyText" style="margin-left:.25in"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td colspan="2" style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 9:</span></b></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif'>Choose your injection site.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     ABASAGLAR is injected under   the skin (subcutaneously) of your stomach area, buttocks, upper legs or upper   arms.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Prepare your skin as   recommended by your healthcare professional.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> </td> <td style="width:275.4pt;border-top:solid windowtext 1.0pt;   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251708416"><span style="left:0px;position:absolute;left:56px;top:-49610px;width:150px;   height:1px"><img height="1" src="#image98" width="150"/></span></span></p> </td> </tr> <tr> <td colspan="2" style="width:275.4pt;border:none;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 10:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style="position:relative;z-index:251709440"><span style="left:0px;position:   absolute;left:379px;top:-49817px;width:151px;height:1px"><img height="1" src="#image99" width="151"/></span></span><span style='font-family:"Times New Roman",serif'>•     Insert the needle into your   skin.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Push the dose knob all the   way in.</span></p> </td> <td rowspan="3" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"></p> </td> </tr> <tr> <td style="width:203.4pt;border:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="271"> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Continue to hold the dose   knob in and <b>slowly count</b> to 5 before removing the needle.</span></p> </td> <td style="width:1.0in;border:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="96"> <p class="MsoHeader" style="margin-top:6.0pt;page-break-after:avoid"><span style="position:relative;z-index:251710464"><span style="position:absolute;   left:5px;top:-49945px;width:55px;height:1px"><img height="1" src="#image100" width="55"/></span></span></p> </td> </tr> <tr> <td colspan="2" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Do not</span></b><span style='font-family:"Times New Roman",serif'> try to inject your insulin by   turning the dose knob. You will <b>NOT</b> receive your insulin by turning   the dose knob.</span></p> </td> </tr> <tr> <td colspan="2" style="width:275.4pt;border:none;   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText" style="page-break-after:avoid"><b><span style='font-family:"Times New Roman",serif'>Step 11:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Pull the needle out of your   skin.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    A drop of insulin at the   needle tip is normal. It will not affect your dose.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in;page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>•     Check the number in the   dose window</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you see “0” in the dose   window, you have received the full amount you dialled.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you do not see “0” in the   dose window, <b>do not</b> redial. Insert the needle into your skin and   finish your injection.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you<b> still do not</b>   think you received the full amount you dialled for your injection<b>, do not   start over or repeat that injection. </b>Monitor your blood glucose as   instructed by your healthcare professional.</span></p> <p class="IFUBulletedBodyText2" style="page-break-after:avoid"><span style='font-family:"Times New Roman",serif'>–    If you normally need to give   2 injections for your full dose, be sure to give your second injection.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif'>The plunger only moves a little with each injection,   and you may not notice that it moves.</span></p> <p class="IFUBodyText" style="page-break-after:avoid"><span style='font-family:   "Times New Roman",serif;color:black'>If you see blood after you take the   needle out of your skin, press the injection site lightly with a piece of   gauze or swab. <b>Do not</b> rub the area.</span></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251711488"><span style="left:0px;position:absolute;left:80px;top:-50069px;width:135px;   height:1px"><img height="1" src="#image101" width="135"/></span></span></p> </td> </tr> <tr height="0"> <td style="border:none" width="265"></td> <td style="border:none" width="92"></td> <td style="border:none" width="351"></td> </tr> </table><p class="MsoNormal"><b><span lang="EN-GB">After your injection</span></b></p><p class="MsoNormal"><span style="position:relative;z-index:251716608"><span style="position:absolute;left:433px;top:-50572px;width:148px;height:1px"><img alt="Step5a" height="1" src="#image102" width="148"/></span></span></p><br clear="ALL"/><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr style="height:94.55pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:94.55pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   12:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Carefully replace the outer   needle shield.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.75pt 2.15pt 5.75pt;height:94.55pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"></p> </td> </tr> <tr> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   13:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Unscrew the capped needle   and dispose of it as described below (see <b>Disposing of pens and needles</b>   section).</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> store the pen   with the needle attached to prevent leaking, blocking the needle, and air   from entering the pen.</span></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251712512"><span style="left:0px;position:absolute;left:82px;top:-50719px;width:154px;   height:1px"><img alt="Step5b" height="1" src="#image103" width="154"/></span></span></p> </td> </tr> <tr style="height:78.7pt"> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:78.7pt" valign="top" width="367"> <p class="IFUBodyText"><b><span style='font-family:"Times New Roman",serif'>Step   14:</span></b></p> <p class="IFUBulletedBodyText" style="margin-left:.25in"><span style='font-family:"Times New Roman",serif'>•     Replace the pen cap by   lining up the cap clip with the dose indicator and pushing straight on.</span></p> </td> <td style="width:275.4pt;border:none;border-bottom:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt;height:78.7pt" valign="top" width="367"> <p align="center" class="MsoHeader" style="margin-top:6.0pt;text-align:center;   page-break-after:avoid"><span style="position:relative;z-index:251713536"><span style="left:0px;position:absolute;left:37px;top:-50892px;width:232px;   height:1px"><img height="1" src="#image104" width="232"/></span></span></p> </td> </tr> </table><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><b><span style='font-family:"Times New Roman",serif'>Disposing of pens and needles</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Put used needles in a closable, puncture-resistant sharps container.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> recycle the filled sharps container.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Ask your healthcare professional about options to dispose of the pens and sharps container properly.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     The directions regarding needle handling are not intended to replace local, healthcare professional or institutional policies.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><b><span style='font-family:"Times New Roman",serif'>Storing your pen</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p><p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>Unused pens</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Store unused pens in the refrigerator at (2 °C to 8 °C).</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> freeze ABASAGLAR. <b>Do not</b> use if it has been frozen.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Unused pens may be used until the expiration date printed on the label, if the pen has been kept in the refrigerator.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p><p class="IFUHeading1" style="margin-top:0in"><span style='font-size:11.0pt; font-family:"Times New Roman",serif'>In-use pen</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Store the pen you are currently using at room temperature [below (30 °C)] and away from dust, food and liquids, heat and light.</span></p><p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"><span lang="EN-GB">•     Throw away the pen you are using after 28 days, even if it still has insulin left in it.</span></p><p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"></p><p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"><b><span lang="EN-GB">General information about the safe and effective use of your pen</span></b></p><p class="MsoNormal" style="margin-left:.25in;text-indent:-.25in;line-height: normal"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Keep your pen and needles out of the sight and reach of children.</b></span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     <b>Do not</b> use your pen if any part looks broken or damaged.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     Always carry an extra pen in case yours is lost or damaged.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><b><span style='font-family:"Times New Roman",serif'>Troubleshooting</span></b></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     If you cannot remove the pen cap, gently twist the cap back and forth, and then pull the cap straight off.</span></p><p class="IFUBulletedBodyText" style="margin-top:0in;margin-right:0in;margin-bottom: 0in;margin-left:.25in;margin-bottom:.0001pt"><span style='font-family:"Times New Roman",serif'>•     If the dose knob is hard to push:</span></p><p class="IFUBulletedBodyText2" style="margin-top:0in"><span style='font-family: "Times New Roman",serif'>–    Pushing the dose knob more slowly will make it easier to inject.</span></p><p class="IFUBulletedBodyText2" style="margin-top:0in"><span style='font-family: "Times New Roman",serif'>–    Your needle may be blocked. Put on a new needle and prime the pen.</span></p><p class="IFUBulletedBodyText2" style="margin-top:0in"><span style='font-family: "Times New Roman",serif'>–    You may have dust, food, or liquid inside the pen. Throw the pen away and get a new pen. You may need to get a prescription from your healthcare professional.</span></p><p class="IFUBulletedBodyText2" style="margin-top:0in"></p><p class="IFUBodyText" style="margin-top:0in"><span style='font-family:"Times New Roman",serif'>If you have any questions or problems with your ABASAGLAR Tempo Pen, contact your healthcare professional for help.</span></p><p class="IFUBodyText" style="margin-top:0in"></p><p class="MsoNormal" style="margin-right:-.1pt;text-align:justify;text-justify: inter-ideograph;line-height:normal"><b><span lang="EN-GB">This leaflet was last </span><span lang="EN-GB">revised in </span></b></p><p class="MsoNormal" style="margin-top:0in;margin-right:6.0pt;margin-bottom:0in; margin-left:6.35pt;margin-bottom:.0001pt;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
	
</section>
							<!-- sections can repeat as necessary -->
						</Composition>
					</resource>
				</entry>
				
			</Bundle>
		</resource>
	</entry>
</Bundle>